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1. TRANSCRIPTIONAL REGULATION 
 Transcriptional regulation of a gene is a highly sophisticated and precise 
mechanism, extremely accurate and efficient, to ensure not only normal cell life 
cycle but also quick responses to stimulus that threat cell survival. With the aim to 
achieve this goal eukaryotic organisms have developed many check-points to 
precisely regulate the transcriptional events. 
 The first level of transcriptional control will be achieved by selecting the 
right polymerase that is going to transcribe the gene. There are three different RNA 
polymerases, I, II and III, in the cell, which are in charge of transcribing the genetic 
information contained in the DNA into RNA. All three enzymes are highly 
conserved among species and they share common subunits as well as distinct 
subunits that confer them substrate specificity. RNApol I, formed by 14 subunits, 
transcribes large ribosomal RNA genes. RNApol II, composed by 12 subunits, is the 
complex that organizes the transcription of protein-coding DNA and some small 
structural RNA genes. Finally, RNApol III, with 17 subunits, is responsible for 
transcribing tRNA, 5S RNA and other small structural RNA genes. 
The second level of transcriptional control is orchestrated by the binding of 
specific general transcription factors (GTFs), defined as the minimum factors 
necessary for in vitro transcription that regulate the pre-initiation complex (PIC) 
assembly. It is noteworthy PIC formation for the RNApol II, the main responsible of 
transcribing protein-coding genes. 
 A third level of transcriptional control comes by the fact that specific gene 
has to be  turned on and off at the appropriate moment  requiring the presence of 
sequence-specific DNA transcription factors that, by binding directly or indirectly 
through other proteins, can specifically activate mRNA synthesis. Three  non-
exclusive mechanisms may be found: 1) Stimulation of the basic transcriptional 
machinery recruitment, mainly RNApol II and GTFs. 2) Post-translational 
modifications such as phosphorylation and acetylation of the transcription factors 
and co-factors already present in the gene promoter, in order to modulate their 
- 20 - 
 activity. 3) An important regulatory mechanism is achieved by modifying the DNA 
template through the interaction with chromatin modifying and remodelling 
complexes and their targeting to the promoters, either before or after PIC 
association. 
  Although the main regulatory points that initiate gene transcription are 
depicted above, to achieve a functional gene expression are also needed many other 
proteins to regulate the overall process. For instance, to initiate the polymerizing 
activity, RNApol II needs elongation factors as TFIIS, FCP1, P-TEFb, elongins, 
TREX, proteosome components or ELL family of proteins (Shilafard et al., 2003 
and Hartzog et al., 2003) and some  factors to ensure elongation through the 
nucleosomes such as FACT (Facilitate Chromatin Transcription), DSIF (DRB 
Sensitivity Inducing Factor), SPT6, CHD1 and ISW1 (Sims et al., 2004). 
Nevertheless, since these additional regulations regarding the messenger RNA were 
not in focus of the present work,  they will only be mentioned in this introduction.  
1.1. TRANSCRIPTIONAL MACHINERY 
When an intracellular or environmental signal affects the state of a 
regulatory protein, altering its nuclear localization, half-life and/or biological 
activity, it triggers multiple signals that finally converge in the promoters of the 
immediate-early genes activating or repressing the transcriptional machinery. As 
previously mentioned, in protein-coding genes, the main actors for the basal 
transcription are:  RNApol II, GTFs (needed for the polymerase assembly into the 
PIC), the mediator complex (acting basically as a link between the activators and the 
RNApol II) and the DNA sequence-specific transcription factors. Although the 
general transcription machinery is similar for the three types of polymerase, there 
are subtle differences among the process that render each of them specific to a 
certain type of genes. We will focus now on the mechanism of action of the RNApol 
II since the group of genes that have been studied are transcribed by this polymerase.  
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1.1.1 RNA Polymerase II  
 RNA polymerase II is the enzyme responsible to transcribe DNA into 
messenger RNA. RNA polymerase II is indeed a relatively large complex formed by 
12 polypeptide components and with a molecular weight higher than 500 kDa 
(Asturias, 2004). The X-ray analysis of the  RNApol II complex captured in a 
RNApol II-DNA-RNA structure has revealed a feasible mechanism of initiation. 
The active side of the polymerase is located at the bottom of a cleft and is blocked 
by a mobile domain termed the “wall” that is not present in the free enzyme. This 
structure and the fact that, when the domain is present, the cleft is too narrow to 
accommodate double stranded DNA, suggest the idea that this domain will “close” 
the enzyme upon binding and it will be the key to the processivity of the enzyme 
(Cramer et al., 2000). 
 RNApol II needs to be targeted to the promoter by specific transcription 
factors, and it is also necessary, the ordered recruitment of GTFs that will form the 
PIC is also necessary. Smale et al., (2003), in an elegant experiment in vitro using 
core promoter sequences and purified GTFs, demonstrated that stable PIC formation 
was sufficient for basal transcription. The pathway for basal transcription requires 
TATA recognition by TBP (TATA Binding Protein) and the subsequent stabilization 
by TFIIA and TFIID. Later on, TFIIB binds TBP in a process that precedes TFIIF-
RNApol II complex recruitment. At this point, TFIIE binds to the polymerase and 
serves as an anchor for TFIIH (Roeder, 2005; Baek et al., 2006). 
 The answer to the question of why this complex is only enough for basal 
transcription is not yet clear as well as the whole requirements of the transcriptional 
machinery. Nevertheless, it seems that another counterpart in the transcription, the 
mediator complex, may emphasize the process either by facilitating RNApol II 
recruitment and PIC assembly (Yudkovsky et al., 2000) or by facilitating the 
successive rounds of transcription (Mason et al., 2005).   
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 1.1.2 PIC and Mediator Formation 
 Regulation of transcription initiation requires a multisubunit “adaptor” that 
bridges specific DNA-binding transcription factors present in the promoter and/or 
enhancer with the general initiation factors bound to the RNApol II. This adaptor 
has been termed as mediator complex and it was first discovered in yeast and later in 
higher eukaryotes. Mediator complexes from both species is highly conserved and is 
also ubiquitously expressed (Conaway et al., 2005).  
The mediator complex of higher eukaryotes is formed by up to 25 different 
polypeptides. Some of them  are highly homologue to the Sacharomyces cerevisiae 
mediator, (for instance SRB7, MED7, NUT2, SRB10, SRB11) but some others are 
so specific that it is even possible to distinguish between different complexes not 
present in yeast, such as TRAP/SMCC (Gu et al., 1999), ARC, DRIP; CRSP 
(Taatjes et al., 2002) or MED (Sato et al., 2003). As an example of this specificity, 
MED1 is a subunit that mediates interaction with class I and II nuclear receptors and 
seems to be only necessary for activation of genes induced upon ligand binding like 
the thyroid hormone receptor (Zhang et al., 2005). 
The mechanisms by which mediator facilitates transcription are still under 
discussion. For instance, it is not yet clear if the mediator is targeted to the promoter 
before RNApol II, suggesting a role in the holoenzyme recruitment, or after the 
binding of the polymerase, indicating a further influence in PIC assembly and 
stability (Malik et al., 2002; Reeves et al., 2003). Wang et al., (2005) gave a clear 
example of mediator function after RNApol II binding by showing that MED23 (a 
subunit of the complex) directly binds to ELK1 and E1A transcriptional activators 
upon serum induction, and correlating it with the delay between polymerase 
recruitment and transcription process initiation. Struhl and et al., (2005) even 
proposed that, since the mediator recruitment seems to be independent of SWI/SNF 
activity, holoenzyme phosphorylation or recruitment of elongating factors (as NELF 
or DSIF), the mediator could be involved in promoter melting or promoter 
clearance. On the contrary, Baek et al., (2006) based on isolation of complexes 
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mediator-RNApol II, suggested that the  function of the mediator may rather be in 
targeting the polymerase to the promoter. 
 Although the actual mechanism is not clear, Asturias (2004) has suggested a 
molecular mechanism in which  the mediator is recruited to the promoter ahead of 
the RNApol II and exerts a function to anchor for the additional components of the 
PIC (Figure 1). 
 
 
Figure 1. Structural model for Mediator initiation and re-initiation. 
Mediator is recruited to a promoter by activator A1 (1), and will suffer a 
conformational change (2) to allow the binding of transcription factors IIB and 
IID (TBP) (3) and RNAPII–IIF complex (4). DNA strand will reach the 
polymerase active site by the action of TFIIE and TFIIH (5). The holoenzyme 
will escape the promoter leaving the anchor for successive rounds of initiation 
(6, then back to 4).  (Asturias, 2004). 
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 Furthermore, to increase the complexity of the whole process, it have been 
characterized other factors that mediate the process of elongation, (as TFIIS, 
elongins, P-TEFb, proteasome components, etc.). Moreover, since the mechanism 
takes place in a chromatin environment, there are also components as FACT 
(Belotserkovskaya et al., 2003), DSIF, SPT6, ISW1, and others (Sims III et al., 
2004) that are needed to facilitate the process.  
To sum up, RNA polymerase activity in a promoter is a highly orchestrated 
mechanism, still to be uncovered, but for one sure thing which is the cooperation of 
multiple assistants. 
1.1.3. Transcriptional Factor Binding 
 The mechanism by which trans-acting sequence-specific transcription 
factors regulate transcription by binding to cis-regulatory DNA sequences emerged 
in 1979 with the experiments of Tjian. This author purified the adenovirus-simian-
virus S40 (SV40) T antigen protein and realized that it could bind to tandem 
palindromic sequences in gene promoters in a selective manner (Tjian, 1979). In the 
following years many other transcription factors (TFs) were discovered: Engelke et 
al., (1980) found out TFIIIA, which is specific for 5S genes, and Dynan et al., 
(1983) isolated the human SP1 transcription factor and located its binding sequence 
upstream of the transcriptional starting point of various genes.  Nowadays, there are 
multiple transcription factor families known, classified depending on its DNA-
binding motifs, arranged structural protein motifs that interact with exposed surfaces 
of the DNA bases and backbone. 
 Transcription factors are modular proteins, as first described by Brent et al., 
(1985) in experiments in which they constructed a chimera containing the 
prokaryotic transcriptional repressor lexA fused to Gal4 activation domain. This 
construct is able to support the transcription of a yeast promoter containing the lexA 
operator. After those first experiments, it was showed that transcription factors also 
contain repression domains (Uno et al., 2001), domains to interact with MAP 
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kinases, dimerization domains and domains that facilitate interaction with other 
proteins (Buchwalter et al., 2004), giving a higher combinatorial complexity of the 
ways in which these factors can be regulated. 
 Transcriptional factors are usually classified according to their DNA binding 
domain which usually has characteristic amino acid sequences. As shown by X-ray 
crystallography, the most common recognition pattern between a trans-factor and a 
cis-sequence is the interaction of an α-helical domain with around 5 base pairs in the 
DNA major groove (Mueller, 2001). An example of  transcription factor family 
sharing  DNA binding domain is ETS (E twenty six) that contains the helix-turn-
helix binding motive (Mo et al., 2000), able to regulate gene transcription by 
binding to a purine rich sequence GGAA/T and by interacting with several specific 
factors (Oikawa et al., 2003). Another highly abundant motif is the zinc finger, able 
to bind zinc ions through various cysteine and/or histidine residues (Klung et al., 
1995), which is present, for instance, in SP1 (Specificity protein 1, Uno et al., 2001) 
and  in EGR-1 (Early growth response- 1, Kachigian et al., 1995). Other well known 
families are the basic helix-loop-helix proteins, as  HIF (hypoxia inducible factors) 
(Kewley et al., 2004), or the one that contains the basic leucine zipper motif, as 
CREB (cAMP response element binding, Acharia et al., 2006) that usually 
facilitates dimmer formation. 
Transcription factors are regulated by many non-exclusive mechanisms: 1) 
Certain factors are tissue-specific. For example the Germ Cell Nuclear Factor 
(GCNF) member of a nuclear receptor superfamily with restricted expression pattern 
in the adult. (Hummelke et al., 2001). 2) The activity of the factors can be regulated 
by direct modification. For instance, Schiller et al., (2006) demonstrated that 
phosphorylation of CREB at serine 133 is essential for c-fos induction. 3) A 
transcriptional factor can also be activated or inactivated when bound to ligands that 
influence the protein localization and/or its ability to bind DNA. This is the case of 
nuclear receptors as the retinoid X receptor (Moras et al., 1998). 4) The availability 
of the factor can also vary, depending on the circumstances. For instance, some 
factors can dimerize with different partners that, depending on the companion, could 
facilitate transcriptional activation or inhibition. When CREB dimerizes with 
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 CREM, though it can bind the DNA cis-sequence, it becomes inactive (Loriaux et 
al., 1994). Moreover, it could also happen that the synthesis of one of them inhibits 
the synthesis of the other partner. 
 On the other hand, although the inhibition by transcription factors has been 
less studied than their role as activators, it has been demonstrated that in some cases 
the transcriptional inhibition takes place without interfering with the binding of 
other activators or GTFs. 
1.2 CHROMATIN ROLE IN TRANSCRIPTION 
Eukaryotic cells have solved the problem of fitting its large genome (around 
2 m long) inside the nucleus (of around 10 µm of diameter) by creating a compact 
structure of DNA and histone proteins, called nucleosome, which is able to fold into 
more complex structures. The ensemble of DNA, histone and non-histone proteins is 
nowadays named chromatin, a formerly cytological term coined by Flemming 
(1882). Nevertheless, the chromatin structure creates an obstacle for the 
transcriptional machinery, as transcription factors have to gain access to the compact 
DNA template. In order to bypass the transcriptional constrictions, the cell has 
organized the binding of transcriptional activators that target chromatin enzymes to 
the promoters allowing changes in the chromatin accessibility. These enzymes can 
be classified into two main classes: chromatin  modifier complexes and ATP-
dependent chromatin remodelling complexes. Those of the first group covalently 
modify the histones, alter  the overall charge of these highly basic proteins and 
disrupt the chromatin structure. Complexes of the second class use the energy of 
ATP hydrolysis to modify DNA-histone interactions, increasing the accessibility of 
nucleosomal DNA to transcriptional factors and to the transcriptional machinery. 
Furthermore, eukaryotic transcription can also be facilitated by alterations in the 
non-core histone protein content of chromatin (Becker et al., 2002). 
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1.2.1 Chromatin Structure 
Nucleosome, the building block of DNA packing, consists of around 200 bp 
(depending on the organism) a histone octamer formed by a tetramer of H3/H4, two 
dimmers of H2A/H2B and a copy of histone H1. The core nucleosome (Figure 2), 
obtained from extensive chromatin digestion with nuclease, has 147 bp that form 1.8 
turns of superhelix around the histone octamer and lacks histone H1 (Thomas et al., 
1975, Richmond 1985 and Richmond et al., 2003). The latter histone settles in the 
linker DNA, between two consecutive nucleosome cores. 
Octamer histones are highly conserved basic proteins characterized by a 
structural domain composed of a long α-helix separated by β-sheet loops from two 
flanking α-helices called “the histone fold”. This motif is responsible for the 
dimerization of histones through a hand-shake motif in which each monomer 
contacts the other in a head-to-tail orientation (Arents et al., 1991 and Luger et al., 
1997). The N-terminal basic tails of the nucleosome core, rich in lysines and 
arginines, protrude from the octamer of histones and are susceptible of covalent 
modifications. These post-synthetic modifications in the histone tails (acetylation, 
phosphorylation and methylation) and outside the histone tails (ubiquitylation, 
glycosylation, SUMOylation and ADP-ribosylation) are important both for 
transcriptional regulation and for the higher-order chromatin structure condensation 
(Turner, 1993 and Spencer et al., 1999). Zatlanova et al., (1998) showed that these 
histone tails regulate the different folding degree states of chromatin fibres by 
interacting with neighbouring nucleosomes and other proteins as HMGs (High 
Mobility Group). 
Nucleosomes arrange in a filament, which adopts a “beads on a string” 
shape (Figure 2). This filament is further folded to yield an irregular fibre of 30 nm 
of diameter. Although its structure is not fully understood, there is increasing 
evidence that it is shaped as a solenoidal arrangement of nucleosomes. The stability 
of the 30 nm fibre depends on the histone H1 and its variants, which control the 
higher-order structures and also stabilize nucleosomal positioning (Khochbin, 2001 
and Bustin et al., 2005).  
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Figure 2. Chromatin compactation levels. DNA binds to the histone 
octamer to form the nucleosome (X-ray structure in black) and then is 
packed into higher-order structure. Adapted from Luger et al., 1997 and 
Molecular ExpressionsTM.  
 
1.2.2. Chromatin Modifications: The Histone Code Hypothesis 
 As previously described, histones are subject to a huge number of post-
translational modifications that can take place mainly at the N- terminus but also  in 
the central domain and C-terminus of the proteins (Mersfelder et al., 2006). This 
complex process has two consequences. On one side, since histone modifications 
alter the global protein charge modifying DNA-nucleosome interactions, it changes 
the nucleosomal dynamics, rendering the chromatin more fluid, and therefore 
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facilitating the protein accessibility to DNA. On the other side, these modifications 
are essential for transcriptional cofactors recruitment (Cosgrove et al., 2004) and for 
transmission of epigenetic information (Lopez-Rodas et al., 1993). Indeed, the fact 
that side-specific combinations of histone modifications correlate well with 
particular biological functions has lead to the hypothesis of an “histone modification 
code” (Strahl et al., 2000, Jenuwein et al., 2001 and Spotswood et al., 2002) (see 
Table 1). For instance, the combination of H4K8 acetylation, H3K14 acetylation and 
H3S10 phosphorylation is usually associated with active transcription. Conversely, 
trimethylation of H3K9 correlates with transcriptional repression (Lachner et al., 
2001). Regardless of this, the term code may be misleading as, in contrast with the 
general conception of a code, the combination of histone marks does not always 
dictate the same biological function. As an example, H3K9 methylation can in some 
cases be associated with actively transcribed genes (Beisel et al., 2002). 
 The hypothesis of a “histone code” is supported by the existence of histone 
modifying enzymes, such as histone acetyltransferases, histone deacetylases, histone 
methyltransferases and histone kinases that are specifically targeted to certain 
histone residues, with the combined action of cofactors containing binding domains 
able to specifically recognize these modifications. These chromatin modifying 
enzymes, whose substrate specificity is shown in Table 1), are targeted to the 
nucleosome by direct interactions with DNA sequence-specific transcriptional 
regulators. For instance, ETS 2 and SP1 act synergistically to recruit histone 
acetyltransferase p300 to the human interleukin-12 promoter (Sun et al., 2006). In 
the same manner, the modifications that affect the overall nucleosome structure and, 
therefore, the chromatin environment, have to be specifically “read” in order to 
delimit  subdomains suitable to be either transcribed or repressed. This translating 
job is achieved by precise protein domains that are able to recognize and bind 
specifically to modified nucleosomes (Marmorstein, 2001). For example, 
bromodomains are able to recognize acetylated residues on the N-terminal tails of 
the histones, and are often associated with histone acetyltransferases and chromatin 
remodelling complexes (Zeng et al., 2002). Similarly, chromodomains bind to 
methylated residues and are often associated to transcriptional repression by 
inducing chromatin remodelling (De la Cruz et al., 2005). Finally, SANT domains (a 
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 DNA binding domain present in SWI-SNF, ADA, NCoR and TFIIIB) show high 
affinity for unmodified histones (Boyer et al., 2004) whereas SLIDE (SANT-like 
domain) domains interact with DNA (Saha et al., 2006). 
Table 1. Histone H3 and H4 modifications. Site-specific modifications of 
histones are depicted with the enzymes responsible of those modifications and 
their putative functions. Picture adapted from Peterson et al., (2004). 
Histone 
modification Histone Aminoacid Enzyme Function 
T3 ? Mitosis 
S10 TG2, AuroraB,MSK1, MSK2 SNF1 
Immediate-early 
activation. Mitosis 
T11 DLK/ZIP/RSK2 Mitosis H3 
S28 MSK1,MSK2 Mitosis. Immediate-early activation 
Phosphorylation 
H4 S1 ? Mitosis 
K4 ESA1, HPA2 Transcriptional activation 
K9 GCN5, SRC-1, PCAF 
Transcriptional 
activation. Nuclear 
receptor coactivation 
K14 
GCN5, SRC-1, TAF-
1, PCAF, p300, TIP60, 
hTFIIC90 
Transcriptional 
activation. Nuclear 
receptor coactivation 
K18 p300, CBP 
Transcriptional 
activation. DNA 
replication 
K23 p300, CBP Transcriptional activation 
H3 
K27 GCN5 Transcriptional activation 
K5 HAT1, p300, TIP60, ATF2 
Nucleosomal 
assembling, 
transcriptional 
activation 
K8 GCN5, p300, ATF2, PCAF, TIP60 
Transcriptional 
activation 
K12 HAT1, TIP60  Histone assembling 
Acetylation 
H4 
K16 MOF, GCN5, ATF2, TIP60 
Transcriptional 
activation.          DNA 
repair 
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Table 1. Histone H3 and H4 modifications. (Cont.) 
Histone 
modification Histone Aminoacid Enzyme Function 
R2 CARM1 In vitro methylation 
K4(diMe) Active euchromatin 
K4(triMe) 
MLL4, SET1, 
MLL, 
SMYD3,SET7/9 
Transcriptional activation 
and elongation 
K9 
SUV39h1 
SUV39h2, ESET, 
G9A, EZH2,     
Eu-HMTase1 
Pericentric 
heterochromatin DNA 
methylation, Rb mediated 
silencing. Transcriptional 
repression.                  X 
chromosome repression 
R17 CARM17 Transcriptional activation 
K27 EZH2, G9A 
Transcriptional repression, 
Policomb repression.       
X chromosome 
inactivation 
K36 SET2 Transcriptional elongation 
H3 
K79 DOT1p Transcriptional elongation 
R3 PRMT1, PRMT5 Transcriptional activation 
K20 
    
(monoMe) 
PR-SET7 Transcriptional silencing 
Methylation 
H4 
K20(triMe) SUV4-20 Heterochromatin 
Ubiquitylation H3 ? ? Spermatogenesis 
SUMOylation H4 ? UBC9 Transcriptional repression 
 
A final and central aspect of the histone code is the interplay between 
modifications both within the same histone and between neighbouring ones (Figure 
3). For instance, H3K4 methylation is able to block H3K9 methylation, as a cis 
effect by facilitating H3K9 acetylation and therefore generally induces gene 
expression (Zegerman et al., 2002), whereas H2BK123 ubiquitylation precedes and 
facilitates H3K4 methylation (Sun et al., 2002). As a result, the general idea would 
be that an inhibition signal would facilitate other inhibitory signals and the contrary 
would happen for the transcription activating signals. 
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Figure 3. Cross-talk of histone modifications. Modifications that facilitate 
other modifications are represented with a green arrow, while those 
modifications that prevent others to occur are showed in red. Adapted from 
Santos-Rosa et al., (2005). 
1.2.2.1. Histone Acetylation: Histone Acetyltransferases and Histone    
Deacetylase Complexes.  
Histone acetyltransferases (HATs) are enzymes that catalyze the transfer of 
an acetyl group from acetyl-coenzyme A to the ε-amino groups of conserved lysine 
residues that are present in histone tails (Figure 4). This process was generally 
linked to transcriptional activity (Kouzarides, 1999), as the neutralization of the 
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basic charge of the histone tails can alter the higher-order chromatin structure. 
Recently, it has been shown that there is also acetylation of the histones not in the 
tails but in the contact regions with DNA, and therefore it has been hypothesized 
that these modifications could alter the nucleosome stability and therefore facilitate 
the transcription process (Roth et al., 2001). In general, the balance between 
acetylation and deacetylation is involved in processes such as replication and 
nucleosome assembly (Barman et al., 2006), repair and apoptosis (Ikura et al., 
2003), higher-order chromatin packing (Horn et al., 2002) and interactions of non-
histone proteins with nucleosomes (Grant et al., 1999). Even though the main role of 
HATs consist in acetylate histones at particular sites, they can also acetylate other 
proteins such as: transcriptional factors, like SP1, ELK or CtBP2 (Zhao et al., 2006), 
structural proteins, as tubulin (Soucek et al., 2006) or chromatin proteins, as HMG 
(Ueda et al., 2006) and thus, regulate the stability, the ability to bind DNA and, the 
function of these proteins. 
 
Figure 4. HAT and HDAC reactions. Schematic representation of 
nucleosomes in which HAT catalyzes the transfer of an acetyl group from 
acetyl-CoA to ε-amino groups of lysine side chain located in the histone tails. 
HDAC enzymes remove acetyl groups from acetylated lysines with the release 
of acetate. 
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HATs were initially classified according to the subcellular localization of 
the complexes that they form: type A was nuclear (Brownell et al., 1996) and type B 
resided in the cytosol (Allis et al., 1985), but recent studies from Poveda et al., 
(2004) showed that also type B complexes can be found inside the nucleus. 
Nowadays HATs are classified into different families according to the homology of 
structural motifs that they posses (Table 2) (Kurdistani et al., 2003).  
Table 2. Classification and characteristics of HAT families. Table adapted 
from Sterner and Berger (2000); Roth et al., (2001); Yang (2004). 
 Catalytic 
subunit 
Function Substrate HAT 
complex 
Interaction 
with other 
HATs 
Gcn5 Coactivator 
Repair 
H3/H2B 
H4 
SAGA 
ADA 
A2 
SLIK 
SALSA 
p300/CBP 
PCAF Coactivator H3/H4 PCAF p300/CBP 
Hat1 Histone 
deposition 
Chromatin 
assembly 
Gene silencing 
H4/H2A HATB  
Elp3 Elongator/ 
Lysine 
demethylase? 
H3/H4 Elongator  
GNAT 
superfamily 
Hpa2 Unknown H3/H4   
Esa1 Cell cycle 
Repair 
Transcription 
H2A/H4 
H3 
NuA4 
Piccolo 
NuA4 
 MYST 
family 
 
Sas2 Gene silencing H4 SAS  
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Table 2. Classification and characteristics of HAT families. (Cont.) 
 Catalytic 
subunit 
Function Substrate HAT 
complex 
Interaction 
with other 
HATs 
Sas3 Elongation H3 NuA3  
MOF Coactivator H4 MAF2  
Chameau PcG-dependent 
gene silencing 
   
MOZ Coactivator H3/H4   
MORF Coactivator H3/H4   
Tip60 Co-regulator/ 
DNA repair/ 
Apoptosis 
H3/H4 
Androgen 
receptor 
TIP60  
Enok Neuroblast 
proliferation 
   
MYST 
family 
 
Hbo1 Replication H3/H4 ORC  
p300 Coactivator 
E4 ubiquitin 
ligase for p53 
H2A/H2B
/H3/H4 
TFs, E1A 
 PCAF 
GCN5 
P300/CBP 
 
 
 CBP Coactivator H2A/H2B
/H3/H4 
TFs 
 PCAF 
GCN5 
Nut1 Transcription 
initiation 
H3>>H4 Mediator 
RNApol 
II 
 Basal TFs 
 
TAFII250 Transcription 
initiation/ 
Kinase/ 
Ubiquitin ligase  
 TFIID  
Specific 
TFs 
TFIIIC Transcription 
initiation 
H3, 
H4>>H2A 
TFIIIC  
CDY 
 
ATF2 Specific DNA 
TF 
H4/H2B   
CDY Histone to 
protamine 
transition during 
spermatogenesis 
H4   
SRC-1 Coactivator H3/H4  p300/CBP 
PCAF 
ACTR Coactivator H3/H4  p300/CBP 
PCAF 
Nuclear 
Receptor 
Cofactors 
TIF2 Coactivator    
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 The GNAT superfamily (Gcn5-related N-acetyltransferase) is closely related 
to the Sacharomyces cerevisiae GCN5 enzyme. These HATs share four conserved 
domains: acetyl-CoA recognition and binding, nucleosomal recognition and binding, 
protein-interaction and an acetyl-lysine binding domain, the bromodomain (Zeng et 
al., 2002; Ornaghi et al., 1999). This family includes acetyltransferases linked to 
transcriptional initiation (GCN5 and PCAF), elongation (ELP3) and histone 
deposition and telomeric silencing (HAT1). 
  The MYST family (named for its founding members: MOZ, YBF2/SAS3, 
SAS2 and TIP60) is characterized by its methyl-lysine binding domain, the 
chromodomain,  and by its domain bearing zinc-fingers as structural motifs (Brehm 
et al., 2004). Members of the MYST family are involved in transcriptional 
elongation and replication (MOZ) and in transcriptional activation (ESA1) (Grant, 
2001). 
The p300/CBP family comprises the highly related p300 and CBP proteins 
that have a bromodomain and three cysteine/histidine rich domains (TAZ, PHD and 
ZZ) that serve as protein-protein interacting domains. Members of this family are 
coactivators for multiple transcription factors and they can also associate with other 
acetyltransferases, as an indication that multiple HAT enzymes can be recruited to 
the promoter to act synergistically during gene activation. 
Other acetyltransferases are grouped as transcription factors, for example 
TAFII250 or ATF2, as it was described by Naar et al., (2001). 
As histone acetylation is a key feature in organizing gene expression, HATs 
should be tightly controlled by non-exclusive mechanisms. The easiest way of 
regulation is to control the availability of enzyme. For instance Tip60 expression 
increases during DNA-damage (Legube et al., 2002). The regulation of the 
enzymatic activity is another mechanism that can be achieved by two means: post-
translational modifications and interactions of the enzyme with other proteins. The 
histone acetyltransferase CBP is stimulated upon cyclin E/cyclin- dependent kinase 
2 (Aitsi-Ali et al., 1998) and its ability to bind CREB is diminished when 
methylated (Zanger et al., 2001). HATs are usually part of large, multimolecular 
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complexes, which modulate the enzyme specificity by recognizing specific 
nucleosomal modifications (Table 2), but the modulation of this activity through the 
regulation of complex assembly has not yet been observed. On the contrary, there 
are many cofactors that can stimulate the HAT activity and that do not form part of 
the complex (f.i. CBP and p300 are stimulated by SP1, ZTA or ELK1 
phosphorylated (Li et al., 2003)). 
 On the other hand, histone deacetylases (HDACs) are enzymes that catalyze 
the removal of acetyl groups from lysine residues in both histone and non-histone 
proteins (p53, E2F, MyoD) (Hubbert et al., 2002). By this process they reverse the 
action of HATs and, through a subtle balance, they maintain the steady-state levels 
of histone acetylation. Broadly speaking, hypoacetylation has been associated with 
transcriptional repression and gene silencing (Forsberg et al., 2001, Verdin et al., 
2003, Czermin et al., 2003), whereas hyperacetylation is linked to gene activation. 
Mammalian HDACs have been classified into three different subfamilies (I, 
II and III), based on their sequence homology to the yeast HDAC RPD3 (Reduced 
Potassium Dependency 3), HDA1 (Histone Deacetylase 1) and SIR2 (Histone 
Information Regulator 2) (Bjerling et al., 2002 and Fishle et al., 2002). Class I and II 
HDACs, from the different subfamilies, contain a zinc cation in the catalytic site and 
they are sensitive to the inhibitor trichostatin A (TSA), whereas class III HDAC are 
insensitive to TSA treatment and require the coenzyme NAD+ as a cofactor 
(Sengupta et al., 2004). A detailed list of the enzymes that form part of each group 
can be seen in Table 3.  
HDACs have to be localized in the nucleus to be active, but some of them 
(class II HDACs, Table 3) can also be found in the cytosol. Targeting of HDACs 
takes place by a nuclear localisation signal (NLS) or by interacting with other 
proteins that translocate them to the nucleus. The return to the cytosol is achieved 
through a nuclear export signal (NES) (Ruijter et al., 2003). For instance, HDAC1 
and HDAC2 are exclusively nuclear, and HDAC3 even though has NLS and NES is 
always found in the nucleus. On the contrary, HDAC 4, 5 and 7 are able to shuttle in 
and out of the nucleus in response to cellular stimuli. HDAC5 can be found in the 
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 nucleus during muscle cells proliferation, but during differentiation is localized in 
the cytoplasm (Bertos et al., 2001). 
Table 3. Histone deacetylase family members. HDAC families from yeast 
and humans are shown, and they are classified into subfamilies according to 
their homology of sequence. Adapted from Butler et al., 2006 and Blander et 
al., 2004. 
HDAC FAMILY 
HDA1 subfamily SIR2 subfamily Origin 
Class I Class II Unknown Class I Class 
II 
Class 
III 
Class 
IV 
Yeast Rpd3 
Hos1 
Hos2 
Hos3 
Hda1  Sir2 
Hst1 
Hst2 
Hst3 
Hst4 
   
Human HDAC1 
HDAC2 
HDAC3 
HDAC8 
HDAC4 
HDAC5 
HDAC6 
HDAC7 
HDAC9 
HDAC10 
HDAC11 SIRT1 
SIRT2 
SIRT3 
SIRT4 SIRT5 SIRT6 
SIRT7 
 
 Regulation of HDACs is achieved by multiple mechanisms as it is expected 
for proteins that play essential physiological roles. First, HDACs are regulated by 
association with other proteins, which confer the ability to activate or inhibit their 
enzymatic activity (all purified HDACs, except HDAC8, are enzymatically inactive 
(Lee et al., 2004)), and also to target them to the DNA or to the histones that they 
are going to modify (generally HDACs do not possess DNA-binding activity). For 
instance HDAC3 is activated upon binding to SMRT and N-CoR by the deacetylase-
activating domain (DAD) (Guenter et al., 2002). In general, the three proteins that 
can activate class I HDACs (MTA2, CoREST and SMRT/N-CoR) all possess the 
putative DNA-binding domain SANT. However, there are HDAC complexes that do 
not contain SANT domain proteins, as Sin3/HDAC complex, and therefore 
alternative components must substitute for the function of this domain. Some 
HDACs complexes can be seen in Table 4. 
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 Table 4. Histone deacetylase complexes. Examples of HDACs complexes are 
depicted. Adapted from Rietveld et al., (2002) and Hakimi et al., (2005).      
HISTONE DEACETYLASE COMPLEX 
Sin3/HDAC  NCoR-1 NCoR-2 NCoR-3 Mi2/NuRD MeCP2 Co-REST 
     Sin3A 
Sin3B 
HDAC1 
HDAC2 
RbAp48 
RbAp46 
SAP30 
SAP18 
NCoR 
HDAC3 
BRG1 
BAF170 
BAF155 
BAF47 
KAP 
NCoR 
Sin3A/B 
HDAC1 
HDAC2 
RbAp48 
RbAp46 
SAP30 
SAP18 
NCoR 
HDAC3 
TBL-1 
Mi-2b 
MAT2 
HDAC1 
HDAC2 
RbAp48 
RbAp46 
MBD3 
MeCP2 
Sin3A/B 
HDAC1 
HDAC2 
RbAp48 
RbAp46 
SAP30 
SAP18 
Co-REST  
HDAC1 
HDAC2  
Mi-2-like 
MTA-like 
BRAF35 
BHC80 
 
 
A second mechanism by which HDAC activity can be regulated is by post-
translational modifications as phosphorylation or SUMOylation. Brosch et al., 
(1992), showed that histone deacetylase 1 phosphorylation from germinating Zea 
mays embryos causes a change in the substrate specificity of the enzyme. 
Afterwards, Tsai et al., (2002) showed that HDAC2 is phosphorylated at the C-
terminus at serines 422 and 424, and these phosphorylations are needed for its 
association with the corepressors mSin3 and Mi2. As phosphorylation is a reversible 
reaction, HDACs can also interact with phosphatases to remove phosphate groups. 
Canettieri et al., (2003) demonstrated that HDAC1 associates with PP1 and triggers 
dephosphorylation of CREB. 
HDAC activity can be also regulated by conjugation with the small 
ubiquitin-related modifier (SUMO-1) that affects the subcellular localization, the 
protein-protein interaction and the enzymatic activity. HDAC1 (David et al., 2002), 
and HDAC4 (Ling et al., 2004), have been demonstrated to be specific targets of 
SUMO-1. 
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 It has been also suggested that gene expression can affect HDAC activity. 
Consequently, Lagger et al., (2002) showed that HDAC2 and HDAC3 protein levels 
increased in HDAC1-deficient ES cells, suggesting a role for HDAC1 in gene 
expression regulation of other HDACs.   
In the case of SIR2-like HDAC, enzymes that require NAD+ for catalytic 
activity, their regulation can be easily achieved by the availability of this metabolic 
cofactor (Anderson et al., 2003). 
 Finally, regulation of HDACs can be achieved by proteolytic processing too, 
as it is the case for hSIR3 that has to be processed by a matrix processing peptidase 
of the mitochondria to be active (Schewer et al., 2002). 
1.2.2.2 Histone Methylation: Histone Methyltransferases. 
The lysine and arginine residues of the histones can be further modified by 
methylation, in a process carried by a family of enzymes called histone 
methyltransferases (HMTs). HMTs contain a SET domain that transfers methyl 
groups from S-adenosyl-L-methionine (SAM) to lysine residues (Baumbusch et al., 
2001 and Kouzarides, 2002) and to arginine residues (Bedford et al., 2005) in a 
process that increments the hydrophobicity but does not alter the global charge of 
the N-terminus of the histones (Peters et al., 2005).  
There are two main families of HMTs depending on the residue that they 
modify (Table 5). Protein arginine methyltransferase (PRMT) alter arginine 
residues, and they are further classified into class I (rendering mono-methylation and 
asymmetric dimethylation) and class II (rendering mono-methylation and symmetric 
dimethylation). On the other hand, lysine residues can be mono-, di- and tri-
methylated by HMTs, such as Suv39h1. Historically, methyl marks over the histones 
have been considered static modifications, because of the low levels of methyl-
group turnover in chromatin. The recent identification of enzymes that antagonize or 
remove histone methylation has changed this view and now the dynamic nature of 
these modifications is being appreciated. The first experimental evidence for 
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“histone lysine demethylases” appeared when Shi et al. (2004) showed that LSD1 
induces amine oxidation of mono- and di-methylated histone H3 lysine 4 to generate 
unmodified lysine and formaldehyde. Some of the demethylation reactions can be 
seen in Figure 5. 
The finding of demethylase activity came from the identification of JmjC 
(Jumonji-C) domains, which are able to catalyze direct hydroxylation of the lysine 
methylamine group using iron and α-ketoglutarate as cofactors for a reaction that 
produces succinate and carbon dioxide. In this process, the hydroxymethyl group is 
spontaneously lost as formaldehyde to liberate one methyl group (Cloos et al., 2006, 
reviewed by Klose et al., 2007). Kose et al., (2006) suggested that JHDM3A, an 
enzyme containing this domain, is a demethylase of H3 lysine 9 and lysine 36 that 
can also act over trimethyl-lysines. Moreover, the proteins of the JARDID1 family 
have been shown to remove the three methyl groups of H3K4 (Steward et al., 2007, 
Lee et al., 2007, Klose et al., 2007 and Christensen et al., 2007), and the same is 
true for the Saccharomyces cerevisiae (Klose et al., 2007) and Droshophila 
melanogaster homologues (Secombe et al., 2007). 
In addition to the recent demonstration of the existence of demethylases, 
several non-enzymatic mechanisms have been proposed to remove this mark. 
Jenuwein et al., (2001), for instance, proposed a cleavage of the histone N-termini; 
Ahmad (2002) suggested the possibility of histone variant exchange, and Banister 
(2002) hypothesized the destabilization by oxidation or radical attack.  
Histone methylation has been associated to both transcriptional activation 
(Castellano et al., 2006) and repression (Mal, 2006) and its function will depend on 
the methylated residue, the degree of methylation and on the interplay with other 
modifications (Lachner et al., 2003). For instance, Dehe et al., (2006) showed that 
H3K4 tri-methylation is found in active genes, whereas mono- and di-methylation 
are marks mainly restricted to repression. Another association of methylation and 
repression was provided by Datta et al., (2005), who demonstrated that DNA 
methyltransferase 3A can interact physically with BRG1 (a subunit of a chromatin 
remodelling complex) in mouse lymphosarcoma cells, and therefore promote gene 
- 42 - 
 silencing. In general, transcriptional repression is correlated with high levels of tri-
methyl H3K36, H4K20 (Kourmouli et al., 2004 and Chadwick et al., 2004), and 
H3K9 (Scripathy et al., 2006) and low levels of H3K4 methylation and H3K9 
acetylation. This modification pattern provides, for instance, the adequate 
environment for the HP1 interaction with the nucleosome to promote 
heterochromatin formation. Nevertheless, H3K4 tri-methylation has also been 
shown to facilitate NURF (an ATP-driven chromatin remodelling complex, see 
later) recruitment and the consequent gene expression (Wysocka et al., 2006). 
 
Figure 5. Enzymatic mechanism to remove histone methylation. 
Arginine methylation can be cleaved by protein arginine deiminases 
(PADs), orange reaction. Mono- and di-methyl lysines can be removed by 
amine oxidation (green reaction), whereas for tri-methyl lysines a non-
experimentally proved radical attack has been proposed (red reaction). 
(Kubicet et al., 2004) 
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Table 5. List of histone methyltransferases. The Table shows both families of 
histone methyltransferases and also the family of DNA methylases and the proteins 
that bind to methylated DNA. T stands for transcriptional. Adapted from Bedford 
et al., 2005, Freitag et al., 2005 and Turek-Plewa et al., 2005.  
Histone methyltransferase 
 Type   Enzyme Substrate/ Function Complex 
PRMT1 H4/TFs/ T. activation 
PRMT2 Unknown 
PRMT3 TFs 
 
CARM1 H3/ CBP/p300/ TFs 
T. Coactivator 
AR, PCAF, 
NCOA2, P300, 
NUMAC 
Class 
I 
PRMT6 PRMT6/ Fibrillarin  
PRMT5 H4/H2A/H3 /Cell cycle Methylosome 
PRMT7 Fibrillarin 
Arginine 
methyl-
transferase 
Class 
II 
PRMT8 Unknown 
 
Suv39h1 H3K9/H3K27/ T. repression E2F1,E2F4 
Suv39h2 H3K9/H3K27/ T. repression E2F1,E2F4 
G9a H3K9/ T. repression  
Eu-HMTase1 H3K9/ T. repression E2F6 
ESET/SETD
B1 
H3K9/ T. repression SET1/ASH2/ 
HCF1 
Lysine 
methyl-
transferase 
 
H3K4 
MTases 
H3K4/ T.activation SET1, MENIN 
DNMT1 CpG maintenance 
DNMT2 Weak activity 
DNMT3A CpG de novo 
DNMT3B CpG de novo 
DNMT3L DNMT3A-B cofactor 
MBD1 T. repression 
MBD2 T. repression 
DNA 
methyl-
transferase 
 
MBD3 Remodelling (Mi-2/NuRD) 
 
MDB4 DNA mismatch repair 
MeCP1 T. repression 
MeCP2 Co-repressor 
CpG-
binding 
proteins 
 
Kaiso 
complex 
Unknown 
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 1.2.2.3. Histone Phosphorylation 
 The core histones and histone H1 undergo phosphorylation of specific serine 
and threonine residues in the N-terminal domain and, in the case of histone H1, also 
in the C-terminal domain (Davie et al., 1999). This post-translational modification 
has been linked to chromatin condensation (Sarg et al., 2006), DNA repair (Hamada 
et al., 2006) and transcriptional competence of immediate-early genes (Clayton et 
al., 2003).  
 Histone kinases act mainly over serine 10 of H3, but this modification can 
have completely opposite effects on gene expression. On one hand, H3S10 
phosphorylation is necessary to promote chromosome condensation in the 
pericentric heterochromatin (Zeitlin et al., 2001). On the other hand, it leads to 
acetylation of H3K14 and subsequent transcription of immediate-early genes. In the 
literature two kinases of the MAPK pathway, which are directly responsible for this 
modification, have been described. They are called RSK-2 (Ribosomal Stress 
Kinase-2) and MSK-1 (Mitogen and Stress-Activated Kinase-1). The removal of the 
phosphate groups has been linked to PP1 (Protein Phosphatase 1) activity. In the 
same manner, a member of the PI3K (phosphatidylinositol 3- kinase) family has 
been related to phosphorylation of serine 139 of the histone variant H2AX 
(Takahashi   et al., 2005), which also leads to transcriptional activation.  
1.2.2.4 Other Histone Modifications 
 As commented above,  histones can be also modified in specific lysine 
residues by ubiquitin and ubiquitin-like proteins as SUMO. As these modifications 
have been less studied than those mentioned above, it is not clear whether their 
function consists in altering the nucleosomal structure (due to the large size of the 
modifiers) or if it consists in promoting or inhibiting interactions with non-histone 
regulatory proteins. Nevertheless, ubiquitination, a traditional proteins proteolytic 
mark, is generally linked to gene activation as assumed, for instance, by  Briggs et 
al. (2002) and Osley (2004) showing that H2B monoubiquitination precedes H3K4 
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methylation and transcription in yeast. On the contrary SUMOylation is related to 
transcriptional repression by facilitating the association of some co-repressors as the 
Mi-2/NuRD remodelling complex (Gong  et al., 2006) or also competing with the 
ubiquitination. 
1.2.3. Chromatin Remodelling 
Eukaryotic transcriptional machinery faces multiple challenges during 
RNApol II assembly. One of them is to gain access to the DNA template, which is 
folded into compact chromatin fibres. To circumvent this problem, there are a family 
of chromatin remodelling enzymes that can alter histone-DNA contacts in the 
nucleosomal core using the energy of ATP hydrolysis. These complexes are indeed 
implicated in the overall dynamic chromatin structure since they have been linked to 
processes as replication (Zhou et al., 2005), DNA repair and recombination (Shim et 
al., 2005), sister chromatid cohesion (Hakimi et al., 2002) and transposon 
integration (Bachman et al., 2005). 
All these complexes contain an ATPase subunit, that belongs to the 
SWI/SNF superfamily, but they are classified into three subclasses according to their 
sequence similarities and associated domains: SWI2/SNF2 (Switch/sucrose 
nonfermentors), ISWI (Imitation Switch) and CHD (Chromodomain, Helicase 
domain and DNA binding domain) (Allard et al., 2004 and Varga-Weisz et al., 
2006) (for a detailed description of each subfamily, see Table 6). It is important to 
remark the specificity conferred by different subunits of the complex, as different 
experiments have indicated that they do not have redundant functions. Nevertheless, 
not all the complex subunits are indispensable, as in some cases null mice are viable. 
ATP-dependent chromatin remodelling enzymes have also been found to 
associate with chromatin modifying enzymes such as HDACs, as it is the case of 
NuRD complex, or arginine methyltransferases, which can be stably 
coimmunoprecipitated with members of the SWI/SNF complex. Moreover, it has 
been reported that SWI/SNF can take part in the release of RNApol II from paused 
promoters (Serna et al., 2006). 
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 The mechanisms of regulation of these complexes still remains obscure, but 
it seems probably that phosphorylation of some of the subunits will change their 
properties, and although other modifications have not been reported so far, it is 
probable that they take place as well (Becker, 2002). On the other hand, it is also 
remarkable that SWI/SNF ATP-dependent remodelling machines can be tethered to 
gene promoters either by the action of co-factors or by direct interaction with the 
RNApol II or with the mediator machinery (Vignali et al., 2000). 
Table 6. Subfamilies of ATP-dependent chromatin remodelling complexes. 
The subunits of each of the complexes are indicated and also the origin of the 
complex. Adapted from Neely et al., 2002. 
ISWI subfamily of ATP-dependent chromatin remodelling complexes 
Dros. 
NURF 
Dros. 
CHRAC 
Dros  
ACF 
Yeast 
ISW1 
Yeast 
ISWI2 
Human 
RSF 
Human 
CHRAC 
Human 
ACF 
Human 
WCRF 
ISWI 
Nurf55 
Nurf38/
iPPase 
p215 
ISWI 
Acf1 
CHRAC
14 
CHRAC
16 
ISWI 
Acf1 
ISWI1 
p74 
p105 
p110 
ISWI2 
Itc2/ 
p140 
hSnf2h 
p3325 
hSnf2h/ 
hSnf2L 
hACF1/ 
WCRF180 
HuCHRAC
15 
HuCHRAC
17 
hSnf2h/ 
hSnf2L 
hACF1/ 
WCRF 
    180 
 
hSnf2h 
hSnf2L 
WCRF 
180 
hACF1 
SWI2/SNF2 subfamily of ATP-dependent chromatin remodelling complexes 
Yeast  
SWI/SNF 
Yeast RSC Yeast INO80 Dros. Brahma Human SWI/SNF, RSC 
Swi2/Snif2 
Swi1,3 
Snf5,6,11 
Swp82 
Swp73/ 
Snf12 
Swp61/Arp7 
Swp59/Arp9 
Swp29 
TafII30 
Tfg3 
Sht1/Nps1 
Sfh1 
Rsc8/Swh3 
Rsc11/Arp7 
Rsc12/Arp9 
Rsc6,1,2,4,14 
Rsc3,30,5,13 
Rsc7,9,10,15 
 
Ino80 
Arp4,5,8 
Act1 
Rvb1,2 
p90, 100,32,26 
Brm 
OSA/Eyelid 
Snr1 
Bap155/Moira 
Bap55,60,111,74 
β-actin/Bap47 
hBRG1,hBRM 
p270/BAF250/hOSA 
hSNF5/INI1/BAF47 
BAF170,155,60a,57 
BAF53/ArpN 
β-actin 
BAF180 (hRSC  
complex only) 
CHD subfamily of ATP-dependent chromatin remodelling complexes 
Human NURD Human NuRD Human NRD Xenopus Mi-2 
CHD4/MI-2β 
CHD3/MI-2α 
HDAC1/NURD63 
HDAC2/NURD59 
RbAp48/NURD56 
RbAp46/NURD55 
MTA1/NURD70 
CHD4/MI-2β 
HDAC1,2 
RbAp48,46 
MTA2, 
MBD3a, MBD3b 
CHD3,4 
HDAC1,2 
RbAp48 
p70,110 
Mi-2 
Rpd3, p66 
MTA1-like 
MBD3, MBD3LF, 
RbAp48/p46 
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1.2.3.1 Mechanisms of Chromatin Remodelling 
Movement of histone octamers can take place in cis (sliding of a 
nucleosome along the DNA), in tras (relocating the nucleosome into a stretch of 
DNA) (Lorch et al., 1999 and Narlikar et al., 2002) or even  leading to the formation 
of di-nucleosome particles (Fry et al., 2001). The mechanisms by which changes in 
nucleosomal position occur are still under discussion, and many hypotheses have 
been suggested. So far, it is well known  how the remodelling complexes contact the 
DNA template but the mechanisms that they use to catalyze DNA exposure or 
hiding vary in the different complexes, probably due to their diverse subunit 
composition (Saha et al., 2006). Among the mechanisms for remodelling, the most 
accepted ones are the twist defect diffusion and the wave-ratched-wave. The first one 
proposes small local alterations in average DNA twisting that propagate around the 
nucleosome. In contrast, the second model, suggests a DNA wave that is generated 
on the nucleosome surface by pulling DNA from the linker into the nucleosomes 
and which is propagated by diffusion to the distal linker (Saha et al., 2006). 
Unfortunately, these mechanisms assume that the octamer remains unaltered, and 
therefore they do not explain the removal or exchange of dimmers from the octamer 
(Flaus et al., 2004).     
NURF, CHRAC and ISWI can move the nucleosomes in cis in 5’ to 3’ 
direction (Alexeev et al., 2003), whereas SWI/SNF is also able to move them also in 
trans (Whitehouse et al., 1999). SWI/SNF or RSC-disrupted nucleosome 
conformation leaves the histone octamer partially associated with the DNA, and 
therefore increases the accessibility of transcription factors and restriction enzymes. 
It can also render dinucleosome-like species, and the stability of the nucleosome 
particle is reduced. On the contrary, ISWI, NURF and CHRAC complexes seem to 
produce a gradual movement of nucleosomes along DNA, resulting in a more 
modest nucleosome alteration (Vignali et al., 2000). Furthermore, ISWI complexes 
require the N-terminus of histone H4 for a productive ATPase cycle, whereas 
SWI/SNF remodelling complexes can deal with nucleosomes lacking these domains 
(Becker, 2002).  
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 1.2.3.2 Integration of Remodelling Complexes and Other Regulatory 
Complexes 
As already mentioned, chromatin remodelling complexes are required to 
modify the dynamics of certain chromatin regions to facilitate gene expression 
and/or repression. Nevertheless, histone modifying complexes are also required to 
fulfil that role. Therefore, the following question may be posed: for which reason 
remodelling and histone modification are coupled together? It seems that a single 
general response does not exist, but, rather, there is a specific answer for each gene. 
Chromatin modifying enzymes can interact with different proteins (for instance, 
K4H3 methyltransferase MLL1 interacts physically with the remodelling factor 
hSNF5/INI1 (Rozenblatt-Rosen et al., 1998)), but also they can recognize previous 
chromatin modification carried out by other enzymes through different domains (see 
Table 7 for a detailed description of association with other complexes and 
recognition domains). 
When the transcriptional state of a gene is changed, usually by  gene-
specific activator binding or repressor releasing, it triggers a cascade of reactions 
that will end in the appropriate chromatin state suitable for the transcriptional 
machinery access. The question arises as to whether the recruitment of chromatin 
modifying enzymes takes place in a specific order or not. This question is not an 
easy one to answer since  there are examples in which first act the HAT complexes 
and then the remodelling ones and examples in the opposite way. Narlikar et al. 
(2002), trying to encompass both data, have suggested that each promoter will work 
using an order of action of these complexes that differs from promoter to promoter 
although ATP-dependent remodelling complexes and chromatin-modifying enzymes 
can influence each other. 
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Table 7. ATP-dependent nucleosome-remodelling complexes and associated 
modification enzymes. (Cosgrove et al., 2004). 
 Complex Central 
ATPase 
Associated 
Histone 
modification 
enzyme 
Recognition 
domain 
Swi/Snf Snf2 SAGA-Gcn5 Bromo 
hSwi/Snf Bgr1 P300-CBP Bromo 
NURF ISWI P300-PCAF Sant-Bromo 
INO80 ISWI-related NuA4  
Activation 
RSC Sth1 NuA4 Bromo 
NuRD Mi-2 HDAC1 Chromo 
ISW2p ISWI Sin3-RPD3 Sant 
hSwi/Snf Brg1 Sin3-RPD3 Bromo 
hSwi/Snf hBrm Sin3-RPD3 Bromo 
Repression 
NCoRC Snf2H HDAC1 Sant 
1.2.4. Other Mechanisms that Regulate the Function of Chromatin 
 The eukaryotic gene expression, able to respond quickly to a great number 
of internal and external stimuli, can also be regulated by DNA methylation and by 
other less studied mechanisms, as replacement of histone variants or interference 
RNA. All these processes take place under certain circumstances to perform specific 
roles in gene regulation and their deregulation can cause many diseases. As an 
example, the disruption of normal DNA methylation has been suggested as a 
hallmark in tumorigenesis (Esteller, 2006). 
1.2.4.1. DNA Methylation 
 DNA methylation, together with the histone modifications, is a 
component of a program or epigenetic process, that despite the fact that although 
does not alter the genetic material itself, can be inherited by mitotic cell divisions 
(Jaenish et al., 2003). Methylation reaction occurs within CpG sequences at cyclic 
carbon atom 5 of cytosine, and it is carried out by a group of enzymes that are 
summarized on Table 5.  
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 The vertebrate genomes contain between 60 to 90 % of CpGs base pairs in a 
methylated state and is noteworthy that methylation is also found at the promoter 
regions in the so called CpG islands (Heinrich, 1998). The pattern of methylation 
over the CpG islands has been related with transcriptional repression (reviewed in 
Fuks, 2005). Furthermore, DNA methylation is linked to some histone regulatory 
modification, as acetylation or methylation, since that DNA modification is easily 
recognized by methyl-CpG binding proteins, as MeCP2 (Methyl-CpG-Binding 
Protein-2),  a protein that is a subunit of complexes containing SIN3A histone 
deacetylase, and establishing a cooperative system for transcriptional silencing 
(Urnov et al., 2001).  
1.2.4.2. Histone Variants 
 Histones H1, H2A, H2B, H3 and H4 are highly conserved basic proteins 
encoded, generally speaking, by multicopy, intronless genes, expressed during cell 
cycle S phase and transcribed into nonpolyadenylated mRNA.  Except for H4, there 
exist non-allelic variants of the histones, which may exhibit some differences in the 
above mentioned properties of their genes. As there is some terminological 
confusion, we will designate the latter as histone variants, whereas the former will 
be further referred to as canonical histones. Histone variants occupy restricted and 
defined locations in the chromatin (Kamakaka et al., 2006), and they are encoded by 
single-copy intron-containing genes, expressed throughout the cell cycle, and their 
transcripts are polyadenylated. Furthermore, in contrast to canonical histones, they 
are deposited in a replication-independent manner (Saha et al., 2006). 
 All the histones except H4 have some specific variants. Histone H1 has 
sequence variants such as H1º or H5. Histone H2A has the largest number of 
variants, including H2A.Z, macroH2A or H2A-Bbd. Histone H2B, on the contrary, 
has few variants that appear to be restricted to the gametogenesis process. Finally, 
among histone H3 variants, the two major are H3.3 and CENP-A, the latter 
corresponding to the centromeric H3 (Pusarla et al., 2005). 
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It seems to be obvious that the presence of histone variants allows new 
possibilities in the regulation of the genes by further modifying the chromatin 
context, but what is the precise function of these proteins? The answer seems to be 
complex, as each variant has a chromatin effect that is correlated with a different 
function. For instance, H3.3 is mainly found in highly transcriptional active genes,  
favouring a nucleosomal structure that facilitates RNA pol II processivity (Ahmad et 
al., 2002), centromeric H3 variant is required for accurate chromosome segregation 
(Blower et al., 2002) and H2A.X phosphorylation serves as a recruitment mark for 
the DNA repair machinery upon UV irradiation (Paul et al., 2000).   
 
 The deposition of canonical histones takes place during the S phase with the 
help of the chromatin assembly factor CAF-1. On the contrary, histone variants are 
deposited into chromatin independently of DNA replication helped by proteins as 
NAP1, HIRA or HIF1 and  by part of ATP-remodelling complexes. Histone H2A.Z 
can be deposited during and outside S phase helped by NAP1 and by SWR1, a 
SWI/SNF-like ATPase (Kobor et al., 2004; Mizuguchi et al., 2004), showing a 
functional link between histone variants and chromatin modifying enzymes.  
 
Finally, the presence of histone variants has profound consequences on the 
general nucleosome structure. They change the stability of  the core nucleosome by 
changing the general interaction pattern  within the octamer of proteins. For 
instance, a nucleosome containing a histone H2A-Bbd organizes only 118 bp of 
DNA (Bao et al., 2004). They may also affect to the post-translational histone 
modifications as some of the histone variants have larger or shorter N-terminal tails. 
Moreover, nucleosomes with histone variant may expose different surface residues, 
as in the case of macroH2A, in which a long          C-terminal tail extends away from 
the nucleosome facilitating an asymmetrical structure important for transcriptional 
repression (Abbot et al., 2004). Undoubtedly, histone variants may also alter 
chromatin higher-order structures by changing the characteristic packaging of the 
chromatin.  
 
 
- 52 - 
 1.2.4.3. Non-codifying RNAs: interference RNA and microRNAs 
 During the last decade, RNA has emerged as a central player in the 
regulation of both transcriptional processes and chromatin related events. On one 
side, RNA interference can drastically alter gene expression by post-transcriptional 
gene silencing and also by transcriptional gene silencing. On the other side, 
noncoding RNAs are intimately involved in processes as dosage compensation by 
heterochromatin formation and epigenetic changes by inducing DNA methylation 
(Lippman et al., 2004, Tomari et al., 2005 and Matzke et al., 2005).  
 RNA interference is a process in which double-stranded RNA triggers gene 
silencing (Fire et al., 1998) by mRNA specific degradation, translational inhibition, 
changes in the chromatin or a combination of these. Post-transcriptional gene 
silencing  requires Dicer (RNAse III ribonuclease) processing of dsRNA, 
exogenously induced by experimental manipulation, viruses, endogenous parasitic 
elements or repetitive sequences. This enzyme, a member of the RNase III family of 
ribonucleases, converts dsRNA into small interfering RNAs (siRNAs) which will 
then be loaded into the RISC (RNA-induced silencing complex) machinery. The 
RISC is a multisubunit complex that has, among other proteins, Argonaute-2 that 
hold nuclease activity (Liu et al., 2004 and Sen et al., 2006) and releases fragments 
of ~21-23 nt (see Figure 6). 
 
 Furthermore, microRNAs (a family of ~21 nt regulatory RNAs encoded by 
endogenous precursor molecules (Filipowicz et al., 2005; Pfeffer et al., 2004)) 
regulate gene expression by imperfect base pairing to the 3’-untranslated region of 
target mRNAs and inhibit RNA synthesis by an unknown mechanism. Maturation of 
miRNA occurs via Drosha (a RNase III, see Figure 6) that processes in the nucleus 
the long structures into ~ 60-70 nt dsRNA-like hairpins that are further processed in 
the cytoplasm by Dicer into final duplex miRNAs of ~21 nt (Eckstein, 2005). 
miRNAs have been so far implicated in multiple biological processes such as stem 
cell differentiation, organ development, disease, cancer, etc. (reviewed in Zhang et 
al., 2007). 
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Figure 6. Scheme of RNA interference action. ShRNA is processed into 
the nucleus by Drosha and later in the cytosol by Dicer in a process that 
finally produces the mRNA translational repression.  
  
There are many published papers showing that noncoding RNA affects other 
chromatin processes as dosage compensation (Bernstein et al., 2005), centromere 
formation (Volpe et al., 2002) or DNA elimination (Mochizuki, 2004). Although the 
precise mechanisms is still far to be completely known, in some cases it seems to 
involve histone methylases and other chromatin modifying enzymes. For instance, 
dosage compensation in mammals is a process achieved by random inactivation of 
an X chromosome that remains silent for the rest of the cell life. This inactivation is 
initiated at a single site (X inactivation centre) by the production of multiple 
noncoding RNAs. The process is followed by chromatin-remodelling events, 
generation of hypoacetylated forms for H3 and H4, methylation of K9 and K27 in 
H3 and K20 in H4 and by the exchange of histone H2A for macroH2A variant 
(Heard, 2004). How all these complex machineries are coupled together remains to 
be unveiled, but the fact that RNA regulation and chromatin function are linked can 
not be denied.     
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 2. SIGNALLING PATHWAYS 
 
The integrated function of the cells in an organism needs the existence of an 
interactive network of protein kinases and other messenger systems that respond 
quickly to extracellular signals as: cytotoxic drugs, light irradiation, heat-shock, 
osmotic stresses, reactive oxygen species, mitogens, growth factors, inflammatory 
cytokines and so on. Generally, these stimuli are detected by cell surface receptors 
that transmit the signal to cytoplasmatic kinases which by sequential stimulation of 
different signalling cascades specifically amplify the signal. The phosphorylation of 
several transcription factors in the cytoplasm and/or the translocation of protein 
kinases into the nucleus where they can modify both transcription factors and 
chromatin modifying complexes, will finally lead to a genetic regulation of cell 
growth, differentiation, apoptosis, development and so on. 
There are many signal transducing pathways, but the principal ones involved 
in stress response are: the Mitogen-Activated Protein Kinases (MAPK) (Thiel et al., 
2005), Protein Kinase C (PKC), Protein Kinase A (PKA), Phosphatidylinositol 3 
Kinase (PI3-K) and Janus Activated Kinase Signal Transducer and Activator of 
Transcription (JAK-STAT) (Jenkis et al., 2004).  As an example, Cuadrado et al., 
reported the activation of the antioxidant gene heme oxigenase (ho-1) due to SP1 
phosphorylation by PI3K and PKC. 
2.1 MAP KINASES 
Mitogen-activated protein kinases (MAPK) belong to a large highly 
conserved family of serine-threonine kinases that play a pivotal role in multiple 
biological processes and cellular responses to external stress signals by activating 
gene expression. They are ubiquitously expressed and proline-directed. In 
eukaryotes can be distinguished three distinctly regulated MAP kinase cascades: the 
extracellular-signal-regulated kinases (ERK), the c-Jun N-terminal or stress- 
activated protein kinases (JNK or SAPK) and p38 MAPK. Among the distinguishing 
features of MAP kinases are the absence of a regulatory subunit and the direct 
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activation by phosphorylation. There are usually two phosphorylation sites in the 
kinase activation loop, a tyrosine and a threonine, separated by a single variable 
residue (Pearson et al., 2001). 
Although there are different families of MAP kinases, there is an interaction 
among cascades to integrate responses and to moderate outputs, implying as a result 
that some MAPKs have overlapping substrate specificities (Lewis et al., 1998). 
MAPKs form complexes that facilitate their activation, nuclear localization and 
specificity (Choi et al., 1994). 
2.1.1 ERK1 and ERK2 
 ERK1 and ERK2 are proteins of ~40 kDa ubiquitously expressed, although 
their relative abundance depends on the tissue. They are activated by serum, growth 
factors, cytokines, certain stresses and ligands for G protein-coupled receptors 
(GPCRs). The common activation pathway involves a tyrosine kinase receptor in the 
cell membrane that transduces the signal to a monomeric G protein, RAS, with the 
help of adaptor proteins such as SHC or GRB2. These, in turn, activate RAF, that 
leads to the ERK1/2 signal cascade. Diversity is achieved by ERK1 and ERK2 
alternative spliced variants, and also by multiple classes of G protein that leads to 
cell type-specific mechanisms. 
 ERK1 and ERK2 are upstream activated upon dual phosphorylation by 
MEK1 and MEK2, generally speaking MKKs (Wu et al., 1993), which can be 
upstream activated by kinases as RAF, generically termed MEKKs (Figure 7 for a 
more detailed cascade). These kinases can, in turn, act upon different transcription 
factors modifying its activity as ELK1, c-JUN, c-FOS and so on. MSK1, which is 
another kinase implicated in phosphorylation of histone H3, is also a substrate of 
ERK2, therefore implicating this pathway in chromatin regulation (Lee et al., 2006). 
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 To target ERK pathway to different biological events, specific kinase 
inhibitors like PD98959 and U0126 were used. The results demonstrated a role in 
processes such as neurite extension, fibroblast proliferation or circadian rhythm 
(Akashi et al., 2000 and Klemke et al., 1997). Strikingly, knockout mice for MEK1 
are not viable, whereas those for ERK1 can survive with minimal phenotypic 
manifestations (Pearson et al., 2001). 
 
 
 
Figure 7.  MAP kinase cascades. Adapted from Pearson et al., 2001. 
 
2.1.2 JNK/SAPK  
 
 JNK/SAPK kinases are a family encoded by three different genes (mapk8, 
mapk9 and mapk10) with more than 10 alternative spliced variants. Like other MAP 
kinases they are activated by cytokines, certain ligands for GPCRs, serum, growth 
factors and agents that interfere with DNA and protein synthesis. 
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 Activation of the kinases takes place after two phosphorylations on a 
tyrosine and a threonine separated by a proline in the activation loop. These 
phosphorylations are achieved by two different MEKs, MEK4 and MEK7 (Figure 
7). MEK4 is thought to act on the tyrosine, whereas MEK7 would act on the 
threonine residue, suggesting an interaction between the two to achieve the proper 
signalling (Lawler et al., 1998 and Lisnock et al., 2000). Both MEKs can act over 
other substrates as p38, but they prefer JNK/SAP kinases. In the same manner, 
MEK7 has been found to coimmunoprecipitate with MEK1, but the nature and 
function of this interaction remains unclear (Holland et al., 1997). 
 In parallel with ERK1/2, JNK seem to be essential for phosphorylation of 
activating protein 1 (AP1), due to cell stress. All the same, JNK/SAPK are 
responsible for the phosphorylation of transcription factors such as ELK1, c-JUN, 
MEF2, which will finally turn on a certain set of genes. 
2.1.3 p38  
p38 MAP kinase pathway shares many similarities with the other MAP 
kinase cascades above, as it can be activated by cytokines (IL-2, IL-7), hormones, 
growth factors (TGF-β) or different stresses (osmotic, shear or heat-shock). There 
are four p38 MAP kinases identified so far: p38α, p38β, p38γ and p38δ, being 
ubiquitously expressed only the first two. p38γ is expressed in skeletal muscle, and 
p38δ can be found predominantly in the lung, kidney, testis, pancreas and small 
intestine. All of them bear the aminoacid sequence Thr-Gly-Tyr in their activating 
loops and they are activated upon dual phosphorylation on threonine 180 and 
tyrosine 182, by upstream MAPK kinases: MKK3 (preferentially activating p38α 
and p38β), MKK6 and MKK4. The latter, shows higher preference for the JNK 
signalling pathway (Figure 7). A MKK independent mechanism of p38 activation 
involves TAK-1 (transforming growth factor-β-activated protein kinase 1). 
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 Other p38 relatives that contain the TGY activation domain are: ERK6 
reported by Lechner et al., 1996, and stress activated protein kinase-3 (SAPK-3). 
Both of them appear to be homologous and are regulated as described by Cuenda et 
al., by MKK6 phosphorylation. 
 
Despite the clear importance of p38 cascade in processes as inflammation, 
cell growth, cell differentiation or cell death, the physiological role of the different 
p38 isoforms that arise from differential splicing of three genes is still unclear. The 
use of inhibitors as pyridinylimidazole compounds (SB 203580/SB202190) that 
inhibit the catalytic activity of the kinase by competing for binding in the ATP 
pocket, has provided direct evidence of physiological substrates, and was also 
correlated with a blockade of cytokine translation, but with no appreciable effect on 
total DNA, RNA or protein synthesis, giving detail of the importance of p38 cascade 
in certain translational and transcriptional responses. 
 
 All this amplified response of the cell to a certain stimulus is aimed to 
modify a huge number of substrates, and in turn elicit the appropriate response for 
the cell survival. Among the targets of p38 cascade we can find: protein kinases 
(RSK1, RSK2, MSK1-2, MNK1-2, PRAK, MAKAPK-2/3), proteins (Tau, eEF2K, 
SAKS1, CDC25, SAP90, SAP97, α1-synthophin) and transcription factors (ELK1, 
CREB, ATF-2, CHOP, MEF2, MRF4, E47, NF-κB or p53). Simone et al., showed 
that in absence of p38 MAKP signalling, the chromatin of the myogenin and MCK 
promoters was not remodelled in differentiation-promoting conditions. This was 
caused due to the inability of the ATPase subunits of the SWI/SNIF complex, BGR-
1 and BRM to bind the promoter, although the acetylated state of the promoter did 
not change and neither did the recruitment of HATs as p300 or PCAF. This could be 
due to the need of phosphorylation of one or more of the subunits of the complex to 
be phosphorylated for its appropriate activity. It has also been proposed the 
importance of p38 MAPK in the regulation of the recruitment of RNA polymerase II 
at least to muscle-specific promoters. Alepuz et al., (2003) showed that HOG1, the 
yeast homolog to p38 MAPK, interacts and helps in the recruitment of the RNA 
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polymerase II complex to yeast stress-responsive promoters such as STL1, by 
association with the Hot1 transcription factor. 
 
Taken together, the substrate specificity of the different p38 isoforms is 
known to overlap, suggesting the existence of cell-type dependent and isoform-
specific phosphorylation events. 
2.2 OTHER SIGNALLING PATHWAYS 
 MAP kinases are the main responsible for stress response in the cell, but 
there are other families of kinases that can also trigger signalling cascades during 
cellular stress, like JAK/STAT or PI3K.  
Janus Activated Kinase/Signal Transducer and Activator of Transcription 
family of transcription factors, was first involved with interferon and interleukin 
response, but recently it has been shown that they can also respond to biological 
stresses such as hypoxia, U.V. light and reperfusion, appearing to interact in this 
later function with p38 MAP kinase cascade (Dudley et al., 2004). STATs comprise 
a family of seven structurally and functionally related proteins: STAT1, STAT2, 
STAT3, STAT4, STAT5a, STAT5B and STAT6, whereas JAKs represent a family 
of four non-receptor tyrosine kinases: JAK1, JAK2, JAK3 and TYK2. Typically this 
cascade is initiated when a cytokine binds to its receptor, and consequently activates 
it and allows the sequential recruitment of STATs that become phosphorylated on 
tyrosine residues, dimerize and translocate to the nucleus where they activate 
specific target genes. JAK/STAT kinases have been linked to activation of 
transcription factors like SP1 or NF-κB (Kisseleva et al., 2002). 
Phosphoinositide 3-kinases (PI3K) are a family of second messengers that 
generate lipids able to control a wide variety of intracellular signalling pathways. 
They have been divided into three classes, but only those belonging to class I have 
been proved responsible for gene targeting. Class I enzymes are further divided into 
IA (containing p110 as catalytic subunit) and class IB (containing p100γ as catalytic 
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 subunit). Type IA are coupled downstream to tyrosine kinases and Ras, whereas 
type IB are linked downstream to GTPase activating proteins and nucleotide 
exchange factors (Vanhaesebroeck et al., 2005 and Foukas et al., 2003).  
2.3 PHORBOL ESTER SIGNALLING PATHWAYS 
Diacylglycerols (DAGs) are glycerol derivatives in which two hydroxyl 
groups are substituted by fatty acids through ester bond formation, that differ ones 
from the others with respect to the type and degree of saturation of their fatty acid 
moieties. DAGs are essential second messengers in mammalian cells that act 
through different targets such as: PKCs, chimaerins, protein kinase D1 (PKD1), 
RasGRPs, Munc13s and DAG kinase γ (Brose et al., 2002).  
Phorbol esters are polycyclic esters used to mimic diacylglycerol-related 
biological processes, as oxidative stress, tumour progression (Geiger et al., 2003), 
apoptosis (Chang et al., 2006) and so on. Phorbols are polycyclic (four-ringed) 
compounds, and the most widely used are: 4β-12-O-tetradecanoylphorbol-13-acetate 
(TPA), 4β-phorbol-12.13-dibutyrate (PDBu) and phorbol 12-myristate-13-acetate 
(PMA), which differ only in their substitutions at positions 12 and 13 of ring B 
(Figure 8) (Silinsky et al., 2003). The signalling cascade produced by these moieties 
was first identified with the help of inhibitory drugs, and it focused mainly in the 
activation of protein kinase C. Nevertheless, Rambaratsingh et al., (2003) found that 
phorbol ester signalling pathway involved also RasGRP1 in mouse epidermal 
keratinocytes, and Bauer et al., (2005) also referred that the use of phorbol esters 
could act through MEK/ERK signalling pathway. Furthermore, Guo et al., (2005) 
demonstrated that TPA activates p38 kinase through an autophosphorylation 
mechanism. All this controversy in the lack of a characteristic phorbol esters 
signalling pathway could be due to the fact that many cascades converge to achieve 
the final goal, that is to say the cell survival or death, or due to the fact that specific 
signalling will depend on the intrinsic cellular conditions.  
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Figure 8. 4β-12-O-tetradecanoylphorbol-13-acetate (TPA). 
 
3. Egr-1 GENE 
3.1 Egr-1 AS AN EARLY-IMMEDIATE GENE 
Egr-1 (early growth response gene 1), also known as tis8 (tetradecanoyl 
phorbol acetate-induced sequence 8), zif268 (zinc finger binding protein clone 268), 
ngfi-A (nerve growth factor-inducible gene A) or krox-24 (gene containing 
sequences homologous to the Drosophila Kr finger probe) (Christy et al., 1988, 
LeMaire et al., 1988, Lim et al., 1987, Milbrandt et al., 1987 and Sukhatme et al., 
1988),  is a member of the early growth response gene family of transcription 
factors, formed also by EGR-2, EGR-3 and EGR-4. All of them have high homology 
of their DNA-binding motif, a zinc finger domain. WT-1 (Wilm’s Tumour 1) is a 
more distant related member of the family that is responsible, as it name indicates, 
with Wilm’s tumour development in the kidney. Egr-1 expression is quickly elicited 
in response to a wide variety of extracellular signals, including growth factors, 
cytokines, hormones, phorbol esters, irradiation and stresses of many kinds, and it 
shows a robust and transient pattern (usually at 3 h post-induction the mRNA is not 
longer detectable). Egr-1 expression has been linked to cellular growth, 
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 differentiation and apoptosis (Thiel et al., 2002), and therefore serves as a link 
between extracellular signals and long-term cell responses by altering egr-1 target 
genes transcription.   
3.2 CIS ELEMENTS ON THE egr-1 PROMOTER 
 Egr-1 promoter contains among other cis-elements, SREs (Serum response 
element), Ets (E-twenty six), CRE (cAMP response element), GCbox (which binds 
SP1-specificity protein 1-) and EBS (Egr-1 Binding site) in its 5’ region (Figure 9). 
EGR-1 is able to bind to its own promoter and to interact with two co-repressors: 
NAB1 and NAB2. Furthermore, EGR-1 regulates nab2 expression, and therefore is 
able to establish an autoregulatory loop that would control its own expression. 
Besides, Thiel et al., (2002) demonstrated that NAB1 only needs to be recruited to 
the transcription unit either by protein-protein or by DNA-protein interaction to 
repress egr-1 expression. Moreover, egr-1 can be further induced by CREB and/or 
SRFs depending upon the stimulus that has elicited the response. 
SRF is a transcription factor, often activated upon serum stimulation 
(Miano, 2003), that bounds as an heterodimer to the target sequence CC(A/T)6GG 
(CArG), and which needs to form a ternary complex with ETS to be fully active. 
ETS usually have their short DNA-specific binding sequence flanking SREs, so the 
ternary complex can be easily formed, and it also serves to confer specificity to the 
transcription factor. In the same manner, CREB is also capable of forming dimmers, 
and depending on the nature of these dimmers, it exerts its functions as an activating 
or as an inhibiting transcriptional factor. For instance, it can dimerize with CREM to 
act as transcriptional repressor, whereas CREB interaction with ATF2 or another 
CREB molecule enables the dimmer to act as a transcriptional activator (Carlezon et 
al., 2005). In addition, all these transcription factors can be modified by acetylation 
and phosphorylation, as another regulatory way to modify and control their binding 
and activity properties. 
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TGGGCGCTTTGGCAGTGGCGGTTCCCTCGGGACTGCGGGGAAGGCCCAGGCCGCCGCGCC 
TGCTCAGTTCTCCCTCACTGCGTCTAAGGCTCTCCCGGCCTGGCTCCGCGCCCAGCCCAG 
ACTACGGGAGGGGGAACGTGGAGGCGACGGAAGAGCCCGTCGCGCCTGGGGCTCCCGAAA 
TACAACCAGAGACCTACAGAGGGCAGCACCGAGCCGTAAACGGGTCCTCCGCACTGCAAG 
CTTGGGGTCGCCAGACTGCCCAAAGCCAAGTCCCCCTCTTTAGGACAGGGCAGGGTTCGT 
GCCCGACCAGTCCCTGGCCTGGATAAAAGTCAGGAAGTGTCTAACCATCACAAGAACCAA 
CAGATCCTGGCGGGGACTTAGGACTGACCTAGAACAATCAGGGTTCCGCAATCCAGGTCC 
CCAAAGGTGGGATCCTCAACCGCAGGACGGAGGGAATAGCCTTTCGATTCTGGGTGGTGC 
ATTGGAAGCCCCAGGCTCTAAAACCCCCAACCTACTGACTGGTGGCCGAGTATGCACCCG 
ACTGCTAGCTAGGCAGTGTCCCAAGAACCAGTAGCCAAATGTCTTGGCCTCAGTTTTCCC 
GGTGACACCTGGAAAGTGACCCTGCCATTAGTAGAGGCTCAGGTCAGGGCCCCGCCTCTC 
CTGGGCGGCCTCTGCCCTAGCCCGCCCTGCCGCTCCTCCTCTCCGCAGGCTCGCTCCCAC 
GGTCCCCGAGGTGGGCGGGTGAGCCCAGGATGACGGCTGTAGAACCCCGGCCTGACTCGC 
CCTCGCCCCCGCGCCGGGCCTGGGCTTCCCTAGCCCAGCTCGCACCCGGGGGCCGTCGGA 
GCCGCCGCGCGCCCAGCTCTACGCGCCTGGCGCCCTCCCCACGCGGGCGTCCCCGACTCC 
CGCGCGCGCTCAGGCTCCCAGTTGGGAACCAAGGAGGGGGAGGATGGGGGGGGGGGGTGT 
GCGCCGACCCGGAAACGCCATATAAGGAGCAGGAAGGATCCCCCGCCGGAACAGACCTTA 
TTTGGGCAGCGCCTTATATGGAGTGGCCCAATATGGCCCTGCCGCTTCCGGCTCTGGGAG 
GAGGGGCGAGCGGGGGTTGGGGCGGGGGCAAGCTGGGAACTCCAGGCGCCTGGCCCGGGA 
GGCCACTGCTGCTGTTCCAATACTAGGCTTTCCAGGAGCCTGAGCGCTCGCGATGCCGGA 
GCGGGTCGCAGGGTGGAGGTGCCCACCACTCTTGGATGGGAGGGCTTCACGTCACTCCGG 
GTCCTCCCGGCCGGTCCTTCCATATTAGGGCTTCCTGCTTCCCATATATGGCCATGTACG 
TCACGGCGGAGGCGGGCCCGTGCTGTTCCAGACCCTTGAAATAGAGGCCGATTCGGGGAG 
TCGCGAGAGATCCCAGCGCGCAGAACTTGGGGAGCCGCCGCCGCGATTCGCCGCCGCCGC 
CAGCTTCCGCCGCCGCAAGATCGGCCCCTGCCCCAGCCTCCGCGGCAGCCCTGCGTCCAC 
CACGGGCCGCGGCTACCGCCAGCCTGGGGGCCCACCTACACTCCCCGCAGTGTGCCCCTG 
CACCCCGCATGTAACCCGGCCAACCCCCGGCGAGTGTGCCCTCAGTAGCTTCGGCCCCGG 
GCTGCGCCCACCACCCAACATCAGTTCTCCAGCTCGCTGGTCCGGGATGGCAGCGGCCAA 
GGCCGAGATGCAATTGATGTCTCCGCTGCAGATCTCTGACCCGTTCGGCTCCTTTCCTCA 
CTCACCCACCATGGACAACTACCCCAAACTGGAGGAGATGATGCTGCTGAGCAACGGGGC 
TCCCCAGTTCCTCGGTGCTGCCGGAACCCCAGAGGGCAGCGGCGGTAATAGCAGCAGCAG 
CACCAGCAGCGGGGGCGGTGGTGGGGGCGGCAGCAACAGCGGCAGCAGCGCCTTCAATCC 
TCAAGGGGAGCCGAGCGAACAACCCTATGAGCACCTGACCACAG 
 
Figure 9. Promoter sequence of Mouse egr1 gene. To distinguish between 
promoter sequence, and transcriptional and translational start, bases are written in 
black, orange and red respectively. Consensus specific DNA sequences for 
transcriptional factors which have at least 90% homology are highlighted in 
colours:  SP1, EGR1, ETS, SRF, CREB and AP2. Overlapping sequences for two 
transcriptional factors are written in brown. 
 
 
 
3.3 EGR-1 AS A PROTEIN: AN ESSENTIAL TRANSCRIPTION FACTOR 
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  EGR-1 is a protein of ~80 kDa which encodes for a modular transcriptional 
factor. The protein has three different domains: an N-terminus activating domain 
stretching from amino acids 3-281, a central inhibitory domain and a DNA-binding 
domain encoded by three zinc fingers (C2H2 type) (Figure 10). Russo et al., (1995) 
identified the central repressive domain as a binding site for two transcriptional co-
factors: NAB1 and NAB2 (NGFI-A binding proteins 1 and 2) that block the 
biological activity of EGR-1. Other members of the EGR family, posses also zinc 
finger domains, but they differ in the sequences outside of this domain, and therefore 
they have different biological functions.  
 
EGR-1 binds to specific GC rich DNA sequences such as 5’-
GCG(G/C)GGGCG-3’ (Lemaire et al., 1990 and Cao et al., 1990) and 5’-
TGCGTG/AGGCGGT-3’ (Thiel et al., 2002) in a zinc dependent manner. This 
binding site is highly similar to SP1 binding site, and it has been suggested that both 
transcriptional factors may compete for the much alike binding site (Huang et al., 
1997) as it happens for instance, in the promoter of the pdgf A (platelet-derived 
growth factor A) gene. In this particular case, SP1 is displaced from the binding site 
when EGR-1 is synthesized upon stimulation of cells with phorbol esters (Kachigian 
et al., 1995). In contrast, Al-Sarraj et al., (2005) propose that EGR-1 has a distinct 
sequence requirement to bind and activate EGR-1 responsive target genes and 
indeed does not compete with SP1 or SP3 during the binding process. However, 
when the genes contain overlapping SP1/EGR-1 or SP3/EGR-1 binding sites, the 
actual concentration of those different zinc finger proteins decides which 
transcription factor binds.  
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Figure 10. Modular structure 
of EGR-1 (ZIF268) 
transcription factor and 
schematic representation of 
zinc finger-DNA binding. 
 
EGR-1 protein regulation is achieved by post-translational modifications 
such as glycosylation (Hedegen et al., 1998), phosphorylation (Huang et al., 1998 
and Jain et al., 1996), acetylation (Adamson et al., 2005) and polyadenylation 
(Simon et al., 2004). It is also probably that Egr-1 can be further modified by 
SUMOylation (Laura Moro and Elisa Brunelli personal communication).  
Phosphorylation of EGR-1 is achieved by CK II (Casein Kinase II), which can 
phosphorylate all the protein domains, and seems to be involved in a decrease in the 
protein binding affinity, and in the activation of pro-apoptotic genes such as p53 or 
p73 (Mora et al., 2005). Nevertheless, acetylation of EGR-1, which takes place 
under conditions of modest egr-1 induction, promotes stabilization of the protein 
and subsequent induction of proliferative and survival genes. Polyadenylation, on 
the contrary, seems to be involved in nuclear EGR-1 translocation upon light 
stimulus.  
 
EGR-1 protein possesses ambiguous effects, as it can stimulate or suppress 
cell growth depending on the intensity of its induction. For instance, Yu et al. 
(2004), showed that EGR-1 in addition to induce apoptosis can also promote 
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 survival in other cell types by means of activating p21 instead of p53 gene.               
.            
In conclusion, the importance of the transcription factor EGR-1 resides in 
the fact that is responsible for the regulation of multiple cellular processes such as 
cell growth and cell development (review in Yan et al., 2000) and pathologies such 
as cancer (Lucerna et al., 2006), cardiovascular pathologies (Khachigian, 2006) or 
neuronal diseases (Awasthi et al., 2003). Consequently, it is very important to 
elucidate the processes that govern egr-1 expression and therefore regulate the 
protein function as a second messenger. Gene expression is achieved by a 
combination of various chromatin dynamic processes: nucleosome composition, 
modification and repositioning, and hence the regional promoter properties vary 
according to those enzymatic activities, that in turn facilitate the ordered access of 
transcription factors to regulatory regions. The aim of this study was to deepen into 
the knowledge of egr-1 expression in a living cell and consequently, in the 
chromatinic changes that take place in its promoter to achieve a proper induction 
pattern.  
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OBJECTIVES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Eukaryotic gene regulation is a highly precise set of mechanisms, each of 
which has to be tightly regulated in order to ensure the adequate cell response to a 
cellular stimulus. Understanding the way in which those mechanisms take place is 
an important goal, both for the basic molecular knowledge and for the therapeutics 
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 of many diseases.  The coordinated action of signal transduction cascades, 
transcription factor binding and chromatin modifying complexes is fundamental for 
the correct interpretation of the genetic information. So far, there is not a general 
mechanism for gene regulation, as each gene has both general and unique features.  
 
The OBJECTIVES of the present work were aimed at unravelling some of 
the epigenetic mechanisms underlying transcriptional activation and repression of an 
immediate-early gene induced by a cellular stress. 
 
1- The first objective consisted in the selection of an adequate biological 
system useful for the detailed analysis of the temporal events that take 
place during the transcriptional regulation. 
2- The second objective was to address the nature of the signalling cascades 
that transduce the signal from the cell surface to the nucleus, signal that 
in turn regulate the access and binding of the RNA polymerase to the 
gene/s of interest. 
3- Thirdly, we intended to notice which transcriptional factors were 
involved in the regulation of expression of immediate-early genes, and 
whether those transcription factors were post-translationally modified in 
order to exert their function. 
4- As DNA in eukaryotic cells is packed with proteins, the access of the 
transcriptional machinery to it has to overcome this fact, and therefore 
becomes necessary to study the gene regulation in the context of the 
chromatin. As a result, our main purpose was to determine which 
chromatin modifying complexes are needed for the adequate gene 
regulation. Moreover, we will try to correlate those complexes with the 
histone modifications that are taking place during the induction process. 
On the other hand, we are intended to establish the changes in the 
distribution of positioned nucleosomes during the gene induction and the 
specific modifications that may determine this nucleosome remodelling. 
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5- In this objective we pretend to study the effect that the lack of the protein 
synthesized by the gene of interest produces in the biological system 
under study. 
6- In consequence, by combining the data that we have obtained in the 
previous objectives we wish to approach towards a model for egr-1 
epigenetic regulation in MLP29 cell line when it is induced by 12-O-
tetradecanoylphorbol-13-myristate (TPA). 
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MATERIALS AND METHODS 
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 1. BIOLOGICAL MATERIALS 
 
All the experiments carried out in this work to achieve a better 
understanding of gene expression regulation were done with cultured cells. These 
cells, which are grown in vitro, are not longer organized in tissues, so they will 
grow, survive and maintain its function in suspension or attached to an inert surface 
such as a plastic plate. 
 
1.1 CELL CULTURE 
 
  Routinely, cell lines were grown at 37ºC in an humid atmosphere containing 
5% CO2 and media (see Table 8), which depended on the cell type cultured, were 
supplemented with 10% FBS1 (Gibco), 200 mM L-glutamine (Gibco), penicillin 100 
U/ml (Sigma), streptomycin 100 µg/ ml (Sigma) and fungizone 2.5 µg/ ml (Gibco). 
All serum was heat inactivated at 65ºC in a water bath for 30 min. For normal 
maintenance of cells 100-mm culture dishes were used, subculturing (trypsinizing) 
them when they were around 70-80% confluence. Cells were then passed to another 
plate at 1:3-1:5 dilutions, depending again on the cell type. In all the experiments, 
cells used were not older than 10-12 subcultures, as some of the non-commercial 
cell lines lose their properties at longer passes. 
 
Table 8. Cell types and their growing medium. 
Cell line Source Media 
Mouse progenitor 
hepatocyte cell line MLP29 
A gift form PhD. E. Medico and PhD. 
C. Boccacio from the Turin University 
DMEM 
(Sigma) 
Mouse fibroblastic cell line 
C3H/10T1/2 
A gift from PhD. Gorospe from the 
National Institute of Health, Baltimore 
MEM 
(Sigma) 
 
NIH3T3 
European Collection of Cell Cultures 
(E.C.A.C.C.) 
DMEM 
(Sigma) 
 
                                                 
1 When starting with a new cell line it is recommended to first test the serum/s and when the 
result is satisfactory, the same batch should be used in all the experiments that should be 
compared between them.  
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 1.1.1 Cell Trypsinization 
 
Splitting of cells was done every three days. Media were aspirated and cells 
were washed twice with PBS, as serum presence inhibits trypsin activity. 100-mm 
cultured dishes were incubated with 1mL of trypsin solution containing 5.3 mM 
EDTA (Gibco) for 3 to 5 min, depending on the cell type. Then, cells were pipetted 
to disaggregate clumps and diluted with 9 volumes of fresh medium containing 
normal serum concentration to inactivate the trypsin. The wanted dilution was 
achieved by transferring the appropriate volume of the cell solution to new plate 
containing culture medium. 
 
1.1.2 Cell Cryopreservation  
 
Cell lines are finally lost after a high number of passages, even though 
frozen stocks can be obtained by cryopreservation at every passage, and thus the cell 
line can be restored again after a certain number of subcultures. For the 
cryopreservation procedure a subconfluent plate was selected and cells were 
removed by trypsinization and recovered by centrifugation at 1100xg for 5 min at 
room temperature. The pellet was then resuspended in 1.8 mL of medium containing 
20% FBS plus 10% DMSO, to prevent membrane cracking. Cells were then stored 
in cryovials and placed in a container with isopropanol at -80ºC for 1 day (to cool 
down slowly the cells temperature), before being stored in a liquid nitrogen tank. 
 
1.1.3 Reconstitution of  Frozen Cells 
 
A cryovial was removed from the liquid nitrogen tank and thawed slowly. 
Cells were then resuspended in 7 mL of tempered growing medium in order to dilute 
the DMSO as soon as possible and centrifuged at 1100xg for 5 min at room 
temperature. Afterwards, the cell pellet was resuspended with the desired amount of 
serum-containing medium and plated in a culture dish. 
 
 
- 73 - 
 1.2 CELL TREATMENTS 
  
Cells needed for each experiment were plated in parallel and they were 
grown until they reached a confluence of 70-80%. Then, all the dishes were kept 
between 12 and 24 h in serum starvation (0.5% FBS) and after treated with the 
appropriated reagents for the desired period of time. Controls were done by adding 
only the correspondent solvent to the cells (vehicle). 
 
1.2.1 Induction of Oxidative Stress to MLP29 Cell Line 
 
To study the effects of oxidative stress in gene expression, serum-starved 
MLP29 cells were incubated with different agents (see Table 9) in experiments of 
dose-response. After the oxidative agent was selected, time-dependent assays were 
done to see the induction profile.   
 
Table 9.  Agents used for stressing the cells. 
Agent Source Solvent 
Concentration 
range 
Exposure time 
TPA Sigma DMSO 25-100 nM 60 min 
U.V. light ____ ____ 65W/m2 5-15 s 
t-BhP Sigma ____ 25-200 nM 30 min 
Arsenite Sigma H2O 100-400 µM 60 min 
 
 
1.2.2 Drug Treatments to MLP29 Mouse Cell Line 
 
Serum-starved MLP29 cells were grown in 6-well plates and after pre-treated with 
different cell signalling inhibitors for 30 min, except for the experiments with 
cycloheximide in which the treatment was for 1 h (see Table 10), and for PRMT1 
inhibition, in which the three compounds were added to the cells 4 hours before the 
treatment with the phorbol ester. Then TPA was added to the medium until a 50 nM 
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 concentration was reached and kept for 1 hour also in a cell growth incubator. All 
the reagents were prepared as a stock solution, filtered through 0.22 µm pore filter 
and stored at -20ºC until use. 
 
Table 10.  Cell signalling inhibition drugs. 
Drug Source Solvent [ ]  stock [ ] final 
C Vitamin Sigma H2O 0.1 M 1mM 
N-Acetyl-Cysteine Sigma H2O 0.1 M 1mM 
Trolox Calbiochem EtOH 0.1 M 1mM 
STAT3 inhibitor Calbiochem H2O 500 µM 100 µM 
Hypericin (PKC Inh.) Sigma DMSO 2,5 mM 10µM 
PD98059 (MEK1/2 Inh.) Calbiochem DMSO 25 mM 100 µM 
SB203580 (P38 Inh.)  Calbiochem DMSO 25 mM 100 µM 
JNK Inhibitor Calbiochem DMSO 25 mM 100 µM 
ERKs Inhibitor Calbiochem H2O 500 µM 20 µM 
Wortmanin (PI-3K Inh.) Calbiochem DMSO 0.25 mM 1 µM 
H89 (PKA Inh.) Calbiochem DMSO 2.5 mM 10 µM 
NFκB inhibitor Calbiochem H2O 0.5 mM 25 µM 
Cycloheximide (Protein synthesis Inh.) Sigma H2O 6.25 µg/µL 25µg/mL 
Okadaic Acid Sigma EtOH 1.25µM 0.5µM 
DL- Homocysteine (PRMT1 Inh.) Sigma DMSO 0.2 M 2 mM 
Adenosine (PRMT1 Inh.) Sigma DMSO 0.2 M 2 mM 
N-methyl-2-deoxyadenosine  
(PRMT1 Inh.) 
Sigma DMSO 0.2 M 2 mM 
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 2. RNA EXTRACTION FROM CULTURED CELLS 
 
Total RNA isolation is a method used to analyze global expression profiles 
or specific gene expression levels. RNA is extracted with a buffer that contains a 
strong detergent that denatures proteins and thus ensures the rapid inactivation of 
RNases and allows the extraction of protein-RNA complexes. Denatured proteins 
are removed by phenol-chloroform extraction and nucleic acids are precipitated with 
isopropanol. 
  
2.1 TOTAL RNA ISOLATION 
 
Total RNA from 6-well cell culture plate was obtained with the TRIZOL 
method (Chomzynski et al., 1987). Treated cells were washed three times with cold 
sterile PBS. When the PBS was totally aspirated, 1ml of TRIZOL was added and 
cells scraped and transferred to a sterile 2 ml eppendorf tube. After 5 min incubation 
at room temperature, to let the nucleoproteic complexes dissociate, 0.2 ml of 
chloroform were added to each tube. Samples were then vigorously shacked and 
incubated 3 more min at room temperature prior to centrifugation for 15 min at 
12000 rpm at 4ºC. The aqueous phase was collected and mixed with 0.5 ml of 2-
propanol by gently inversion of the tube. Incubation of the mix for 10 min at room 
temperature and then centrifugation for 10 min at 12000 rpm at 4ºC leads to RNA 
precipitation and recovery. Pellets were washed once with 1 ml of ethanol 75%, and 
after dried in the speed-vac for 5 min and dissolved in 30 µl of RNA sterile H2O. 
RNA concentration was estimated by measuring the absorbance at 260 nm and its 
purity double checked by calculating the ratio A260/A280 (RNA was considered pure 
when the ratio was close to 2) and by RNA visualization on agarose formaldehyde 
gel electrophoresis. 
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 2.2 SIZE FRACTIONATION OF TOTAL RNA ON AGAROSE FORMAL-
DEHYDE GEL ELECTROPHORESIS 
 
Electrophoretic RNA fractionation was done according to Sambrook et al., 
1989. To ensure that the RNA mobility depends only on the size of the fragments it 
is needed to destroy secondary structures with formaldehyde, and therefore is not 
possible to use buffers containing amino groups as Tris. 
 
1.2% agarose gel was prepared by melting in water, and after cooling until 
50ºC, 1/10 of MOPS buffer (10mM EDTA, 50mM Na-acetate, 200mM MOPS, 
pH7) and formaldehyde up to 2.2 % were added in a hood. 
 
RNA concentrations were equilibrated by their absorbance at 260 nm, and 
then from 10 to 30 µg of RNA were mixed with 4 volumes of 1.25X loading buffer 
(44% deionised formamide, 5.9% formaldehyde, 20 mM MOPS, 5 mM sodium 
acetate, 1 mM EDTA, 6.4% glycerol, 0.025%(v/v) of saturated aqueous 
Bromophenol blue solution and 0.1 µg/µL ethidium bromide) and they  were 
incubated at 65ºC for 10 min. Samples were chilled on ice and after loaded on their 
respective wells. Electrophoresis was run in MOPS-formaldehyde buffer (1X 
MOPS, 1.1 M formaldehyde) at 5 V/cm, and it was stopped when the Bromophenol 
dye had migrated 10 cm from the edge. Then, the gel was exposed to an UV 
transiluminator and photographed. 
 
2.3 TOTAL RNA RETROTRANSCRIPTION 
 
1 µg of RNA was retrotranscribed to cDNA using Superscript II RNase H- 
(Life Technologies) following the manufacturer’s instructions. Instead of oligo dT, it 
was always used random hexamers (Sigma). Reaction was carried out at 42ºC for 50 
min and the enzyme was heat inactivated at 70ºC for 15 min. 
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 2.4 cDNA ANALYSIS BY SEMI-QUANTITATIVE POLYMERASE CHAIN 
REACTION (PCR) 
 
PCR reaction allows the specific amplification of an exact DNA fragment 
even in the presence of millions of other DNA molecules. The DNA polymerase is 
able to produce the complementary strand of an already existing DNA molecule 
with the only requirements of nucleotides (deoxyadenosine, deoxyguanosine, 
deoxycytidine and thymidine) and primers (small DNA molecules that specifically 
hybridise with the target that is to be amplified). 
 
 cDNA from the samples was amplified by PCR using the oligonucleotides 
from the Table 4 and DNA polymerase Amplitaq (N.E.E.D. S.L.). As an internal 
control, rRNA 18S gene was amplified in the same reaction tube together with the 
gene of interest. To achieve a proportional amplification between the internal control 
and the gene to be studied, the signal of the first was reduced by adding 
oligonucleotides that compete with the ones for rRNA 18S. These competitors have 
the same sequence as the ones that amplify rRNA 18S, but they have the 3’-terminus 
blocked with an amino group, disabling the amplification by the polymerase. The 
proportion of rRNA 18S oligonucleotides and competitors was experimentally 
determined for each gene. PCR conditions are described in Table 12 and the 
annealing temperature for each of the primers is shown in Table 11.  
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 Table 11. Oligonucleotides used for the semi-quantitative and real time 
PCR. The sequence of the oligonucleotides is shown in the Table 12, its 
position from the starting point and also the annealing temperature specific 
for each reaction, except for the real-time, in which the temperature is 
always 60ºC. 
 
Gene Oligo forwd/rev 
Fragment 
size (bp) 
Exon Annealing (ºC) 
Semi-Quantitative PCR 
c-fos 
CGAAAGGGCAGCAGCAGC/ 
GGCCAGATGTGGATGCTTGC 
248 4 55.6 
rRNA 
18S 
TGGTTGATCCTGCCAGTAGC/ 
CTCTCCGGAATCGAA CCCTG 
433 1 
Idem to the gene 
co-amplified 
c-jun 
TCCGCGCCAAGAACTCGGAC/ 
CACTGGGAAGCGTGTTCTGG 
231 1 61.0 
egr-1 
CAGAAGCCCTTCCAGTGTCG/ 
GATGGGTAGGAGGTAGCCAC 
263 2 57.3 
pip92 
ACAAGTGGGCACGCTTGTG/ 
GGCAGCAACTACGACCAGC 
299 1 61.1 
gadd153 
GGGCCAACAGAGGTCACACG/ 
TGGTCTCCACCTCCCTGGTC 
259 4 60.0 
trx 
GGAAGCCTTGGACGCTGC/ 
AAAACTGGAATGTTGGCGTGC 
203 1-3 54.9 
nur77 
ATCCTCCAGCGGCTCTGAG/ 
AGAACTCTGGGCCAGGCTG 
352 2 60.0 
nab2 
CACTTGTGGGCATGGCAAGC/ 
CCCTGACCCAAGCTCTGCAC 
291 2 60.9 
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 Table 11. Oligonucleotides used for the semi-quantitative and real 
time PCR. (Cont.) 
 
Gene Oligo forwd/rev Fragment size (bp) Exon 
Real Time PCR 
c-fos 
AGAGGAAGAGAAACGGAGAATCC/
AGAGGAGCGAGCGACCAA 
76 3 
rRNA 
18S 
CACGGCCGGTACAGTGAAA/ 
AGAGGAGCGAGCGACCAA 
71 1 
gadd153 
CAACAGAGGTCACACGCACAT/ 
CCTGGGCCATAGAACTCTGAT 
69 4 
egr-1 
GCCTCGTGAGCATGACCAAT/ 
ACGATGAAGCAGCTGGAGAAG 
66 2 
nab2 
CACTTGTGGGCATGGCAAGC/ 
GTCATGATCGTCCATCTCAAA 
75 2 
 
 
Table 12. Semi-quantitative and real time PCR conditions for the 
analysis of gene expression. The annealing temperature for the semi-
quantitative reactions is depicted beside the oligonucleotides used in Table 
11. 
 
Semi-quantitative Real Time 
cycles 
Temperature 
(ºC) 
Time 
(min) 
cycles 
Temperature 
(ºC) 
Time 
(min) 
1 93 4 1 93 10 
93 0.5 
annealing 0.5 30 
72 0.5 
40 60 1 
1 72 7 Melting 95-65 30 
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 2.4.1 DNA Agarose Gel 
 
Products from PCR reaction were visualized on agarose gels. Agarose 
(Roche) was dissolved in hot TBE 0.5X (45mM basic Tris, 45mM boric acid and 
1mM EDTA, pH 8.0) and ethidium bromide was added up to 0.1 µg/ml final 
concentration. Solution was poured on the casting tank and when the gel was 
polymerized samples were mixed with the adequate volume of 6X DNA loading 
buffer (40% (w/v) sucrose, 0.25% bromophenol blue in water) and loaded into the 
wells. Gels were run in 0.5 X TBE at 10 V/cm for around 30 min and the bands were 
visualized under UV light. Usually 0.8% and 2% gels were done, and in each case 
molecular weight markers were use to confirm the right size of the products. 
Agarose concentration depended on the size of the fragment that was to be 
visualized; smaller DNA fragments required higher agarose concentrations to 
increase resolution. 
 
2.5 cDNA ANALYSIS BY REAL TIME PCR 
 
Real time PCR allows the detection in “real time” of the amplification of our 
gene of study. For this purpose a fluorescent molecule is released from a quencher 
each time that the polymerase amplifies the fragment of interest, and thus the 
fluorescence that is emitted at each cycle of PCR will be proportional to the amount 
of DNA that is being amplified.  
 
Real time PCR reaction were carried out in ABI GeneAmp 7000 Sequence 
Detection System, (Perkin-Elmer, applied Biosystems). cDNA was amplified using 
the oligonucleotides from the Table 11 and the conditions of Table 12. Each of the 
reactions was done in triplicate and the fusion curves were done with the software 
Dissociation Curves (Applied Biosystems), to ensure that only one fragment is 
amplified. As a loading control rRNA 18S gene was also analyzed. 
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 3. CHROMATIN IMMUNOPRECIPITATION (ChIP) FROM MOUSE 
HEPATOCITE CELL LINE MLP29  
 
Chromatin Immunoprecipitation (ChIP) assay is used to evaluate the 
association of proteins like transcription factors, HATs, HDACs or HMTs 
complexes, with specific DNA regions. The technique requires a formaldehyde 
crosslinking of the proteins with DNA, by means of formamide bond formation, and 
the latter chromatin fragmentation prior to the immunoprecipitation with the desired 
antibody. The segment of the genome associated with the protein is then identified 
by PCR amplification of the DNA present in the immunoprecipitates. 
 
3.1 PREPARATION OF FORMALDEHYDE CROSSLINKED CHROMATIN 
 
The assay was carried out according to a protocol described by Wells et al., 
2002, optimized for mammalian cells. MLP29 cells were grown in 10 cm Petri 
dishes (1X107 cells per dish) until they reached a confluence of approximately 75-
80%. Serum starved cells (12-24 h in 0.5% FBS) were treated with 50 nM TPA 
(Sigma) for the desired times. To fix the samples, growing medium was removed 
and the dishes were incubated with 10 ml of PBS–1% formaldehyde for 4 min at 
room temperature with constant shaking. To stop the crosslinking reaction, glycine 
was added to a final concentration of 0.125 M and cells incubated for 5 min at room 
temperature on continuous agitation. Then attached cells were washed twice with 
ice-cold PBS, scraped and recovered by centrifugation at 1500xg at 4ºC for 5 min. 
The pellet was resuspended in cell lysis buffer (5 mM HEPES, 85 mM KCl, 0.5% 
NP40 pH 8.0) containing 2 µL/mL of protease inhibitor and phosphatase inhibitor I 
and II cocktails (Sigma). Samples were then incubated on ice for 15 min and nuclei 
were recovered by centrifugation at 3500xg for 5 min at 4ºC. The sediment was 
gently resuspended in nuclear lysis buffer (50 mM Tris-HCl, 10 mM EDTA, 1% 
SDS pH 8.1),  aliquoted and stored at -20ºC until use. 
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 3.1.1 Formaldehyde Crosslinked Chromatin Fragmentation 
 
To achieve a good immunoprecipitation, soluble chromatin fragments 
should have an average size around 500 and 600 bp. This population size is obtained 
by a compromise between the time of formaldehyde crosslinking and the number of 
sonications (for optimization see Annex 1). Chromatin pooled from 6 cell dishes was 
sonicated 12 times for 10 s at 37% setting (“Vibra-Cell VCX-500 sonicator”), and 
kept in ice for 1 min between each sonication. Insoluble fraction was discarded after 
centrifuging at 14000xg for 15 min until there was no more pellet. 50 µL aliquot is 
separated to extract and quantify DNA, while another 5 µL diluted 1/100 in 1% SDS 
are taken for a direct measure of the chromatin absorbance at 260nm. The remaining 
sample is then diluted 1:10 with dilution buffer (1.1% Triton X-100, 1.1 mM EDTA, 
167 mM NaCl, 2 µL/mL protease inhibitor and phosphatase I and II cocktails 
(Sigma), 16.7 mM Tris-HCl pH 8.0). These samples can once more be frozen in 
liquid nitrogen and stored at -20ºC until use.  
 
Annex 1: Optimization of the size of the chromatin  
 
Experimental conditions used for the chromatin fragmentation of murine 
MLP29 cells were established by varying the time of formaldehyde exposure and 
also the number of sonications. Excessive formaldehyde crosslinking has the 
disadvantage of giving long chromatin fragments that are hardly broken by 
sonication, and has the risk of coimmunoprecipitate more than one gene, and thus 
give misleading results. It could also have problems for the antibody in recognizing 
the epitope. On the other hand, small fragments of less than 300 bp diminish the 
population than can be immunoprecipitated and difficult the following quantification 
by PCR. As a result a compromise between the fixation time and the number of 
sonications has to be established for ChIP experiments with different cell lines or 
tissues. 
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  As it can be seen in Figure 11, long fixation times (6 min) produce longer 
fragments that can hardly be broken by sonication, whereas shorter incubations with 
formaldehyde (4 min) produces chromatin fragments in the range of 300-1000 bp, 
which is the intended size for the following immunoselection.  
 
 
Figure 11. Chromatin fragmentation 
conditions for MLP29 mouse cell line. 
Samples are formaldehyde crosslinked 
for 2, 4 and 6 min and sonicated for 9, 12 
or 15 times. P100 molecular weight 
markers can be seen in the last line of the 
agarose gel. 
 
 
3.2 REVERSAL OF FORMALDEHYDE CHROMATIN CROSSLINKING 
AND DNA EXTRACTION 
 
50 µL aliquot of sonicated chromatin (section 3.1.1) is diluted to 500 µL 
with TE buffer (1mM EDTA, 10 mM Tris-CL, pH 8). 40 µL/mL of RNase A are 
added to remove RNA from the sample and it is incubated at 65 ºC overnight to 
reverse the crosslinking. Then SDS to a final concentration of 1% and proteinase K 
(100 µg/mL final concentration) is added to the sample in order to deproteinize it for 
1 h at 37ºC. DNA is extracted once with phenol, once with 
phenol/chloroform/isoamyl alcohol (25/24/1) and once with chloroform/isoamyl 
alcohol (24/1). DNA is then precipitated by addition of 2.5 volumes of ethanol and 
1/10 volume of 3 M sodium acetate, pH 5.2 and incubated at -20ºC overnight. The 
pellet is washed with 70% ethanol and resuspended in 400 µL of TE buffer pH 8.0. 
DNA quantification is carried out in a 96-well plate using “Pico Green DNA 
quantification Kit” (Molecular probes) and following the manufacturer’s 
- 84 - 
 instructions. Briefly, a reference curve is obtained by measuring the fluorescence of 
100 µL of increasing amounts of a known λ DNA concentration diluted in TE buffer 
(1 mM EDTA, 10 mM Tris-HCl, pH 7.5) plus 100 µL of Pico Green fluorophor 
(diluted 1/1000 in the same buffer). Fluorescence is recorded with the instrument 
Fujifilm FLA3000 and the results are analyzed with Image Gauge V3.12.software. 
Excitation wave length was fixed at 480 nm and emission wave length at 520 nm. 
The reference curve that correlates the fluorescence with the λ DNA concentration 
was used to interpolate the results of the unknown samples. Comparison between the 
absorbance measurements at 260 nm (of chromatin in 1% SDS) and the results from 
the picogreen (DNA) showed that one unit of absorbance corresponds approximately 
to 15 µg/mL of DNA. Then, in order to determine the size of the chromatin 
fragments, samples were loaded  and were run on a 0.8% agarose gel electrophoresis 
in 0.5X TBE buffer and stained with ethidium bromide (see 2.4.1).  
 
3.3 IMMUNOPRECIPITATION OF CROSSLINKED CHROMATIN 
 
For each immunoprecipitation it was used 3.5 units of absorbance measured 
at 260 nm, which corresponds approximately to 50 µg of DNA. The size of the 
chromatin used was previously checked (see 3.2).  
 
Samples containing the soluble chromatin fragments were thaw on ice and 
then each of them was incubated with 30 µL of protein A/G-sepharose (Amersham 
Biosciences) that had been previously blocked for 3 h with constant shaking at 4ºC 
with 100 µg/mL of sonicated λDNA (Sigma), 100 µg/mL of sonicated and denatured 
λDNA (5 min at 100ºC and then quickly chilled on ice), 1 mg/mL BSA (Sigma) and 
250 mg/mL tRNA (Sigma). After 3 h of this preclearing, which serves to avoid the 
unspecific union of DNA fragments to the sepharose beads, suspensions were 
centrifuged at 14000xg for 1 min and the supernatants were incubated overnight 
with the desired antibody in the adequate concentration (see Table 13) at 4ºC with 
constant shaking. One of the samples, did not contain antibody (No Ab) and serves 
both the bound fraction as control of unspecific binding of the reaction, and the 
unbound fraction as a total input of the reaction. 
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 The following day 50 µL of protein A/G-sepharose, previously blocked as 
before, are added to each of the chromatin samples containing the antibody, and 
incubated for 4 h at 4 ºC on gently rotation. The complex consisting on chromatin 
fragments-antibody-protein A/G-sepharose was recovered by centrifugation at 
14000xg for 1 min, and the supernatant of the sample that did not contain antibody 
was also recovered as the total input fraction and kept until used. Samples were then 
extensively washed with 1 mL of  different buffers; twice with  Low Salt buffer (50 
mM Tris-HCl pH 8.0, 150 mM NaCl, 0.5 % Deoxycolic Acid, 0.1% SDS, 1% NP-
40, 1 mM EDTA), twice with High Salt buffer (50 mM Tris-HCl pH 8.0, 500 mM 
NaCl, 0.5 % deoxycolic acid, 0.1% SDS, 1% NP-40, 1 mM EDTA),  twice with 
LiCl buffer (50 mM Tris-HCl pH 8.0, 1 mM EDTA, 250 mM LiCl, 1% NP-40, 0.5 
% deoxycolic acid) and finally twice with TE buffer pH 8 (Tris 10 mM, EDTA 0.25 
mM). In each of the washes, samples were kept on rotation for 5 min at room 
temperature and sepharose complexes recovered by centrifugation at 14000xg for 1 
min. Chromatin fragments immunoselected were recovered from sepharose beads by 
two consecutive elutions of 10 and 5 min at 65 ºC with 100 µl of freshly made 
elution buffer (100 mM NaHCO3, 1% SDS). Eluted fractions and 1/5 of the input 
fraction, which had SDS added to a final concentration of 1% to correlate with the 
rest of the samples, were incubated overnight at 65ºC to revert crosslinking between 
protein complexes and the DNA. The following day, samples were incubated with 
proteinase K 1µL/100µL for 1 h at 37ºC to deproteinize the samples. DNA was 
purified by PCR purification Kit (Quiagen) following the manufacturer instructions. 
DNA eluted in 60 µl is stored at -20ºC until used.  
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 Table 13.  ChIP Antibodies. Antibodies used for ChIP experiments and the 
quantity used for each one.  
 
Antibody Comercial Reference 
µg  
used 
Antibody Comercial 
Cat. 
number 
µg   
used 
α-SRF Santa Cruz (sc-335) 2 α-H3 K4 Me2 Abcam (ab 7766) 2 
α-SP1 Santa Cruz (sc-59) 2 α- H3 K4 Me3 Abcam (ab 8580) 0.5  
α-Elk Santa Cruz (sc-355) 2 α-H3 K9 Ac Abcam (ab 4441) 2  
α-CREB Santa Cruz (sc-186) 2 α-H3 K14 Ac Upstate (07-353) 1  
α-EGR-1 Santa Cruz (sc-110) 2 α-H3 K18 Ac Abcam (ab 1191) 2 
α-CREB-P Santa Cruz (sc-7978) 2 α-H3 K27 Ac Upstate (07-360) 0.5 
α-Elk-1-P Santa Cruz (sc-8406) 2 α- H3 S10Ph -
K14 Ac 
Upstate (07-081) 2  
α-Nab-1 Santa Cruz (sc-22813) 2 α-H4 K5 Ac Abcam (ab 1758) 2  
α-Nab-2 Santa Cruz (sc-22815) 2 α-H4 K8 Ac Abcam (ab 1760) 2  
α-RNAPol 
II 
Santa Cruz (sc-899) 2 α-H4hiperAc Upstate (06-598) 2 
α-mSin3A Santa Cruz (sc-994) 2 α-H4 K16 Ac Upstate (07-329) 1  
α-Brm Santa Cruz (sc-28710) 2 α--PRMT1 Santa Cruz (sc-13392) 2 
α-Bgr1 Santa Cruz (sc-10768) 2 α-GCN5 Santa Cruz (sc-6304) 2 
α-HDAC3 Santa Cruz (sc-11417) 2 α-CBP Santa Cruz (sc-369) 2 
α-NCoR Santa Cruz (sc-8994) 2     
 
 
3.4 PCR ANALYSIS OF ChIP ASSAY 
 
DNA resulting from each of the immunoprecipitated fractions was analyzed 
by PCR in a Perkin-Elmer 9600 thermocycler (Applied biosystems). Before starting 
with the analysis of the samples, linearity was determined for each input fraction. 
All PCR reactions were performed at the conditions indicated in Table 14, with the 
oligonucleotides from Table 15. 
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 Table 14.  PCR conditions for the analysis of the ChIP fractions. 
Reagent/ 
Source 
Volume 
used 
(µL) 
Final 
concentration Cycles 
Temperature 
(ºC) 
Time 
(min) 
10X Taq 
Buffer 
N.E.E.D. S.L 
2 1X 1 93 4 
MgCl2 
N.E.E.D. S.L 0.6 1.5mM 93 0.5 
25 mM dNTPs/ 
Invitrogen 0.2 250 µM 
Forward oligo  
Isogen-
lifescience 
0.1 0.5µM 
Reverse 
oligo/Isogen-
lifescience 
0.1 0.5µM 
Betaine /Sigma 6 1.5M 
H2O 8  
Taq / N.E.E.D. 
S.L 1 
1U/PCR 
(20µL) 
Annealing 
temperature of 
each primer 
0.5 
2 
Input 
1/2500 
dilution 
35 
72 0.5 
Sample 
2 Immuno 1/30 dilution 1 72 7 
 
 
Table 15.  Oligonucleotides used for the analysis of ChIP results.  
Gene 
name 
Oligo forwd/rev (5’-3’) 
Fragment 
size (bp) 
Annealing 
(ºC) 
α-actin 
CACCTGACCACAGGGCATCC/ 
AACTGGCTCCAAGGCTCACG 
227 58.1 
β-actin 
TCTGGCTTTCCGGCTATTGC/ 
AGTTTTGGCGATGGGTGCTG 
306 59.1 
egr-1 
TTCCCTAGCCCAGCTCGCAC/ 
GAACAGCAGCAGTGGCCTCC 
352 62.5 
nab2 
ACTGCGCTCTCGGCTCACAG/ 
GAGCCTTGGAGAGGCTGCTG 
300 63.4 
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 Products were analyzed in a 1.8% agarose gel, in which the molecular 
marker P100 ladder (Pharmacia Biotech) was also loaded to confirm the size of the 
amplified fragment. The gel is afterwards photographed on an U.V. transiluminator. 
 
Annex 2: Antigen distribution along the promoter 
 
 The intensity of the amplifications of the DNA obtained by ChIP 
experiments depends, among others, on the number of molecules that contain the 
amplicon used. Consequently, the intensity decreases as the amplicons are further 
away from the position recognised by the antibody used in the immunoprecipitation.  
 
 If the size (L) of the chromatin fragments used in the ChIP was to be 
constant, the intensity (I) of the amplification, normalized to 1 for the point where 
the antigen is found, would vary with the distance (d) between the antigen and the 
amplicon used, according to the following linear equation:  
 
 In the case of a ChIP experiment, L is a random variable that we assume 
normally distributed with mean (m) and standard deviation (σ), thus the intensity I, 
which is function of the random variable L, is also a random variable. If we calculate 
the probability density function for the intensity (fI(i)) knowing that L is normally 
distributed, we obtain 2: 
   
 
 This equation, normalized for each value of d, gives the plot in Figure 12, in 
which the wavelength of the colours represented is proportional to the density of 
probability (red colour would indicate the highest probability, whereas violet colour 
would indicate the lowest probability). For this plot, an m of 500 bp and a σ of 167 
                                                 
2 Mathematical equation kindly developed by Francisco José Rodríguez Fortuño.  
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 bp has been used. Note that the mode of I (the value i at which its probability density 
function attains its  maximum  value, and  thus  the  most  likely  outcome in an 
experiment) for a fixed d, does not coincide with the mean of I ( ).
  
       
 
Figure 12. Density function of the intensity probability (fI(i)) for a 
ChIP experiment in which the mean of the fragments used is 500 
bp, and the standard deviation is 167 bp. 
 
 
4. RNAPol- ChIP 
 
RNAPol-ChIP technique, developed by us (Sandoval et al., 2004), consists 
in the detection of the presence of the RNAPol II in the coding region of a gene, 
therefore, allowing knowing the “real time” transcription of a gene. This application 
of the ChIP technique consists in the immunoprecipitation of the samples with an 
antibody that recognizes the RNAPol II, and afterwards the immunoprecipitated 
fragments are amplified in the coding region of the gene (Table 16) and visualized 
- 90 - 
 on 1.8% agarose gels. The only consideration is that the coding sequence that is 
going to be amplified should  reside far enough from the transcription starting point, 
in order to avoid the immunoselection of the RNAPol II that is paused at the 
promoter of some genes. 
  
Table 16. Oligonucleotides used for the analysis of the RNAPol-ChIP. 
Gene 
name 
Oligo ford/rev (5’-3’) 
Product 
extension 
(bp) 
Annealing 
(ºC) 
α-actin 
ATCCTGGCCTCGCTGTCCAC/ 
CACCCTGCAACCACAGCACG 
169 59.8 
β-actin 
ACGCCATCCTGCGTCTGGAC/ 
ATGACCTGGCCGTCAGGC 
226 59.9 
egr-1 
CAGAAGCCCTTCCAGTGTCG/ 
GATGGGTAGGAGGTAGCCAC 
263 57.3 
nab2 
CACTTGTGGGCATGGCAAGC/ 
CCCTGACCCAAGCTCTGCAC 
291 60.9 
 
 
5. NUCLESOME ChIP 
 
This method allows ChIP analysis at nucleosome resolution by taking 
advantage of the fact that micrococcal nuclease (MNase) can efficiently digest 
chromatin to mononuclesomes and thus serves us to study histone modifications and 
factor occupancy on nucleosomes, but not if the factors are recruited to naked DNA 
sequence. It should be noted however that, if two neighbouring nucleosomes are 
bridged via intermediary factors, they are not expected to be resolved. In order to 
investigate individual nucleosomes, the sonication step of the standard protocol is 
replaced by micrococcal nuclease complete digestion of chromatin, in order to 
obtain a population highly rich in mononucleosome-size fragments. 
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 5.1 NUCLEI EXTRACTION 
 
Cell culture dishes were washed once with PBS and then cells were scraped 
with PBS containing 2 µl/ml protease inhibitor cocktail (Sigma), 2 µl/ml 
phosphatase inhibitor cocktail I and II (Sigma) and 10mM sodium butyrate (Sigma). 
Afterwards, cells were centrifuged 5 min at 1800xg and the pellet was resuspended 
in cell lysis buffer, containing also protease and phosphatase inhibitors and sodium 
butyrate and left 15 min on ice. Nuclei were recovered  by centrifuging 5 min at 
3000 rpm, and then washed with digestion buffer I (15 mM Tris pH7.5, 60 mM KCl, 
15 mM NaCl, 3 mM MgCl2, 20% glycerol, 5 mM β-mercaptoethanol, 2 µl/ml 
protease inhibitor cocktail (Sigma), 2 µl/ml phosphatase inhibitor cocktail I and II 
(Sigma), 10 mM sodium butyrate). Then samples were centrifuged 5 min at 3000 
rpm and the pellet was resuspended in digestion buffer I without inhibitors. At this 
stage the absorbance of the sample was measured, so it could be diluted until a 
concentration of 0.25 mg/ml approximately.  
 
5.2 MICROCOCCAL NUCLEASE (MNase) DIGESTION 
 
To digest the chromatin, 300 µl aliquots of the nuclei sample were incubated 
inside a termoblock at 37ºC. For the MNase reaction 3 µl of 0.1 M CaCl2 (1 mM 
final concentration) and 100 U/ml of MNase were added, and the reaction was left to 
proceed for 5 min. In these conditions the product is composed mainly of 
mononucleosomes. Reaction was stopped by addition of EGTA to a final 
concentration of 1.5 mM and incubation of samples on ice. Finally, the sample was 
centrifuged at 14000xg 10 min at 4ºC and the supernatant containing the 
nucleosome fraction was recovered. 10 µl aliquot was used to measure the 
absorbance of the sample at 260 nm, and another 10 µl aliquot were run on a gel to 
visualize the percentage of mono-di and tri-nucleosomes. To the rest of the sample it 
was added 5 mM β-mercaptoethanol, protease and phosphatase I and II inhibitor 
cocktail (Sigma) and spermidine 0.14 mM), in order to protect it from degradation.  
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 5.3 Formaldehyde Mononuclesomal Crosslinking 
 
Nucleosomes were fixed with formaldehyde at 0.5 % final concentration at room 
temperature for 3 min on constant shaking (see annex 3 for time conditions 
optimization). Reaction was stopped by addition of 2.5 M glycine to a final 
concentration of 0.125 M and left for 5 min also on constant shaking. Samples were 
then frozen with liquid nitrogen and stored at -20ºC until use. 
 
Annex 3: Formaldehyde crosslinking optimization 
 
Crosslinking conditions were optimized for the mononucleosomal ChIP to 
ensure that the fixation time was enough to preserve the nucleosomes, but not too 
much as to produce crosslinking between the different nucleosomes. The conditions 
were visualized on a 1% agarose gel stained first with Comassie to see the proteins 
and afterwards with ethidium bromide to see the DNA. As it can be seen in Figure 
13 the optimum time was 5 min. 
 
 
Figure 13. Formaldehyde crosslinking 
conditions for the nucleosomal ChIP.  
MLP29 mouse cell line chromatin 
digested with MNase 100 U/ml was 
formaldehyde crosslinked for 0, 3 and 5 
min and visualized on 2 % agarose gel. 
P100 molecular weight marker can be 
seen in the first well. 
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 5.4 IMMUNOPRECIPITATION OF FORMALDEHYDE CROSSLINKED 
NUCLEOSOMES 
 
The procedure used for the immunoprecipitation of nucleosomes is the same 
as the one described in section 3.3. 
 
5.5 PCR ANALYSIS OF THE IMMUNOPRECIPITATES 
 
DNA fragments from the immunoprecipitation were analyzed by semi-
quantitative PCR and visualized on 2.2% agarose gels run in 0.5X TBE and also by 
real-time PCR to quantify the differences in histone modifications.  
 
 
6. NUCLEOSOMAL POSITIONING IN CELL CULTURE 
 
Identification of nucleosomal position in egr-1 was achieved according to 
the method described by Steward et. al., (2004) with minor variations (see annex 4). 
This technique not only allowed us to determine the position of the nucleosome but 
also to detect the changes that may take place in that position during the induction of 
the gene. 
 
6.1 THEORETICAL PREDICTION OF NUCLEOSOMAL FORMATION 
SITES 
 
As a preliminary study, egr-1 sequence was analyzed to investigate whether 
it contained sequences with a high nucleosome formation potential (NFP). NFP is 
based on an algorithm of the set of nucleosome positioning sequences found in the 
nucleosomal DNA database (Ioshikhes et al., 1993). Two programs were used for 
this purpose: one based on the algorithms derived by Drew and Calladine (Drew et 
al., 1987 and Estruch et al., 1989) and a second which predicts the nucleosome 
position according to the thermodynamic possibility of the twists required for the 
nucleosome formation (Anselmi et al., 2000). 
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 6.2 NUCLEOSOME ISOLATION FROM MLP29 MOUSE CELL LINE 
 
Confluent cells were kept in serum starvation and treated with 50 nM TPA 
for the desired times (0, 15, 30, 60, 180 min) and harvested to obtain pure 
preparations of nuclei. The protocol used to obtain fresh nucleus corresponds to the 
one described in section 6.1, but for this purpose nuclei were resuspended in 5 mL 
of digestion buffer (15 mM Tris-HCl pH 7.5, 60 mM KCl, 15 mM NaCl, 3 mM 
MgCl2, 20% V/V glycerol, 5 mM β-mercaptoethanol and 10 mM sodium butyrate). 
10 µl aliquot of the sample was mixed with 990 µl of 1% SDS and the DNA 
concentration measured with a spectrophotometer. DNA concentration should be 
around 0.3 mg/ml with a 260/280 ratio of 1.4-1.6. After the aliquot is taken, 2 
µL/mL of phosphatase inhibitor cocktail I and II and protease inhibitor cocktail from 
Sigma are added to preserve the sample from degradation. These inhibitor cocktails 
were not added before because their solvent interferes with the absorbance of the 
sample, and thus could give us misleading results. 
 
6.3 NUCLEI DIGESTION WITH MICROCOCCAL NUCLEASE 
 
Aliquots of 80 µg (measured as naked DNA in 1% SDS) of nuclei 
suspension (~ 300 µl) were used for each digestion, and CaCl2 was added to each 
one to reach a final concentration of 1mM prior to the micrococcal nuclease 
treatment, in order to avoid endogenous digestion as much as possible. Digestions 
were carried out by adding 100 U of MNase at 37ºC for 5 min. Reaction was 
stopped by addition of EDTA to a final concentration of 5 mM, SDS at a final 
concentration of 1% and placing the sample on ice for 5 min. DNA is recovered by 
sequential treatment with RNase for 1 h at 65ºC and then with 100 µg/mL of 
proteinase K for 30 min at 37ºC. Nucleosomal DNA is purified by phenolization 
(phenol-phenol/chloroform/isoamyl alcohol-chloroform/isoamyl alcohol (24:1)) and 
precipitation with 2.5 vol of ethanol and 1/10 vol of 3 M sodium acetate at -80ºC. 
The pellet is afterwards dissolved in 30 µL of sterile water. The obtained 
nucleosomal ladder is visualized by loading 2 DNA µg of each sample onto a 1.8% 
agarose gel and staining with ethidium bromide. To determine the correct size of the 
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 fragments a molecular marker p100 (Pharmacia Biotech) was used. Finally, 
fragments of 145-200 bp from each sample were collected by gel purification and 
quantified by using picogreen.  
 
6.4 NUCLEOSOME MAPPING: PCR AMPLIFICATION AND 
QUANTIFICATION 
 
To determine the nucleosomal arrangement in egr-1 promoter, both real-
time and semi-quantitative PCR were used with a set of amplicons spanning the 
region of interest, from the transcription start to -800 (Figure 14 and Table 17). Each 
amplicon was designed to cover approx 100 bp on the template sequence, so that the 
regions of the promoter containing nucleosomes can be amplified if the full template 
is available. As primers of different amplicons do not have similar characteristics, 
and therefore similar efficiency, a control of total undigested DNA, sonicated to 
achieve a size of around 200 bp and purified from the gel with a size in between 150 
and 200 bp, was used to normalise the efficiency of the reaction. 
 
 
 
Figure 14. Schematic representation of amplicons along egr-1 
promoter. The cis-sequences of putative transcription factors are also 
represented in different colours, and TATA box is depicted as a yellow bar. 
 
 
 
 
- 96 - 
 Table 17. Overlapping nucleotides for the analysis of egr-1 promoter. The 
oligonucleotides used for real-time PCR are described in the table with its 
relative position to the starting point. 
 
Name 
Oligo forward/reverse 
(5´-3´) 
Position 
(bp) 
Egr-1 
1/2 
AGGTGGGATCCTCAACCGCA/TGCATACTCGGCCACCAGTC -1006/-894 
Egr-1 
3/4 
CCAGTAGCCAAATGTCTTGGCC/TGAGCCTCTACTAATGGCAGGG -763/-695 
Egr-1 
5/6 
GCCATTAGTAGAGGCTCAGGTC/CGAGTCAGGCCAGGGTTCTA -707/-601 
Egr-1 
7/8 
TTCCCTAGCCCAGCTCGCAC/TCCCAACTGGGAGCCTGAGC -569/-468 
Egr-1 
9/10 
GACCCGGAAACGCCATATAA/AAGCGGCAGGGCCATATT -396/-335 
Egr-1 
11/12 
ATATGGCCCTGCCGCTTCCGGCTC/GTATTGGAACAGCAGCAGTGGCCTC -335/-200 
Egr-1 
13/14 
GGGGCAAGCTGGGAACTCCA/AGAGTGGTGGGCACCTCCAC -286/-184 
Egr-1 
15/16 
CGTCACTCCGGGTCCTCCCG/AGGGTCTGGAACAGCACGGGCC -123/-16 
 
Annex 4: Validation of the method 
 
To validate the method used for mapping the nucleosome position in the 
promoter of egr-1, a DNA bearing 12 repetitions of a region (208 bp) of Lytechinus 
variegatus 5S gene3, whose nucleosomal position is well known (Georgel et al., 
1993), was studied. Amplicons utilized for mapping the region are shown on Table 
18, and the results obtained by semi-quantitative PCR agree with the known 
nucleosomal position. As a control, naked DNA, also from the array, has been 
sonicated and fragments from around 200 bp have been gel purified. As seen in 
Figure 15, primers 1/2, which are located inside the nucleosome region, give higher 
signal than the control, showing a probability higher than random of finding the 
                                                 
3 Kindly provided by Dr. Ramón  Sendra  
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 nucleosome located there. On the contrary, primers 3/4 that require the whole 
internucleosomal region do not give any signal. In the case of primers 5/6, which 
overlap only in part with the internucleosomal region, a signal is detected but it has 
lower intensity than the control in both samples, indicating that the probability of 
finding the nucleosome in that region is lower than hazard.  
 
 
 
Figure 15. Nucleosomal mapping of the reconstituted 5S Lytechinus 
variegatus (sea urchin) gene. Figure A shows the schematic representation of 
the reconstituted gene with a scale bar to indicate the oligonucleotides 
position. Image B shows the result of the semi-quantitative PCR on a 2.0% 
agarose gel. C1 and C2 correspond to two independent naked DNA samples 
sonicated and gel purified to have an average size of 200 bp, whereas M1 and 
M2 correspond to two independent samples of gel purified mononucleosomes 
obtained by MNase I digestion.  
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 Table 18. Overlapping primers used to map the reconstituted 5S 
Lytechinus variegatus (sea urchin) gene with semi-quantitative PCR.  Both 
the sequence and the position related to the starting site are shown in the Table.  
 
Name 
Primer up/dn 
(5´-3´) 
Position 
(pb) 
Genic 
Region 
5s 1/2 
AAGCCGATGACGTCATAACATCCCTG 
ATTCAGCATGGTATGGTCGTAGGCTC 
+25 
+98 
Exon 1 
Exon 1 
5s  3/4 
GCTCGGTTAGTACTTGGATGGGAGA 
CGGCTTATAAATCCCTGGAAGTTATTCG 
+149 
+238 
Exon 1 
Exon 1 
5s 5/6 
GCTGAATATACCGGTTCTCGTCCGA 
GTATTCCCAGGCGGTCTCCCAT 
+101 
+187 
Exon 1 
Exon 1 
 
 
 
7.  DESIGN OF RNA INTERFERENCE FOR EGR-1  
 
RNA interference (RNAi) is a powerful method of knocking down gene 
activity. In mammalian cells introduction of short sequence-specific RNA duplexes 
that are 21-23 nt long is able to initiate post-transcriptional gene knockdown and 
avoid triggering the non-specific effect of the interferon response that may direct the 
cells to apoptosis. The RNAi process takes place by the cleavage of long double-
stranded RNA (dsRNA) into 21-23 nucleotide short (or small) interfering RNA 
(siRNA) duplexes which is carried out by an enzyme called Dicer. The siRNA 
associates with an intracellular multi-protein RNA induced silencing complex 
(RISC), which is responsible for recognizing and cleaving complementary mRNA. 
This is then targeted for degradation and leads to the knock down of post-
transcriptional gene expression in the cell. siRNAs can be transfected into cells 
(chemically synthesized or in vitro transcribed siRNAs) or endogenously expressed 
from vectors like pSUPER (transient expression) or viral vectors (stable expression). 
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 7.1 SELECTION OF TARGET SEQUENCES AND OLIGO DESIGN 
 
Selection of target sequences to clone into pSUPER is similar to the method 
used to select synthetic siRNAs targets. 19 mer oligonucleotides were designed 
using Qiagen siRNA design tool program and sequences were selected based on:  
 
-similar position, of already existing siRNA of the same gene, in different species. 
-sequences flanked in the mRNA with AA at the 5’ and preferable also TT at the 3’ 
-the region at the mRNA to select the 19 nt from, should be preferably in the coding 
region: 100bp from the start or the termination of translation. 
-GC richness should be preferably more than 30%. 
-The 19nt selected should not contain a stretch of four or more Adenines or 
Thymines, as this will give premature termination of the transcript. 
-The sequence should not match any other gene when blasted against the entire 
genome. 
 
Table 19. Target sequences for the siRNA for egr-1 and oligonucleotides used 
to clone into pSUPER. The sequences for the oligonucleotides are in capitals 
while the sequences for cloning are in lower-case. 
 
 
Name Target Sequence Oligonucleotides forward/reverse (5’-3’) 
gatccccGTCGGGCTCCCAGGACTTAttcaagaga 
TAAGTCCTGGGAGCCCGACtttttggaaa 
Sh1egr-1 aacgaagaggcataccaa 
agcttttccaaaaaGTCGGGCTCCCAGGACTTAtctcttgaa 
TAAGTCCTGGGAGCCCGACggg 
gatccccAACGCAAGAGGCATACCAAttcaagaga 
TTGGTATGCCTCTTGCGTTtttttggaaa 
Sh2egr-1 gtgggagggaagtttgccag 
agcttttccaaaaaAACGCAAGAGGCATACCAAtctcttgaa 
TTGGTATGCCTCTTGCGTTggg 
gatccccAAGCTAGATGATGGGGCGAttcaagaga 
TCGCCCCATCATCTAGCTTtttttggaaa 
Scrbl ggaattcagcgtagctgact 
agcttttccaaaaaAAAGCTAGATGATGGGGCGAtctcttgaa 
TCGCCCCATCATCTAGCTTggg 
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 Once the three target sequences were selected (Table 19) they were used to 
design the oligonucleotides used to clone into the pSUPER vector (Table 19). As a 
non-interfering vector was used a non-codifying sequence (scrbl) and as an 
additional control sh1egr-1 sequence was mutated in three positions to ensure that it 
did not worked (sh1egr-1mut).  
 
7.2 CLONING THE OLIGOS INTO PSUPER 
 
7.2.1 Insert Preparation 
 
Each pair of oligonucleotides, HPLC purified, was dissolved in the right 
amount of water to achieve 1 mM scale. 1µl of each one (forward and reverse) was 
added to 48 µl of freshly made annealing buffer (100 mM potassium acetate, 30 mM 
HEPES-KOH pH 7.4, 2 mM Mg-acetate) and incubated for 4 min at 95º C to destroy 
any secondary structure they may form. Then they were incubated for 10 min at 
70ºC to let them hybridize and slowly cooled down to 4 ºC. The annealed 
oligonucleotides were phosphorylated by the T4 polynucleotide kinase (New 
England Biolabs), following the manufacturer instructions, and stored at -20ºC until 
use. 
 
7.2.2 Vector Preparation 
 
pSUPER (Figure 16) was digested with BglII-HindIII and CIPed, using 
CIAP from Biotools. In doing this, the 5’-P groups from the linear plasmid are 
removed and therefore the religation with itself becomes more difficult. The sample 
was purified by gel extraction before to use it the ligation reaction. Ligation was 
done with 1 µl of ligase (Invitrogen) and leaving the reaction at room temperature 
overnight. 
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Figure 16. pSUPER 
vector.  Schematic 
representation of pSUPER 
vector used to transiently 
transfect cells with RNA 
interference for EGR-1. 
Below there is an example 
of the sequences used in the 
experiment. Target 
sequence is depicted in 
orange, whereas the 
sequences in black are 
responsible for the short 
hairpin formation. 
 
 
7.2.3 Ligation Reaction 
 
Ligated plasmid was used to transform competent bacteria. Bacteria were 
grown and use to plate a LBA Petri dish for screening of single colonies. Around 5 
of the grown colonies were tested in each case for the correct insert, by double 
digesting them with EcoRI and HindIII. Positive clones should have inserts around 
360 bp, and empty ones should have around 300 bp long fragment. 
 
7.2.4 Bacterial Transformation 
 
Genetic manipulations require large quantities of DNA. One of the easiest 
ways to get high amounts of DNA is to place the desired DNA into bacteria, allow 
them to grow and after harvest the bacteria and isolate the DNA. The transformation 
process consist in the uptake of a plasmid (which contains the desired DNA and a 
gene that gives resistance to an antibiotic), from a competent bacteria. Bacteria are 
later selected by plating then on agar plates that contain the antibiotic to which they 
are resistant. 
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 7.2.4.1 Competent Bacteria Production for Thermal Transformation  
 
100 ml of Dh5α bacteria were grown overnight, and 1 ml of the stationary 
culture in LB was seeded in 300 ml of LB. The culture was let to grow at 37ºC till it 
reached an A660 between 0.3 and 0.4 (around 2-4 h). Afterwards, culture was cold on 
ice for a couple of min and then it was centrifuged for 10 min at 3500 rpm. The 
pellet was resuspended in 20 ml of cold medium RF1 (0.1 M ClRb, 50 mM 
Cl2Mn.2H2O, 10 mM CaCl.2H2O, 15% glycerol, 30 mM potassium acetate, pH 5.8 
achieved with acetic acid 0.2 M), and the bacteria were left 30 min on ice. Bacterial 
suspension was centrifuged again for 10 min at 3500 rpm and afterwards the pellet 
was resuspended in 3 ml of cold RF2 (10 mM ClRb, 75 mM Cl2Ca.2H2O, 15% 
glycerol, 10 mM MOPS, pH 6.8 achieved with NaOH). Bacteri were left on ice for 
15 min and aliquots of 50 µl were prepared to freeze them quickly in an acetone bath 
containing dry ice. Stocks were kept at -80ºC. 
 
7.2.4.2 Thermal Bacterial Transformation 
 
Frozen competent bacteria (Dh5α) were thaw in ice, and an amount of DNA 
between 0.1 to10 ng, in a volume not higher than 5 µl, added and mixed by slow 
rotation of the tube on the ice. Competent bacteria were left on ice for 30 min, and 
meanwhile 1 ml of LB was warmed at 37 ºC for each transformation. Then, bacteria 
were heated at 42ºC for 40 s. After the thermal shock bacteria were left 2 min on ice, 
and then 1 ml of preheated LB was added and kept for 1 hour at 37ºC in slow 
agitation. 100 µl from the grown cell culture were plated in a Petri dish with 
ampicilline (100 µg/ml). It is important to remember to have a negative control 
(competent bacteria without DNA insert that have followed the same treatment). 
Plate dish were grown at 37ºC overnight. The following morning there will be only 
colonies in the transformed plate and no colonies on the negative control. 
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 7.2.4.3 Preparation of Electrocompetent Bacteria 
 
Single E. coli colony was selected from a fresh LB plate inoculated the 
previous night and it was diluted into 10 ml of LB and let to grow overnight at 37ºC 
on a shaker (250 rpm). This starter culture was used to inoculate 1 L of 2X YT 
medium and it was incubated at 37ºC in a shaker until the absorbance of the cells at 
600 nm was between 0.6 and 0.9 (log phase growth). At this point, cells were placed 
on ice4, and the culture was divided into four equal parts and centrifuged at 4000 
rpm for 25 min at 4ºC. Supernatant was removed immediately, as cell pellet begins 
to lift quickly, and the bacteria were gently resuspended in 200 ml of ice-cold 
distilled water. Cells were once more centrifuged at 4000 rpm for 25 min at 4ºC, and 
this time they were resuspended in 100ml of ice-cold distilled water, prior to a third 
centrifugation at 4000 rpm for 25 min at 4ºC. The four bacterial pellets were 
resuspended in 20 ml of 10% glycerol and transferred to two chilled 50ml conical 
tubes. Samples were then centrifuged at 4000 rpm for 10 min at 4ºC, and finally 
resuspended in 1ml of ice-cold 10% glycerol (OD600 of resuspended cells should be 
around 200-250). Cell suspension was stored in 70 µl aliquots in pre-chilled 1.5 ml 
eppendorf tubes and frozen in liquid N2. Cells were kept at -80ºC until use. 
  
7.2.4.4 Electroporation of Competent Bacteria 
 
Frozen competent bacteria (Dh5α) were thaw in ice, and 1 µl of the ligation 
reaction was added. Mixture was then transferred to the electroporation cuvettes 
(Bio-Rad) that are kept at 4ºC. The conditions for the electroporation5 are set at 25 
µFD, 200 Ω, and 1.8 kV, with a time constant around 3-4 ms. Once the instrument is 
set, electroporation cuvettes containing the cells are well dried and placed into the 
electroporation device. The tone indicates that cells have been successfully 
electroporated, whereas if there is a sparking coming for the cuvette cells indicates 
that cells have died and that the procedure should be repeated. When successfully 
done, add 0.5ml of LB to the cells in the cuvette immediately and transfer them to a 
                                                 
4 It is very important to keep cells at 4ºC, or on ice, for the remainder of the protocol. 
5 Electroporation conditions vary from cell strain. 
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 new eppendorf tube so they can grow for 1 h at 37ºC, and therefore they can recover 
from the treatment. After, centrifuge at 500xg for 5 min to pellet the cells and 
discard all the media but 100 µl to resuspend them. Plate the cells in a Petri dish 
with ampicilline (100 µg/ml) and remember to have a negative control (competent 
bacteria without DNA insert that have followed the same treatment). Grow the plate 
dish at 37ºC overnight. The following morning there will be only colonies in the 
transformed plate and no colonies on the negative control. 
 
7.2.5 Small-Scale Plasmid DNA Purification Kits 
 
Transformed bacteria producing the desired construction were grown 
overnight in 5 ml of LB containing 100 µg/ml of ampicilline at 37ºC, and then 
centrifuged to pellet the bacteria. The plasmid was obtained by alkaline lysis using 
the QIAprep Spin Miniprep Kit (Quiagen), and following the manufacturer’s 
instructions except for the elution step which was done with sterile water, so the 
buffer would not interfere in the following treatments. Plasmid DNA concentration 
was calculated by measuring the absorbance at 260 nm and stored at -20ºC until use. 
 
7.2.6 Glycerol Stocks 
 
Bacteria producing the short interference sequences that proved efficient 
were stored in glycerol solution to preserve them for one or two years. To do this 
750 µl of overnight-grown culture were added to 750 µl of LB media containing 
40% glycerol in a screw-cap vial and then kept at -80ºC until use. 
 
To revive the stored stock, streak some of the glycerol stock on a LB plate 
containing 100 µg/ml of ampicilline, the following day, screen for single colonies. 
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 7.3 TESTING OF shRNA ACTIVITY AGAINST egr-1 BY CELL 
TRANSFECTION 
 
Cells used for transfection had been grown without antibiotics until they 
reached a confluence of around 80%, and then kept for 24 h in serum-starvation. The 
transfection was carried out using Lipofectamine 2000 (Invitrogen) reagent and 
following the manufacturer’s instructions. Once cells had been transfected for 24 h, 
egr-1 presence was tested either by real-time PCR or immunofluorescence. 
 
8. IMMUNOFLUORESCENCE OF MLP29 MOUSE CELL LINE 
 
Immunofluorescence is a technique that allows the visualization of a specific 
protein or antigen in cells or tissue sections by the binding of an antibody that is 
chemically conjugated with a fluorescent dye (for example, fluorescein 
isothiocyanate (FITC)). This is termed direct immunofluorescence in opposition to 
the indirect immunofluorescence, in which the first antibody is recognized by a 
secondary antibody labelled with a fluorochrome. Immunofluorescence staining can 
be done both on cells fixed on slides and tissue sections, and the resulting stained 
samples are examined under a fluorescence or confocal microscope. 
 
MLP29 cells were plated on sterile coverslips (immersed in 100% ethanol 
and air dried) 24 h before fixation, at an optimum density to reach 50% confluence. 
The following day cells were treated with the desired drug (TPA, kinase inhibitors, 
and so on.) for the appropriate time interval and washed twice with room-
temperature6 PBS prior to be fixed by addition of 10% formaldehyde neutralized and 
stabilized with methanol (Panreac) during 30 min at 37ºC. Solution was removed by 
washing the slides with 0.1 M PB-0.05% Triton X-100, and the detergent served 
also to permeate the cells. To block the unspecific antibody union, coverslips were 
incubated with 10 % NGS (Normal Goat Serum, Gibco) diluted 1:10 in 0.1 M PB-
0.05% Triton X-100, for 1 hour at room temperature. Samples were then incubated 
overnight with 200 µl of the antibody Egr-1 (Santa Cruz, sc-110, 1:1000 diluted in 
                                                 
6 It is important to wash the cells with room temperature PBS, otherwise cells may shrink. 
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 10% NGS in 0.1 M PB- 0.05% Triton X-100) in a humid chamber at 4ºC. The 
unattached antibody was removed by extensively washing the cells three times 
during 10 min with 0.1 M PB. Addition of the secondary antibody labelled with 
Anti-Rabbit Ig TRITC (Jackson, dilution 1:200 in 10% NGS in 0.1 M PB-0.05% 
Triton X-100) was done in the same manner. Cells were incubated for 1h at room 
temperature on a humid chamber with 200 µL of the antibody dilution. Slides were 
washed, as before, three times with 0.1 M PB and then mounted with a drop of 
Fluorsave (Calbiochem) containing DAPI7 (Sigma, 5mg/ml, water diluted) 1:1000 
dilution on the slide. Let the chemical to polymerize for at least 2 h at room 
temperature and the preparation is ready to be seen on the fluorescence or confocal 
microscope in the next two days. Samples prepared this way can be stored at 4ºC for 
up to two months.  
 
Analysis of the samples was done with a Leico TCS-SP2 confocal 
microscopy equipped with argon and helium-neon lasers, and connected to an 
inverted Leica DM1RB microscope. 
 
 
 
 
 
 
 
 
 
                                                 
7 DAPI has to be well shacked, as it has solubility problems. Once diluted can be froze stored 
at -20ºC, protected from light. 
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RESULTS AND DISCUSSION 
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 1. SELECTION OF THE SYSTEM OF STUDY 
 
1.1.  SELECTION OF THE CELL LINE 
 
The use of cell cultures in the research field has implied a great advantage to 
study, at a chromatin level, the changes that take place in promoters of mammalian 
genes, when they are activated by means of different stresses. Firstly, it enables a 
more accurate control of the experimental conditions and secondly, it ensures a 
greater reproducibility of the results, as it avoids the problems regarding the 
animals’ genetic background. Moreover, it serves as a simplifying model that can 
afterwards be corroborated by in vivo studies.  
 
In order to find an appropriated biological system to study the changes 
caused by oxidative stress it was decided to test the response to arsenite of two cell 
lines: the fibroblastic cell line C3H10T1/2 (ECACC 85012201) and the liver 
progenitor cell line MLP29 (Medico et al., 1996). Arsenite was added to serum 
starved cells to a final concentration of 400 µM for 1 h (Li et al., 2001), and the 
levels of expression of diverse immediate-early genes typically induced during this 
stimulus, such as  c-fos (Nriagu et al., 2000; Hu et al., 2002), c-jun (Nriagu et al., 
2000; Hu et al., 2002) and gadd153 (Guyton et al., 1996; Tang et al., 2002), were 
analyzed by RT-PCR.. The results obtained (Figure 17) show a clear increase in the 
expression of all genes tested, the only difference being a higher increase of c-fos in 
MLP29 than in C3H10T1/2 cell line.  
Given the fact that no large differences between the expression patterns of 
both cell lines exist, the decision to choose any of them was based in the biomedical 
interest of the study. In this sense, the study in the hepatic cell line seems to be of 
higher interest since different researchers correlated pathological processes as 
hepatocellular carcinome development (Bernstam et al., 2000), acute inflammation  
(Jaeschke, 2000) or problems derived from  hepatic transplantation (Cantisani et al., 
2004), with the presence of reactive oxygen species (ROS) in this cellular type. 
Taken this information into account, the liver progenitor cell line MLP29 (Figure 
18) was selected to be used in the following experiments. 
- 109 - 
  
 
 
Figure 17. Analysis of c-jun (A), c-fos (B) and gadd153 (C) expression in 
MLP29 and C3H/10T1/2 cell lines stimulated with 400µM arsenite for 1 
hour. Total RNA from untreated (C) and arsenite treated (A) cells was 
purified and analyzed by semi-quantitative RT-PCR. As an internal control 
rRNA 18S gene was co-amplified with the genes of interest. They are shown 
in duplicates of two independent experimental samples. 
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Figure 18. Micrography of the mouse liver progenitor cell line (MLP29). 
Cells were grown in 100 mm X 20 mm dishes until 40% (A) or 60% (B) 
confluence. Pictures were taken with a Nikon FG-20 camera connected to an 
inverted Nikon DIAPHOT microscopy (100X magnification).  
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 1.2.   SELECTION OF THE STRESS CONDITIONS 
 
Following the selection of MLP29 cell line as a biological material, the next 
step was to select the appropriated conditions to generate an oxidative stress in those 
cells. From the main drugs used in the literature to produce a robust gene expression 
pattern, we tested four stress-inducing agents: sodium arsenite, 12-O-
tetradecanoylphorbol-13-acetate (TPA), ter-butylhydroperoxide (t-BhP) and UV 
irradiation. Besides, these agents have biological significance, since, for instance, 
sodium arsenite is a tumour promoter (Luster et al., 2004) involved as well, in many 
important pathologies as type 2 diabetes (Navas-Acien et al., 2006) or TPA is a 
carcinogen (Lee et al., 2006). The cells, after serum starvation, were treated in a 
range of concentrations from 25 to 100 nM for TPA (Zheng et al., 2002) for 1 h, or 
from 100 to 400 µM for sodium arsenite during 1 h (Li et al., 2001) (Figure 19).  
 
Furthermore, to mimic an oxidative stress caused by production of hydroxyl 
radicals (Hwang et al., 2002), t-BhP in a concentration range from 25 to 100 mM for 
30 min was also used (Figure 19). Finally, cells were, alternatively, irradiated with 
UV light for time intervals between 5 and 15 s at 65 W/m2 (Giordani et al., 2000). 
Total RNA from those treated cells was purified and expression of some sensor 
genes such as gadd153, trx, c-jun or c-fos was analyzed by RT-PCR to select the 
appropriate treatment conditions (Figure 20 and 21).  
  
The results from semi-quantitative PCR (Figure 19) were normalized against 
rRNA 18S gene and plotted (Figure 20). The data obtained show a strong induction 
of the genes in response to TPA and arsenite, in contrast to a much weaker 
stimulation of expression produced when cells are exposed to either t-BhP or UV 
light. Moreover, in general, TPA induction seems to be more homogeneous and 
dose-dependent than arsenite for the genes tested. 
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Figure 19. RT-PCR analysis of gadd153 gene expression induced by 
different stress-inducing agents. MLP29 cells were either treated with 
different concentrations of TPA (from 0 to 100nM), arsenite (from 0 to 
400µM) and t-BhP (from 0 to 100mM) or UV irradiated (during 0 to 15s at 
65 W/m2). Total RNA was purified and analyzed by semi-quantitative RT-
PCR. As an internal control rRNA 18S gene was co-amplified with the gene. 
Results are representative of, at least, three different experiments. 
 
To further check the differences between the treatments with TPA and 
arsenite with on one part and those with t-BhP and UV light, real-time PCR analysis 
of c-fos and gadd153 genes was carried out, and the results proved to be comparable 
to those obtained by semi-quantitative PCR (Figure 21).   
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Figure 20. RT-PCR analysis of c-jun, c-fos, trx and gadd153 gene 
expression. MLP29 cells were treated with TPA (A), arsenite (B), t-BhP (C) 
or UV irradiated (D), and total RNA was purified and gene expression 
analyzed by semi-quantitative RT-PCR. Bands were scanned and standardised 
relative to rRNA 18S gene expression. Control, without treatment, was 
arbitrarily assigned to 1.  
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Figure 21. Real-time RT-PCR analysis of c-fos and gadd153 gene 
expression. MLP29 cells were either treated with TPA (A), arsenite (B) and   
t-BhP (C) or UV irradiated (D). Total RNA was purified and gene expression 
was analyzed by real time RT-PCR, and normalized relative to rRNA 18S 
gene expression. The control without treatment was arbitrarily assigned to 1. 
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In conclusion, since TPA shows a more homogenous induction expression 
pattern than arsenite and, as Berstam et al., (2000) pointed out, the latter produces  
morphological aberrations in hepatic cell lines that lead the cells to apoptosis, it was 
decided to use TPA as an induction agent in the following experiments. Moreover, 
the signalling pathways elicited by TPA seem to be more specific and defined than 
those started by arsenite, which simultaneously acts upon many different kinases 
(Tanaka-Kagawa et al., 2003). 
 
Once the agent to be used was selected, the remaining issue was to choose 
an appropriate concentration, in order to obtain an increment in the gene expression 
without producing an excessively toxic effect in the cells. For this reason, it was 
decided to use a 50 nM concentration, which significantly induces all the genes 
tested in a short period of time without affecting the morphology of the cells. 
 
1.3.  SELECTION OF THE GENE TO STUDY  
 
To fulfil a convenient study of the chromatin changes that take place in a 
gene during its induction, it is necessary to select a gene whose expression pattern is 
clearly altered in response to a certain stimulus. Consequently, once we had 
established the biological model to carry out the experiments, that is to say mouse 
liver progenitor cell line (MLP29) and the concentration and the agent to induce 
expression (50 nM TPA), we proceed to analyze the expression pattern of a set of 
genes involved in biological processes such as: transcriptional regulation, immune 
response, cellular signalling, aminoacid metabolism or apoptosis. This set of genes 
was partially extracted from a work in which the changes of global expression of 
mouse cells subjected to oxidative stress with H2O2, was analyzed by DNA 
microarrays. This work was carried out in collaboration with the Physiology 
Department of the Faculty of Medicine of Valencia.  
 
Among the genes analyzed by semi-quantitative RT-PCR, those of which 
expression was found to increase with TPA treatment were the following: trb3 
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 (tribbles homolog 3), hif1 (hypoxia inducible factor 1), atf3 (activating transcription 
factor 3), atf4 (activating transcription factor 4), atf5 (activating transcription factor 
5), C/EBP-γ (CCAAT/enhancer binding protein gamma), asns (asparagine 
synthetase), gc/m (glutamate-cysteine ligase, modifier subunit), gys1 (glycogen 
synthase 1, muscle), psme-1 (proteasome 28 subunit, alpha), psph (phosphoserine 
phosphatase), sclc1a4 (solute carrier family 1-glutamate/neutral amino acid 
transporter-member 4), pycs (pyrroline-5-carboxylase synthetase: glutamate gamma-
semialdehyde synthetase), pck1 (phophoenolpyruvate carboxykinase), Ier2 or pip92 
(immediate early response 2), egr-1 (early growth response 1) and nur77 or Nr4a1 
(nuclear receptor subfamily 4, group A, member1). 
 
As an example of the genes analyzed, Figure 22 shows the induction of egr-
1, pip92 and nur 77 in cells stimulated by TPA. The three of them encode for 
transcriptional factors involved in different gene activation process, and therefore, 
they are interesting for our study as they have to act in a chromatin environment. As 
seen in Figure 22, egr-1 and, in less extension, pip92 have a significant increase in 
their expression at a relatively short time from the treatment, whereas the expression 
of nur77 is somewhat delayed on time and its increase is more subtle.  
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Figure 22. RT-PCR analysis of egr-1, pip92 and nur77 expression. 
Serum-starved MLP29 cells were treated with 50 nM TPA, and total 
RNA was purified and analyzed by semi-quantitative RT-PCR. As an 
internal control rRNA 18S gene was coamplified in each case. 
  
In view of the above reasons, we decided to make egr-1 the gene of choice 
to study the structural and functional changes in its chromatin, since it encodes for a 
transcriptional factor that exerts important roles in regulating cell proliferation 
(Wada et al., 2003), apoptosis (reviewed by Ahmed, 2004) or tumour suppression 
(reviewed by Liu C. et al., 1996) by activating secondary-response genes. 
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 2. ANALYSIS OF egr-1 EXPRESSION 
 
The study of the events that take place in the chromatin of the promoter of a 
gene during its induction require an accurate analysis of its expression, in order to 
correlate those events with the transcription process. Among the most common 
methods used to quantify transcriptional rate, the more useful and powerful is RT-
PCR. This technique allows a sensitive detection of mRNA with a relative small 
amount of starting sample although all the variables that influence the amplification 
reaction should be tightly controlled. Its main disadvantage is that it only measures 
steady-state levels of mRNA, and not the actual transcriptional rate.  
 
Chromatin immunoprecipitation (ChIP) is a powerful approach that allows 
the analysis of the interaction of transcriptional factors with DNA, thereby providing 
a live cell picture of the native chromatin structure. A novel application of this 
methodology termed RNAPol ChIP and developed by us (Sandoval et al., 2004), 
consists in detecting the RNA polymerase II within the coding region of the gene 
under study. Using this technique, in combination with the standard RT-PCR, we 
have established a precise pattern of the transcriptional rate of egr-1 in MLP29 cells 
treated with TPA. For these experiments we used oligonucleotides that specifically 
amplify a region within exon 2 of the coding region (Figure 23). 
 
The results obtained with RNAPol-ChIP technique show that it is possible to 
detect egr-1 transcription as soon as 5 min after TPA treatment. This transcriptional 
rate increases until it reaches a maximum around 30 min, and then decreases 
steadily, being no longer detectable after 180 min of the induction. Some differences 
can be observed between the results obtained by RNAPol-ChIP and by mRNA 
analysis by RT-PCR. The early RNA pol II activity at 5 min, cannot be detected by 
mRNA analysis in which the induction of egr-1 is first noticeable at 15 min after the 
treatment. Moreover, the maximum level of mRNA is observable at 45 min, when 
measuring it by both, semi-quantitative and real-time RT-PCR. These minor 
differences in the expression timing of RNAPol-ChIP and RT-PCR analysis can be 
due to the fact that the first is able to detect real-time transcription, whereas the latter 
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 detect steady-state levels of mRNA that may be influenced by the messenger 
metabolism.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23. Transcriptional analysis of egr-1 in MLP29 cell line after TPA 
treatment. (A) RNAPol-ChIP assay of egr-1 transcription. The panels in the top 
show PCR analysis of the DNA extracted from: input samples, 
Immunoprecipitated with RNA pol II antibody (α-RNAP II) and as a specificity 
control, without antibody (No Ab). The left panel shows an electrophoresis of the 
sonicated samples to estimate the size of the chromatin fragments. (B) RT-PCR 
analysis of egr-1 transcription. Total RNA was purified and analyzed by semi-
quantitative RT-PCR. As an internal control rRNA 18S was used. (C) Quantitative 
analysis of real-time RT-PCR of egr-1 expression. Samples were analyzed in 
triplets and normalized versus rRNA 18S. The sample untreated with TPA was 
arbitrarily assigned to value 1. The melting curves of the amplicons and the plot of 
amplicon production versus number of cycles are given as PCR product 
verification. 
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 3.  SIGNALLING PATHWAYS INVOLVED IN egr-1 ACTIVATION 
 
Once the pattern of egr-1 expression was established, we were interested in 
knowing which signalling pathway drives TPA induction of the cells towards the 
promoter of the egr1 gene. To answer this question, serum-starved cells were pre-
treated during 30 min with inhibitors of the main kinase cascades (i.e. ERK, MEK 
1/2, p38, PKA, PKC and PI3K) prior to the incubation of the cells with TPA. 
 
Figure 24 shows the expression level of egr-1 analyzed by real-time RT-
PCR after using each of the inhibitors tested. Results show that both MEK 1/2 
(inhibitor PD98059) and p38 (SB203580) kinase cascades are involved in the 
transduction of the signal from TPA to egr-1 promoter, as gene expression is greatly 
reduced. On the contrary, the remaining cascades tested: JNK (inhibitor peptide i-
JNK), PKC (inhibitor hypericin), PI3K (inhibitor wortmanin) or ERK1 /2 (inhibitor 
peptide i-ERK 1/2) do not seem to have any control over egr-1 expression induced 
by TPA. All the same, the use of inhibitors specific for transcription factors, such as 
NFκB or STAT3, shows that none of the signalling pathways in which those factors 
are involved regulates the expression of the gene.  
 
These results prompted us to study weather TPA induction of  egr-1 is 
caused by means of oxidative stress, due to the presence of free radicals. To address 
this issue, we analyzed the effect of diverse antioxidants, like ascorbate, Vitamine C, 
Trolox or N-acetyl-cysteine, in the activation of the gene by phorbol esters.  The 
results shown in Figure 24 indicate that only Trolox reduces the induction to less 
than 50% the induction, whereas the two other antioxidants have only minor effects.  
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Figure 24. Effect of the protein kinase inhibitors and of the antioxidants 
over egr-1 expression in TPA treated MLP29 cells. (A) Serum-starved 
cells were or were not pre-incubated for 30 min with MEK1/2 inhibitor 
(PD98059), p38 inhibitor (SB203580), JNK1/2 inhibitor (peptide i-JNK), 
PI3K inhibitor (Wortmanin), PKA inhibitor (H89), PKC inhibitor 
(hypericin), ERK1/2 inhibitor (peptide i-ERK 1/2), NFkB inhibitor (peptide 
i-NFkB) and STAT3 inhibitor (peptide i-STAT3) at the indicated doses 
(section 1.2.2 from Materials and Methods). Then, cells were or were not 
treated with TPA during 1 h and then harvested. Total RNA from those cells 
was purified and analyzed by real-time RT-PCR using oligonucleotides that 
spans egr-1 coding region (Table 11) and the results were normalized 
relative to rRNA 18S gene. Control sample, TPA untreated cells, was 
arbitrarily assigned to a value of 1. Data are representative of three 
independent experiments. (B) Serum-starved cells were pre-incubated or not 
for 30 min with different antioxidants such as vitamin C, Trolox or N-
acetyl-cysteine prior to 1 h TPA treatment, and egr-1 expression was 
analyzed as in panel A. 
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 These experiments indicate that the signalling cascade that connects egr-1 
expression to TPA treatment is not mainly caused by the action of free radicals but 
through MEK 1/2 and p38 cascades. Bauer et al., (2005) correlate egr-1 induction 
upon TPA treatment with activation of the MEK-ERK pathway. Our results do show 
the importance of MEK 1/2 in the activation, but nevertheless they do not seem to 
give the same importance to the ERK pathway. The reasons for this discrepancy are 
not clear, and therefore the results are misleading, but it could be due to the 
existence of a different MEK 1/2 signalling pathway that bypasses ERK 1/2 for egr-
1 activation. It is also important to note that TPA strongly activates p38, in 
agreement with previous data showing that the phorbol ester can phosphorylate p38 
(Guo et al., 2005), but to date, no report has implicated both signalling cascades in 
the up-regulation of egr-1.  
 
Finally, it has to be remarked that interestingly in our system, TPA does not 
act through PKC to activate egr-1, despite the commonly accepted fact that phorbol 
esters act mainly through this particular protein kinase (Brose et al., 2002). 
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 4. TRANSCRIPTIONAL FACTORS ASSOCIATED TO egr-1 PROMOTER 
DURING ITS INDUCTION 
 
Data presented until this point have enabled us to know that TPA activates 
the MEK 1/2 and p38 kinase cascades, which in turn must have an effect over the 
chromatin of egr-1 and therefore dictate its robust and quick induction. The question 
to be addressed now is how this effect takes place over the promoter of the gene, 
which kind of histone modification, remodelling complexes and transcriptional 
factors are needed to regulate the expression of the gene by TPA. To answer it, we 
have used the chromatin immunoprecipitation technique, ChIP, using antibodies 
against the different factors. As previously mentioned, the method allows the in vivo 
detection of proteins bound to the chromatin, and as a result, it enables us to study 
which proteins and at what time are they bound to egr-1 promoter. This, in turn, may 
give us a clue as to what factors have a role in the regulation of the gene. 
 
First, we analyzed which transcriptional factors are recruited to egr-1 
promoter during its activation. To this purpose, we performed ChIP studies of 
MLP29 cells at different times after TPA treatment. Crosslinked chromatin obtained 
at different times after induction was subsequently immunoprecipitated with 
antibodies against: SRF, ELK1, SP1, EGR1, CREB, NAB1 and NAB2. All these 
transcription factors have putative binding sites in the promoter of egr-1 (see point 
2.2 from Introduction section), as was established by TRANSFAC program 
analysis, except for NAB1 and NAB2 that have been described to bind to EGR1 in 
order to stimulate its repressing activity (Thiel et al., 2002).  
 
Serum response factor, SRF, is a transcriptional factor whose functionality 
depends on the formation of a ternary complex with the DNA and an Ets element 
(Shaw et al., 1989). Its binding sequence can be found in many genes, and it has 
been related to biological events such as neuronal transmission or cellular growth 
(Chai et al., 2002). In our results, (Figure 25 B), SRF is intensively and 
constitutively bound to egr-1 promoter. The high signal obtained could be 
attributable on one hand, to the high affinity of the antibody, but one the other hand, 
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 there are five putative binding sites for SRF and this factor is able to bind as a 
dimmer, which no doubt could produce a signal for SRF higher than for the other 
transcription factors that are less represented. Furthermore, ELK1, one of the Ets 
domain transcription factors, involved in cellular functions like cell differentiation or 
proliferation upon ternary complex formation with DNA and SRF (reviewed in 
Buchwalter et al., 2004) is also constitutively bound. This could lead us to 
hypothesize that this ternary complex is permanently present all the time in the 
chromatin of egr-1 promoter, but it is not always active, possibly because it needs to 
be further modified by any of the kinase cascades activated by TPA.  
 
CREB (cAMP response element binding) is a transcriptional factor which 
binds to specific sequences in the DNA to increase or to decrease the transcription of 
certain genes. CREB can be bound by CBP (CREB binding protein) in a process that 
enhances its activity (reviewed in Johannessen et al., 2004). This transcriptional 
factor has many functions in different organs such as long term memory in the 
neurons (Barco et al., 2006). Our results show (Figure 25 B) that CREB is also 
constitutively bound at the promoter, though it seems to decrease slightly during the 
peak of transcription, between 15 and 30 min after TPA induction. There could be 
various reasons for this: firstly, it could be that CRE, which is located near the 
transcription starting point, has only a weak effect in the egr-1 induction in TPA-
induced expression. Secondly, it could be that the epitope recognized by the 
antibody against CREB, due to the localization of the factor near the starting point, 
is somewhat inaccessible to the antibody because it may be hidden by the PIC and/or 
mediator machineries. The importance of CREB in TPA-induced egr-1 expression is 
still controversial, as some authors gave a marginal role to CREB (Bauer et al., 
2005), whereas other authors show that egr-1 expression was up-regulated in 
constitutively active CREB mutants, indicating an important role for this 
transcription factor in the induction (Raychowdhury et al., 2002). These results, 
reveal that CREB is always bound to its binding site, but do not let us, so far, to 
decide its role in controlling gene expression because a previous phosphorylation to 
become functional might be required. This assumption was afterwards checked, as 
shown below.  
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 Among the transcriptional factors analyzed, stimulating protein factor, SP1, 
belongs to a family of transcription factors which bind GC/CT- rich elements found 
in the promoter of multiple genes (reviewed in Safe et al., 2005). In our studies, SP1 
has been the only one whose significant decrease has been detected at the peak of 
transcription (Figure 25 B). These results are in agreement with those of Cao et al., 
(1993), in which they demonstrate a drop in SP1 binding abilities upon TPA-
induction of egr-1. A feasible reason for this could be that, since SP1 and EGR1 
have partially overlapping binding sites (Silverman et al., 1998), both factors may 
compete for binding egr-1 promoter, although the presence of both proteins at 60 
min post-induction does not seem to agree with such possibility. In any case, SP1 
would have a repressive role. For instance, SP1 can be deacetylated by HDAC1 and 
so mediate transcriptional repression (Bouwman et al., 2002).  Inocente et al., 
(2005) also related SP1 activity to the repression of cyclin B1 transcription. 
  
Finally, EGR1 factor, which is able to bind to specific GC-rich sequences, 
and which has been related to the regulation of tumour suppressor (Baron et al., 
2006), has been shown to bind to its own promoter at 15 min after the gene 
induction. EGR1, remains bound until 3h, when is not longer detectable by ChIP. 
This protein, as mentioned in the Introduction, has an activating and a repressing 
domain. The repressive domain becomes active upon binding two proteins: NAB1 
and NAB2 (Thiel et al., 2000). Our results show that both NAB1 and NAB2 are not 
recruited to the promoter until 30 min after the treatment. Therefore, it seems 
reasonable to argue that EGR1 may bind first to its promoter to enhance its own 
transcription and subsequently, the union of the co-repressors activates its repressive 
domain. This mechanism serves as an autoregulatory loop, in which EGR1 is 
implicated in the inhibition of its own expression. The situation, indeed, is more 
complex, because EGR1 is also responsible for activating NAB2 transcription, albeit 
NAB1 is constitutively expressed (Swirnoff et al., 1998; Lucerna et al., 2003).   
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Figure 25. Recruitment of transcription factors to egr-1 promoter. (A) 
Map of egr-1 promoter with coloured boxes representing the binding sites for 
the different factors: ELK1 (ELK1 binding site), SRE (SRF binding site), EBS 
(EGR1 binding site), GC box (SP1 binding site) and CRE (CREB binding 
site). (B) Time-dependent ChIP analysis of MLP29 cells incubated or not with 
TPA. Crosslinked chromatin was immunoprecipitated with antibodies against 
SRF, ELK1, SP1, EGR1, NAB1, NAB2 and CREB. Immunoprecipitated 
DNA was assayed by PCR with primers (Table 15) specific for the promoter 
region of  egr-1. As a negative control a fragment of the promoter of α-actin 
gene (right panel) was amplified. Figures are representative of at least three 
different experiments. 
 
ChIP analysis enables a reliable image of the proteins bound to the 
chromatin, but the sensitivity of the method is given by the average size of the 
fragments analyzed (normally around 500 bp), and therefore is not accurate enough 
to distinguish between the occupancy of neighbour sites for the same protein. The 
analysis of the putative binding sites for egr-1 promoter (see the map in Figure 25) 
reveals the presence of two different CG boxes were SP1 can bind, as well as two 
separated groups of SREs, the proximal cluster containing two binding sites and the 
distal cluster containing three binding elements for SRF. To obtain more precise 
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 data on the occupancy of these sites, we analysed the immunoprecipitated DNA by 
real-time PCR with the appropriate oligonucleotides to obtain overlapping 
amplicons spanning the egr-1 promoter (Figure 26). The analysis of the probability 
of SP1 occupancy within the two GC boxes (proximal GC box and distal GC box) 
indicate that when the gene is inactive SP1 is located at the more proximal GC box 
(GC box, within amplicon 15/16 in the Figure 26), since a linear adjustment shows 
that the probability of finding SP1 is inversely proportional to the distance (see 
Annex 2 from Materials and Methods section). On the contrary, the distal GC box 
(GC box within amplicon 11/12 in the Figure 26) does not seem to be occupied by 
the transcription factor.  
 
In the case of SRF occupancy, the results are noticeably different (Figure 
27). The peaks of probability show that, both the proximal (SRE, within amplicon 
15/16 in the Figure 27) and the distal (SRE, within amplicon 9/10 in the Figure 27) 
clusters, seem to be occupied by the transcriptional factor. The importance of one or 
the other SRE clusters in egr-1 expression is not yet clear since Bauer et al., (2005) 
assign a predominant role to the distal SRF. Promoter deletion studies give a 
predominant role to the distal SRF cluster in TPA-induced egr-1 expression in 
human hepatoma cells (Bauer et al., 2005), whereas Grundker et al., (2004) suggest 
that during GnRH stimulation of egr1 expression the predominant role corresponds 
to the SREs present in the proximal cluster. Our studies are not able to rule out any 
of the possibilities, but rather show that in vivo both clusters are occupied in MLP29 
cells, and it makes sense to think that both may contribute to the final output. 
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Figure 26. SP1 occupancy of the GC box along egr-1 promoter. 
Crosslinked chromatin of MLP29 control cells with an average size of 500 bp 
was immunoprecipitated using an antibody against SP1, and the purified DNA 
was amplified by real-time PCR using the oligonucleotides depicted in the 
gene scheme (Table 17). The plot shows the probability of finding SP1 along 
egr-1 promoter at the centre of the amplicons along egr-1 promoter. Coloured 
boxes in the map represent the binding sites for the different factors: ELK1 
(ELK1 binding site), SRE (SRF binding site), EBS (EGR1 binding site), GC 
box (SP1 binding site) and CRE (CREB binding site). A linear fit with a 
correlation coefficient (r)= 0,9913 is also shown (Annex 2). 
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Figure 27. SRF occupancy along egr-1 promoter. Crosslinked chromatin of 
MLP29 control cells, with an average size of 500 bp, was immunoprecipitated 
using an antibody against SRF, and the purified DNA was amplified by real-
time PCR using the oligonucleotides (Table 17) for the amplicons shown in the 
promoter map. The plot shows the probability of SRF binding at the centre of 
the amplicons as in figure 26.  
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 The results shown until now indicate that all transcriptional factors studied 
are present during the inactive state of the gene. Therefore, it seems that their 
binding is not part of an activating mechanism to induce egr-1 expression. There are 
abundant data in the literature (reviewed in Gardiner, 2006) that several of those 
factors are activated by post-translational modifications (for instance, 
phosphorylation) to be able to switch on gene transcription. To test this possibility 
we studied the phosphorylation state of the constitutively present factors during egr-
1 transcriptional activation by TPA, and specifically of CREB and ELK1, as we 
considered these two factors to be more interesting than the rest. 
 
Our results point out that both ELK1 and CREB become phosphorylated 
when the gene is being actively expressed (Figure 28). Nevertheless, the 
phosphorylation of ELK1 seems to be more stable than that of CREB, since the 
latter is only visible at 15 min whereas ELK1 phosphorylation is also observable at 
30 min after TPA treatment. To sum up, these results suggest that phosphorylation 
of CREB and ELK1 is a feasible mechanism by which those transcriptional factor 
may act to trigger egr-1 expression. 
 
Results shown in Figure 28 are in agreement with the fact that these proteins 
can be phosphorylated by MEK 1/2 and p38 kinase cascades (Shaw et al., 2002 and 
Patak et al., 2004), which, as previously shown, are the two signalling networks 
involved in coupling egr-1 expression to TPA stimulus. To analyze if any of those 
kinase cascades is indeed involved in the phosphorylation of those transcriptional 
factors, we decided to do a ChIP experiment with cells treated with MEK 1/2 and 
p38 inhibitors. For these assays we used cells treated with TPA for 15 min, a time in 
which both CREB and ELK1 are phosphorylated (Figure 28). Figure 29 illustrates 
the results of this experiment, which indicate that both MEK 1/2 and p38 kinase 
cascades are responsible for CREB and ELK1 phosphorylation. It has also to be 
noted that RNApol II from Figure 29, although amplified from the promoter region 
reflects quite well the transcriptional state of egr-1, that is to say the polymerase is 
more abundantly found in TPA-treated cells, that are actively transcribing egr-1 
gene, than in the cells treated with MEK 1/2 and p38 inhibitors.  
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Figure 28. Recruitment of transcription factors to egr-1 promoter. Time-
dependent ChIP analysis of MLP29 cells incubated or not with TPA. 
Crosslinked chromatin was immunoprecipitated with antibodies against SP1, 
ELK1, ELK1-P, CREB and CREB-P or in absence of antibody (NA). 
Immunoprecipitated DNA was assayed by PCR with primers (Table 15) 
specific for the promoter region of egr-1. As a negative control α-actin 
promoter region (right panel) was amplified. Figures are representative of, at 
least, three different experiments. 
 
Figure 29. Recruitment of phosphorylated CREB and ELK1 
transcription factors to egr-1 promoter in cells treated with MEK 1/2 
and p38 inhibitors. ChIP analysis of MLP29 cells pre-incubated or not with 
MEK 1/2 (PD98059) or p38 (SB203580) inhibitors and treated with TPA 
for 15 min. Crosslinked chromatin was immunoprecipitated with antibodies 
against RNAPol II, ELK1-P and CREB-P or in absence of antibody (NA). 
Immunoprecipitated DNA was assayed by PCR with primers (Table 15) 
specific for the promoter region of   egr-1. 
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All these results suggest that CREB and ELK1, the latter probably forming 
part of the TCF (DNA and SRF), are implicated, via phosphorylation of the factors, 
in the transduction of the signal produced by TPA that activates egr-1 expression.  
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 5. CHROMATIN MODIFYING ENZYMES ASSOCIATED TO egr-1 PRO-
MOTER DURING ITS INDUCTION 
 
Post-translational modifications of histone tails are among the most 
important mechanisms which serve to regulate the chromatin state of a gene and 
consequently to direct its expression or repression in the cell.  Rice et al., (2001) 
reviewed the cross-talk between these complex modifications and deepened into the 
“histone code”, which would be read by proteins bearing characteristic binding 
domains that recognize specific modifications (for instance bromodomains 
recognize and bind acetylated lysines and chromodomains recognize methylated 
lysines and arginines).  
 
5.1 CYCLOHEXIMIDE EFFECT  
 
Cycloheximide is an inhibitor of the protein synthesis in eukaryotic 
organisms that acts suppressing the elongation of translation, and therefore it is 
widely used in in vitro experiments to test the importance of newly synthesized 
proteins in gene expression mechanisms. 
 
To test the effect of this compound in our model system, we treated MLP29 
cells with cycloheximide for 1 h at 25mg/mL, and then total RNA was purified and 
analyzed to determine egr-1 transcriptional rate. Results from Figure 30 show that 
cycloheximide on its own is able to stimulate intensely the expression of the gene 
under study, suggesting the existence of a repressor that is being continuously 
synthesized and which is able to silence the gene. There are various possibilities to 
explain the effect of the cycloheximide. On one side, we have previously suggested 
a repressive role for SP1 and, since this transcription factor is constitutively 
expressed in our system (data not shown), it could make sense to consider that 
cycloheximide-induced egr-1 activation could be due to the inhibition of SP1 
synthesis, and therefore could be affecting the repressive co-factors that it may be 
recruiting such as histone deacetylases. On the other side, it could be also feasible 
that cycloheximide would be affecting part of the mediator or elongation machinery 
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 needed to express the gene. Similar consequences of cycloheximide treatment on 
egr-1 super induction were also reported by Chauhan et al., (1994) in Jurkat cells as 
well as in different experiments carried out by Frick et al., (1997) in mouse 
calvarian cells.  
 
Okadaic acid (inhibitor of PP1 and PP2A) has also been reported by Chauan 
et al., (1994) as an inducer of egr-1 transcription. Therefore we next studied if this 
stimulation could increase the cycloheximide effect and whether it could be possible 
to correlate these two effects. Our results, in spite of showing an increase in the 
stimulation with the combined treatment are not significantly different from the 
results obtained with cycloheximide alone to establish a synergistic effect of these 
two substances (Figure 30).  
 
 
Figure 30. Effect of cycloheximide over egr-1 expression in MLP29 cells. 
Serum-starved cells were incubated or not with cycloheximide (protein 
synthesis inhibitor) at the indicated doses (section 1.2.2 from Materials and 
Methods) and then were or were not treated with TPA and/or okadaic acid 
(OK) and harvested 1 h following the drug treatment. Total RNA was purified 
and analyzed by real-time RT-PCR and the results were normalized against 
rRNA 18S gene. Control sample, TPA untreated cells, was arbitrarily assigned 
to a value of 1. Results are representative of, at least, three different 
experiments. 
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 5.2 HISTONE DEACETYLASE AND HISTONE ACETYLTRANSFERASE 
COMPLEXES INVOLVED IN egr-1 REGULATION 
 
Nucleosome core particles with their conservation through evolution serve 
primarily to package DNA. Nevertheless, they possess a second important function, 
namely, their ability to carry epigenetic information through post-translational 
histone modifications. These modifications are performed by specific enzymes such 
as histone acetyltransferases, deacetylases, methylases, kinases, etc.  
 
   To study the epigenetic mechanism involved in the regulation of egr-1, we 
proceed to analyze the HDACs and HATs that are present in the promoter of the 
gene, and, therefore, are potentially able to imprint specific signals that regulate its 
transcription. Traditionally, histone acetylation has been linked to gene expression, 
assuming that it neutralizes the basic charge of the histones, weakening its 
interaction with DNA and rendering it more accessible to the transcriptional 
machinery. For instance, Wallberg et al., (1999) demonstrated that SAGA complex 
was needed to mediate transcriptional activation of chromatin templates on yeast. 
On the contrary, histone deacetylation has been related with transcriptional 
repression (Laherty et al., 1997). Therefore, HATs are in general considered 
activators and HDACs have been ascribed to the role of gene expression repressors. 
While the relationships between histone acetylation and transcriptional activity are, 
generally speaking, firmly established, the ultimate reasons seem to be much more 
complex than a simple charge neutralization, and the participation of the signalling 
implied by the histone code hypothesis has to be considered. 
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Figure 31. Recruitment of HDAC complexes to egr-1 promoter. Time-
dependent ChIP analysis of MLP29 cells incubated or not with TPA. 
Crosslinked chromatin was immunoprecipitated with antibodies against 
HDAC3, NCoR and mSIN3A or in absence of antibody (NA). 
Immunoprecipitated DNA was assayed by PCR with primers (see Table 15) 
specific for the promoter region of egr-1. As a negative control α-actin 
promoter region was also amplified. Results are representative of at least three 
different experiments. 
 
The analysis by ChIP assay of the presence of HDAC and HAT complexes 
in the promoter of egr-1, detects the presence of at least, two different HDAC 
complexes (Figure 31). One of them is the mSIN3A, complex that is usually 
associated to HDAC1 and HDAC2. In our case, it is probable that this two 
deacetylase activities form part of the complex, but the results obtained (data not 
shown) are not completely clear, probably due to the fact that the antibodies do not 
work properly for ChIP experiments. The second one, represented by NCoR, 
contains also HDAC3 activity (Figure 31). Association of NCoR and HDAC3 was 
first described by Wen et al., (2000) in pull-down assays in HeLa cells. Our results 
show a clear correspondence for the binding of both proteins in the promoter of egr-
1. mSIN3A and NCoR complexes are present when the gene is inactive, and leave 
the promoter during induction, around 15 to 30 min. Later, when the gene is 
switched off at 60 and 180 min, the complexes become again detectable in the 
promoter. The significance of the presence of at least two HDAC complexes 
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 implicated in egr-1 repression is not yet clear, but maybe it is needed for a strict 
chromatin regulation of this immediate-early gene expression. 
 
Next, we studied the recruitment of HAT complexes to the chromatin of 
egr-1, and for this purpose, we selected among the different possible HATs, CBP 
and GCN5 for different reasons. CBP and p300 are highly homologous general 
transcriptional coactivators usually found together (Grant et al., 1999), and therefore 
we decided to look only for one of them. ChIP analysis presented in Figure 32, 
shows that CBP complex is bound at the promoter during the basal state of the gene, 
and that it is released when the gene is active to return again when the gene 
expression decreases. The presence of the HAT complex in egr-1 promoter during 
the repression of the gene may mean that CBP is implicated in maintaining a basal 
state of histone acetylation. The basal state of acetylation may keep the immediate-
early gene in a potentially active transcriptional state ready to answer to the 
appropriate cellular stimulus. This hypothesis is sustained by the fact that the gene 
already has all the transcriptional factors required for its induction, and that even the 
RNApol II is paused in its promoter. These results are in agreement with those of 
Chen et al., (2001), who showed that a diminution in CBP activity occurs when it 
was incubated with phosphorylated CREB in in vitro acetylation experiments with 
HeLa nuclear extracts, and this may also occur in egr-1 transcriptional activation. 
Nevertheless, since histone acetylation is mainly related to gene expression, the 
complex of GCN5 would be, according to our results, the enzyme responsible for 
the specific acetylations that would direct egr-1 to its expression. ChIP analysis 
demonstrates that GCN5 is specifically recruited as early as 15 min and leaves the 
promoter again at 60 min after TPA treatment (Figure 32). We also tried to 
determine whether PCAF, a HAT from another complex, was also present in the 
gene, but we were not able to detect its presence in egr-1 promoter (data not shown). 
Nevertheless, these data can not rule out completely its presence because it could be 
possible that the antibody is not able to recognize the protein in the complex 
containing PCAF within egr-1 promoter. 
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Figure 32. Recruitment of HAT complexes to egr-1 promoter. Time-
dependent ChIP analysis of MLP29 cells incubated or not with TPA. 
Crosslinked chromatin was immunoprecipitated with antibodies against CBP 
and GCN5 or in absence of antibody (NA). Immunoprecipitated DNA was 
assayed by PCR with primers (Table 15) specific for the promoter region of 
egr-1. As a negative control α-actin promoter region was amplified. Results 
are representative of, at least, three different experiments. 
 
 
So far, we have been able to correlate egr-1 regulation with three different 
chromatin modifying complexes. At this point, we asked ourselves if there may be a 
non random distribution of these enzymes along the promoter. To respond to this 
question, we decided to analyze the intensity of the signal by using overlapping 
amplicons of around     100 bp along the promoter. Basing ourselves in previous 
results, (Figures 31 and 32), we used cells untreated with TPA to analyze HDACs 
(HDAC3 and mSIN3A), and cells incubated with TPA for 30 min to analyze GCN5. 
We did not study CBP distribution due to its presence prior to the induction, which 
probably indicates a less important role for the enzyme in the induction process. 
Data displayed on Figures 33 and 34 show that despite the difference in intensity, 
the three enzymes seem to have a highly similar distribution along the promoter. In 
view of these results, we wonder whether these three more probable sites could 
correspond to nucleosomes located at the gene, and as a result we decided to deepen 
later in the histone octamer position along egr-1 promoter.  
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Figure 33. HDACs distribution along egr-1 promoter. Crosslinked 
chromatin of MLP29 cells, untreated with TPA, with an average size of 500 
bp was immunoprecipitated using antibodies against HDAC3 and mSIN3A, 
and the purified DNA was amplified by real-time PCR using the 
oligonucleotides (Table 17) for the amplicons shown in the promoter map. 
The plot shows the probability of HDAC3 and mSIN3A binding at the centre 
of the amplicons as in figure 26. 
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Figure 34. HAT distribution along egr-1 promoter. Crosslinked 
chromatin of MLP29 cells, treated with TPA for 30 min, with an average 
size of 500 bp was immunoprecipitated using antibodies against GCN5 
and the purified DNA was amplified by real-time PCR using the 
oligonucleotides (Table 17) for the amplicons shown in the promoter 
map. The plot shows the probability of GCN5 binding at the centre of the 
amplicons as in figure 26.  
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 Next we asked ourselves if the presence of HDAC complexes was affected 
by treatment of the cells with inhibitors of the signalling cascades responsible for 
egr-1 induction (Figure 35) or by treatment of the cells with cycloheximide (Figure 
36). For this reason we carried out ChIP experiments in which the cells were 
previously treated with the corresponding kinase inhibitors. Results shown in Figure 
35 indicate that N-CoR needs a phosphorylation to be released from the gene. This 
phosphorylation can be carried out by MEK, as treating the cells with the inhibitor 
of this kinase hinders NCoR release from the promoter, and although the signal is 
less clear, p38 should also be capable to phosphorylate the factor. Therefore our 
results do not allow us to rule out any of the kinase cascades. On the contrary, 
mSIN3A appears to be less represented when the cells are treated with the p38 
inhibitor prior to their induction with TPA, and consequently it would imply that the 
complex requires a phosphorylation to remain bound to the promoter. On the 
contrary, Figure 36 illustrates that the protein synthesis inhibitor does not seem to 
affect any of the co-repressor complexes and as a result there must be, at least, a 
third one that is holding back egr-1 expression. Finally, looking at the results 
obtained for RNAPol II, we have to say that its presence in the promoter of egr-1 
correlates accurately with the events that are taking place at the chromatin of the 
gene. In other words, when cells are treated with cycloheximide and the gene is 
being actively expressed, the polymerase is more tightly bound to the promoter, 
whereas when the cells are pre-incubated with inhibitors of the kinase cascades the 
amount of RNA Pol II detected at egr-1 promoter is less than the that detected in the 
control sample, that is to say, cells treated with TPA (Figures 35 and 36). Despite 
this fact, in considering these data it should be kept in mind that the region amplified 
corresponds to the promoter and not to the coding region of the gene.   
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Figure 35. Recruitment of repressors and transcription factors to egr-1 
promoter. ChIP analysis of MLP29 cells incubated or not with: MEK inhibitor 
(i-MEK, PD98059) (left panel) and p38 inhibitor (i-p38, SB203580) (right 
panel), and treated with TPA (15 min) and. Crosslinked chromatin was 
immunoprecipitated with antibodies against RNAPol II, mSIN3A and NCoR or 
in absence of antibody (NA). Immunoprecipitated DNA was assayed by PCR 
with primers (Table 15) specific for the promoter region of egr-1. Results are 
representative of, at least, three different experiments. 
 
 
 
 
Figure 36. Recruitment of repressors and transcription factors to egr-
1 promoter. ChIP analysis of MLP29 cells untreated and cells incubated 
with cycloheximide. Crosslinked chromatin was immuno-precipitated 
with antibodies against RNAPol II, mSIN3A and NCoR or in absence of 
antibody (NA). Immunoprecipitated DNA was assayed by PCR with 
primers (Table 15) specific for the promoter region of egr-1. Results are 
representative of, at least, three different experiments. 
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 5.3 HISTONE MODIFICATIONS OF egr-1 PROMOTER 
 
As previously mentioned, the mechanism for storing information and 
regulating genomic function relies within a variety of post-translational 
modifications of histones (i.es phosphorylation, acetylation, methylation, ADP-
ribosylation and mono-ubiquitination). Consequently, the “histone code” hypothesis 
has assigned crucial regulatory roles to those modifications that govern the 
accessibility and function of the genome. In our model, we intended to determine the 
pattern of histone modifications produced by the HDAC and HAT complexes found 
in  egr-1 promoter that may shift the gene to a transcriptionally competent state.  
 
Figure 37 shows the pattern of histone modifications obtained by ChIP 
experiments with antibodies recognizing specific histone modifications either with 
inactive (cells not treated with TPA) or active (cells treated with TPA for 30 min) 
egr-1. At first glance, one can conclude that our gene of study has a highly level of 
basal acetylation, result that could correlate nicely with the presence of CBP at time 
0 min, despite the presence of the HDACs. It is also noticeable that the level of basal 
acetylation is reduced in the coding, implying a differential pattern of modifications 
in those regions. This result is not surprising, as the RNApol II machinery has to be 
recruited by a tightly regulated mechanism, whereas the coding region has only to 
recruit those factors that facilitate the passing of the polymerase through the 
chromatin template. As a control, α-actin was analyzed as an inactive gene and, 
consequently, devoid of modifications related to gene transcription,       β-actin was 
also analyzed as representative of a gene which is being continuously expressed and 
possibly does not possess specific modifications that may be related to immediate-
early gene transcription. 
 
Among the different posttranslational modifications of the histones, lysine 
acetylation is the most extensively modification studied. For instance, Brownell et 
al.  (1996) linked H3 K14 acetylation to gene activation. Grant et al. (1999) did the 
same three years later with H3 K9 and H3 K18 modifications, whereas Schiltz et al. 
(1999) established the importance of H4 K5 and K8 acetylations in gene activation. 
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 Later on, H4 K16 (Kawasaki et al., 2000) and H3 K23 acetylation (Daujat et al., 
2002) were also correlated with gene expression.  
 
When studying the specific pattern of acetylations in egr-1 promoter, we 
noticed that histones were already acetylated even in its inactive state, mainly at H3 
(in H3K9Ac, H3K14Ac and H3K18Ac), whereas histone H4 had only lysine K5 
acetylated. Nevertheless, the acetylation level of H3 increased during the expression 
of the gene, specially in the lysines K18 and K27, as the latter is the only one 
studied in H3 that is absent in the basal state. It is also important to note that H3K18 
signal is also present in the β-actin gene, which would indicate that such 
modification may not be specific for immediate-early gene activation.   
 
The case of histone H4 acetylation seems to be even more interesting, as 
there is an increase in the level of all the acetylations studied (H4K5Ac, H4K8Ac 
and H4K16Ac), and except for H4K5Ac, the others are restricted to the promoter 
and not to the coding region. This combination of histone modifications appear to be 
related to immediate-early gene transcription as they are absent from the active β-
actin gene.  
  
Regarding to histone methylation we centred our studies in the modification 
of lysine 4 of H3 (H3K3Me), and its differential state of di- or tri-methylation 
(H3K4Me2 vs. H3K4Me3). Bernstein et al. (2005) have correlated lysine 
trimethylation as well as H3K9/14Ac with sites near the transcription, whereas di-
methylation was mainly found in the vicinity of active genes in both human and 
mouse samples. Our results show that both H3K4Me2 and H3K4Me3 seem to be 
present in egr-1 promoter independently of the transcriptional state of the gene. 
These results suggest that methylation of lysine 4 from H3 would not be a universal 
specific signal for triggering gene transcription. It is also noticeable that the 
abundance of di- and tri-methylation seems to differ in the promoter and in the 
coding region, because H3K4Me3 is more represented in the promoter and 
H3K4Me2 is more abundant in the coding region (Figure 37). On the other hand, 
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 methylation seems to be a mark for active genes (such as β-actin) or for potential 
active genes (such as egr-1). 
 
 
Figure 37. Post-transductional histone modifications in egr-1 promoter. 
ChIP analysis of MLP29 cells non-treated (repressed) or treated (active) with 
TPA for 30 min. Crosslinked chromatin was immunoprecipitated with antibodies 
against H3K9AcS10P (PA), H3K9Ac, H3K14Ac, H3K4Me3, H3K4Me2, 
H3K18Ac, H3K27Ac, H4K5Ac, H4K8Ac, H4K16Ac and H4HiperAc or in 
absence of antibody (NA). Immunoprecipitated DNA was assayed by PCR with 
primers specific for the promoter (see Table 15) and coding region (see Table 
16) of egr-1. β-actin and α-actin genes were also amplified as positive and 
negative controls. Results are representative of, at least, three different 
experiments. 
 
- 147 - 
 Deepening into the specific modifications of egr-1 promoter, it has to be 
noted that there is an increment in phosphorylation of serine 10 in histone H3, as 
shown by the increase in the signal obtained with the antibody PA that specifically 
recognizes the modification of H3 lysine 9 acetylation and serine 10 
phosphorylation (H3K9AcS10P). This combination has been related to immediate-
early gene activation by Cheung et al. (2000), and accordingly it appears in the 
induction of our gene, but not in the constitutively expressed β-actin gene. However, 
this modification is specific for the promoter, as it is lacking in the coding region 
amplified. Phosphorylation of serine 10 is usually carried out by kinases 
downstream MEK, one of the signalling networks implicated in the egr-1 activation, 
as it is the case for MSK1 and RSKs (Chee et al., 2004). 
 
So far, we have been able to determine some of the modifications that are 
needed for the activation of egr-1 transcription by TPA, as well as the enzymes that 
seem responsible for those modifications. Although we cannot establish a direct 
correlation between enzymes and modifications, we may suggest that GCN5, 
detected by ChIP at 15 min after TPA treatment, can account for the acetylations at 
H3K9, H3K14, H4K18 and H4K16 acetylations, as all of them increase in the 
promoter upon gene induction. In the same manner, CBP which attributable function 
may be to maintain the basal level of acetylation, could be responsible to acetylate 
H3K14 and H3K18 residues, that are substrates described in the literature for this 
HDAC activity. Anyway, it can not be ruled out that any of the modifications can be 
carried out by different HATs, whose presence we have not yet detected, as 
reviewed in the introduction (see section 1.2.2 from Introduction).  
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 6. NUCLEOSOMAL POSITIONING AT egr-1 PROMOTER 
 
Nucleosome positioning has an essential role in facilitating the regulated 
transcription of eukaryotic genes, and therefore it is not possible to study the 
mechanism of egr-1 transcriptional regulation without examining at the chromatin 
structure of the promoter. As previously described, some transcription factors are 
able to bind to DNA only when it is appropriately wrapped around the histone core, 
in contrast to those whose binding ability is impeded by the severe deformation of 
the DNA structure. Furthermore, positioned nucleosomes can facilitate the 
transcription process by providing the appropriate scaffold to allow the interaction of 
regulatory factors bound at distant sites. 
 
To map nucleosomes on the egr-1 promoter, we searched for sequences in 
the promoter which had high nucleosomal formation potential, by means of studying 
the gene sequence with two programs. One that predicts the nucleosome position 
basing its algorithms in the analysis of the frequency of distribution of di- and tri-
nucleotides in the minor groove when it points out or when it faces the histone 
octamer, in 177 different nucleosome cores of chicken erythrocyte (Drew et al., 
1987 and Estruch et al., 1989) and the other, that predicts nucleosome position 
basing its algorithms on thermodynamic criteria (Anselmi et al., 2000). As shown in 
Figure 38, both programs predict the probability of finding two positioned 
nucleosomes. The first program (Figure 38A) locates a nucleosome around position 
-230 bp from the starting point and another one around -820 bp from the starting 
point. The second program used (Figure 38B) predicts almost the same positions 
with minor differences. The first histone octamer would be centred at about -200 bp, 
whereas the second would be around -800 bp. In conclusion, both regions are highly 
favourable for the localization of nucleosomes, as they have a region that spans 
approximately 100 bp with a predicted high potential for nucleosome formation. 
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Figure 38. Theoretical analysis of the nucleosomal rotational formation 
potential at the egr-1 promoter sequence. (A) Prediction based on known 
DNA sequences which are found in histone octamers. Lower peaks show the 
higher probability of finding the dyad axis of a nucleosome. Panel (B) shows the 
nucleosome prediction pattern based on energy minimization criteria. In 
between both Figures there is a schematic representation of egr-1 promoter 
containing the binding sites for different transcription factors and also the 
predicted centres of the nucleosomes according to both predictions: green stands 
for the prediction in A and black for that of B.  
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 The experimental mapping of nucleosomes within egr-1 promoter was done 
by micrococcal nuclease treatment of MLP29 cells, following a modification of a 
method previously described by Steward and Sano (2004), (see Section 7 of 
Materials and Methods). As already commented, this technique allows us to 
determine nucleosomal positions due to their protection against micrococcal 
nuclease digestion. 
 
The results obtained (Figure 39) suggest the existence of three putative 
nucleosomes: N3 (dyad axis located around -800 bp), N2 (placed between -435 and -
585 bp) and N1 (around -200 bp). Both N3 and N1 would be positioned by their 
sequence, as they correlate with the high probability of nucleosome positioning 
predicted by the two theoretical programmes used to analyze the sequence (Figure 
39B). On the contrary, position of N2 nucleosome would be established indirectly 
by the existence of N1 and N3 or other factors bound in the promoter, such as the 
SRF clusters. Moreover, it is a general feature that between two sites of high 
probability of nucleosome formation potential may be indirectly positioned another 
nucleosome if there is enough space, as it happens at egr-1 promoter.  
 
The presence of positioned nucleosomes encouraged us to search for ATP-
dependent remodelling enzymes that could be bound to the promoter and as a result 
act over the found nucleosomes. ChIP analysis of the presence of these enzymes 
shows that two different ATPases, BRG1 and BRM, (which belong to the SWI/SNF 
family) are bound to egr-1 promoter (Figure 40). According to their binding pattern, 
both seem to be present when the gene is not being expressed, that is to say in the 
basal state (0 to 5 min after TPA treatment) and when the repression of the gene is 
resumed (60 to 180 min after TPA treatment). On the contrary, when the gene is 
active (15 to 30 min after TPA treatment) none of those remodelling complexes is 
bound to the promoter. This unexpected binding profile could be explained through 
different hypothesis. Firstly, it could be that the remodelling activity was as quick as 
5 min after TPA induction and then the enzymes were to leave the promoter to allow 
the rest of co-activators to bind. Secondly, it could be that BRG1 and BRM were 
forming part of some complex, as for instance of mSIN3A complex and therefore its 
- 151 - 
 function was mainly related to this complex activity. In this case, remodelling at 
egr-1 promoter would be carried out by another undetected remodelling machine. 
Pal et al., (2003) co-purified a complex formed by mSIN3A, HDAC2, PRMT5 and 
BRG1, and linked this complex to the cad gene repression process. In our results 
(Figures 31 and 40) the timing of detection of mSIN3A, BRG1 and BRM by ChIP 
analysis in egr-1 promoter correlates quite well, so we can not rule out a similar 
possibility. A third hypothesis would be to link the function of BRG1 and BRM with 
egr-1 repression; this would imply that the remodelling activities are required to 
keep the nucleosomes at their basal position so avoiding gene expression. 
Remodelling activities, although traditionally related to gene activation, have also 
been linked to gene repression. Wang et al., (2004) linked BRG1 and BRM 
chromatin modifiers with estrogen antagonist-mediated growth suppression through 
the estrogen receptor, whereas Strobeck et al., (2000) showed in C33A cells that the 
lack of BRG1 inhibited Rb cell cycle arrest, deficiency that was rescued through 
ectopic expression of BRG1. 
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Figure 39. Study of the nucleosomal probability pattern in egr-1 
promoter of MLP29 cells. Chromatin was digested to 
mononucleosomal size with MNase, and DNA was purified and 
analyzed by real-time PCR using various sets of oligonucleotides, so the 
amplicon spans the promoter region. Each amplicon was designed to 
cover around 100 bp on the template sequence, so that the regions of the 
promoter containing nucleosomes could be amplified if the full template 
was available. (A) Plot shows the nucleosomal probability of samples 
treated with 50 nM TPA at different time intervals (0 and 180 min), 
represented according to the centre of the template amplified, and 
normalized versus random DNA of around 150 bp. (B) Diagram that 
illustrates the binding sites for the transcriptional factors found at egr-1 
promoter. The putative position of the “inert” nucleosomes is depicted 
in light orange, in accordance with the centre of the template amplified. 
It can also be seen the position of the amplicons used during the 
experiment. (C) Nucleosome prediction pattern based on energy 
minimization. 
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The fact of finding two remodelling complexes bounded to egr-1 promoter 
prompted us to study the nucleosomal pattern in egr-1 during the activation process, 
searching for a feasible movement of the octamers due to the remodelling activities 
found. 
 
 
 
Figure 40. Recruitment of ATP-dependent chromatin remodelling 
enzymes to egr-1 promoter. Time-dependent ChIP analysis of MLP29 cells 
incubated or not with TPA during the indicated times. Crosslinked chromatin 
was immunoprecipitated with antibodies against BRM and BRG1 or in 
absence of antibody (NA). Immunoprecipitated DNA was assayed by PCR 
with primers (see Table 15) specific for the promoter region of   egr-1. As a 
negative control α-actin was amplified. Results are representative of at least 
three different experiments. 
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Figure 41. Study of the nucleosomal remodelling pattern in egr-1 promoter 
of MLP29 cells during its induction by TPA. Chromatin was digested to 
mononucleosomal size with micrococcal nuclease and DNA was purified and 
analyzed as in Figure 39. (A) Plot shows the nucleosomal probability of 
samples treated with 50 nM TPA for different time intervals (0, 15, 30 and 180 
min), represented as in Figure 39. (B) Diagram that illustrates the binding sites 
for the transcriptional factors found at egr-1 promoter. The putative position of 
the “inert” nucleosomes is depicted in orange according to the centre of the 
template amplified, whereas the nucleosome that moves is coloured in green at 
the new position, also according to the centre of the template amplified. It can 
also be seen the position of the amplicons used during the experiment. (C) 
Nucleosome prediction pattern as in Figure 39. Results are representative of, at 
least, three different experiments. 
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 Figure 41 shows the putative gene induction-dependent changes in the 
positioning of the three nucleosomes detected in the basal state. Our results indicate 
a movement of N1, during egr-1 expression, but the other two nucleosomes remain 
static. Furthermore, when the gene is not active, nucleosome N1 protection to 
micrococcal nuclease is not as significant as in the case of N3 and N2, suggesting 
that N1 is not as strictly positioned as N2 and N3. In other words, it might be sliding 
to and fro along the DNA. On the contrary, when the gene is induced N1 seems to 
be forced to a new position further upstream (around -260 bp location for the dyad 
axis) in which, the protection probability satisfactorily correlates with the 
probability found for N3 and N2. Nevertheless, we have to bear in mind that we 
have represented the nucleosomes at the centres of the amplicons and that these 
positions should be precisely defined to exactly locate the nucleosome.   
  
Classically, the nucleosomal organization of chromatin has been considered 
as a constraint for gene transcription, and therefore it would be necessary to 
reorganize their position. We have empirically corroborated the existence of three 
nucleosomes: N1, N2 (positioned by the boundary effect of N3) and N3. Our results 
suggest that the nucleosomal positioning probability of N1 is about half of that for 
N3 and N2, and just this nucleosome becomes displaced during egr-1 activation. We 
hypothesize that this movement could be caused by BRM, an ATPase subunit of the 
SWI/SNF family of ATP-dependent chromatin remodelling complexes, and 
therefore that would imply that the cell is using energy to repress an important gene 
as egr-1, which encodes a transcriptional factor. It is important to remember that the 
promoter of the gene also contains at least two more co-repressors: mSIN3A 
complex and NCoR/HDAC3 (Figure 31).  
 
This N1 “nucleosomal oscilation” would correlate to the need of the 
transcriptional machinery to recruit other factors that are also required for the 
transcription, as for instance, the mediator complex, which will probably facilitate 
the successive rounds of initiation, or elongation factors as P-TEFb (Positive 
Transcription Elongation Factor b) that is needed to phosphorylate serine 2 of 
RNApol II CTD (C-terminal Domain). Some authors have suggested that the 
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 mediator could be the responsible for recruiting the RNA pol II to the promoter, but 
this possibility can be ruled out for our gene, as the polymerase is paused in the 
promoter. Nevertheless, the movement of the nucleosome will be required to 
guarantee that components of the PIC and of the elongation complex have enough 
space to bind and act.  
 
So far, it has not been described a gene in which a remodelling complex is 
impeding the accurate nucleosomal position for transcription. On the contrary, the 
usual model is that remodelation is required to allow transcriptional factors to gain 
access to the template which is being occupied by the nucleosome. Despite this fact, 
BRM and its counterpart BRG1, have been widely implicated in the literature in 
transcriptional repression. As it has been previously said, Wang et al. (2004) 
proposed a mechanism in which JNK1 pathway induces their recruitment to prevent 
estrogen-induced growth. In the same way, Kemper et al., (2004), described the 
arrest of cholesterol 7α hydroxylase gene (cyp7a1) gene by the recruitment of a 
complex formed by mSIN3A and SWI/SNF. Furthermore, the fact that BRM seems 
to leave the promoter upon gene induction and returns to it when egr-1 is again 
repressed, supports our hypothesis.  
  
To this point, we have been able to describe the movement of the 
nucleosome but the actual remodelling mechanism remains obscure. As commented 
above, Pal et al. (2003) described the need of HDAC2/mSIN3A/PRMT5 for the 
BRG1 complex to repress the MYC target gene cad. Having these results in mind, 
we tried to know whether any histone methyltransferase, as PRMT5, was present in 
egr-1 promoter by using ChIP assay at nucleosomal resolution (see section 6 from 
Materials and Methods). Mononucleosomal resolution provides a significant 
advantage over classical ChIP results, despite the fact that the amount of sample 
required is noteworthy higher, this limiting the number of experiments that can be 
done.  Figure 42, shows that the histone methyltransferase PRMT1 (the main 
responsible to methylate H4R3) is differentially recruited to the nucleosomes and 
that the histone modification associated to this enzyme, H4Arg3Me2a, also occurs 
there. Asymmetric methylation seems to increase only in N2, and remains more or 
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 less constant in the other two nucleosomes. This could be in agreement with the fact 
that PRMT1 is detected upon nucleosome N2 only in the activated state and not in 
the repressed one. The objective of this experiment was to determine if the 
methylase was specifically bound to N1 nucleosome. Our results, as previously 
mentioned only show an increase in the methylation state of nucleosome N2. 
Therefore, to search for other possible specific causes for the movement of N1 
nucleosome, we next examined the phosphorylation of the enzymes involved in the 
process.   
 
Figure 42. Recruitment of PRMT1 HMTs to specific nucleosomes at the 
egr-1 promoter and analysis of histone methylation. ChIP analysis of 
MLP29 cells expressing or not egr-1 mRNA. For the active sample, cells 
were treated with TPA for 15 min. Crosslinked mononucleosomes were 
immunoprecipitated with antibodies against H4R3Me2a and PRMT1 or in 
absence of antibody (NA). Immunoprecipitated DNA was assayed by PCR 
with primers 1/ 2, 7/ 8 and 13/ 14 (Table 17) contained into nucleosomes 
N1, N2 and N3 of egr-1. 
 
We further decided to investigate the mechanism to understand the specific 
movement of N1 nucleosome during activation. For this purpose, N1 position was 
analyzed in samples treated with okadaic acid (an inhibitor of protein phosphatases 
PP1 and PP2A) and with D-L-homocysteine, adenosine and N-methyl-2-
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 deoxyadenosine (inhibitors of PRMT1; Smith et al., 2004) (Figure 43). Our results, 
analysing the amplicons 11/12 and 13/14 that cover the positions of nucleosome N1 
under repression and activation of egr-1 respectively, indicated that histone 
methylation of N1 by PRMT1 did not seem to have an effect on remodelling 
activity. On the contrary, inhibition of the phosphatases did result in an increase in 
the remodelling abilities of our system, suggesting that the level of phosphorylation 
of certain proteins has an important role in the overall remodelling process.  
 
 
Figure 43. Effect of phosphatase and methylase inhibitors in the 
nucleosomal remodelling induced by TPA in MLP29 mouse cell line. 
Serum-starved cells were treated or not with okadaic acid (OK, PP1 and PP2A 
inhibitor), S-L-homocysteine, adenosine and N-methyl-2adenosine (PRMT1 
inhibitors, i PRMT1) for 1 h prior to 30 min treatment with TPA. 
Mononucleosomal chromatin fragments were purified and analyzed by real-
time PCR. The control was arbitrarily set to 1. Results show the average + S.D. 
of, at least, three independent experiments. 
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 Finally, we decided to check the importance of phosphorylation in the 
remodelling mechanism by analysing egr-1 expression in cells treated with okadaic 
acid. As seen in Figure 44, okadaic acid by itself is able to induce egr-1 expression, 
despite the fact that it is not as pronounced as when the cells are treated with TPA. 
Cao et al. (1991) described a sustained induction of egr-1 upon okadaic acid 
treatment, as a consequence of the multiple phosphorylation of EGR1 at multiple 
sites. The phosphorylated isoforms are more stable than the usual unphosphorylated 
form that is produced in cells not treated with serine/threonine phosphatase 
inhibitors. Nevertheless, our results suggest that the induction could be related to the 
remodelling that takes place in N1, despite the fact that the other transcription 
factors are not bound and therefore the induction is not as high as with TPA 
treatment. Even though, this explanation does not exclude that there is a sustained 
egr-1 expression due to the phosphorylation of the gene product. 
 
Figure 44. Effect of okadaic acid (PP1 and PP2A phosphatase inhibitor) 
in egr-1 expression in MLP29 mouse cell line. Serum-starved cells were 
treated or not with okadaic acid for 1 h prior to 30 and 180 min treatment 
with TPA. Total RNA was extracted and analyzed by real-time PCR. The 
control used was arbitrarily assigned to 1. Results show the average + S.D. 
of, at least, three independent experiments. 
- 160 - 
 7. HISTONE MODIFICATIONS AT MONONUCLEOSOMAL LEVEL 
DURING egr-1 INDUCTION 
 
Nucleosomal histones are the target of covalent modifications and, therefore, 
they play an intrinsic role in the regulation of transcription (Turner et al., 2002). 
Nevertheless, there is only limited information regarding the modifications found at 
specific nucleosomes at a given gene after the activating signals. To know if there 
are specific modifications over defined nucleosomes in our model system, we 
prepared chromatin of mononucleosomal size and immunoprecipitated it with some 
of the antibodies that we had previously analyzed: H3K9AcS10P (PA), H3K4Me3, 
H3K9Ac, H3K14Ac, H3K18Ac, H3K27Ac, H4K5Ac and H4HiperAc. It is 
important to note that in the case of N1, the nucleosome displaced during the 
induction process, the oligonucleotides used to amplify the immunoprecipitated 
fragments from the repressed and activated state are different. This fact may difficult 
the comparison between the results, due to the potential differences in the quality of 
the oligonucleotides used. Nevertheless, it was the only possible way to perform the 
experiment, as using the same set of oligonucleotides would not have allowed us to 
amplify the signal in one of the gene states.   
 
The analysis of the modifications present in the three nucleosomes detected in 
egr-1 promoter can be seen in Figure 45. The results show a similar pattern for the 
three positioned nucleosomes analyzed, although there are subtle differences among 
them in the activated state. For instance, H3K4Me3, H3K9Ac and H4K5Ac increase 
in all the cases relative to the control cells. On the contrary, phosphoacetylation of 
H3 increases in the two nucleosomes that are nearer the transcriptional start, and 
remains unchanged in N3. In the case of H4, the hyperacetylation shows an opposite 
pattern, that is to say, increases greatly at nucleosome N3, only a little in 
nucleosome N2 and it remains unchanged at nucleosome N1. There are also certain 
modifications that seem to decrease, as H3K27Ac, which could be explained 
because, as mentioned above, in the mononucleosomal ChIP we have used two 
different sets of oligonucleotides to amplify the samples from the repressed (0 min 
TPA) and the activated (15 min) states, and therefore the quality of the 
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 oligonucleotides may differ. Another possible reason could be the fact that we have 
two molecules of each histone in each of the nucleosomes, and maybe the 
modification of only one of them is enough to account for the induction process. 
Therefore, these results would suggest a more precise print of histone changes in the 
nucleosomes nearer the transcriptional start, probably due to the need of a highly 
specific signal to dock the proteins necessaries for transcription. 
 
 
Figure 45. Post-translational histone modifications of the nucleosomes 
located at egr-1 promoter. ChIP analysis of MLP29 cells expressing or not 
egr-1 mRNA. For the active sample, cells were treated with TPA for 15 min. 
Crosslinked mononucleosomes were immunoprecipitated with antibodies 
against H3K9AcS10P (PA), H3K9Ac, H3K14Ac, H3K4Me3, H3K18Ac, 
H3K27Ac, H4K5Ac, and H4HiperAc or in the absence of antibody (NA). 
Immunoprecipitated DNA was assayed by PCR with primers with primers 1/ 
2, 7/ 8 and 13/ 14 (Table 17) that fall, respectively, within nucleosomes N1, 
N2 and N3 of egr-1.  
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 In conclusion, there are differences between the histone modifications of the 
three nucleosomes found at egr-1 promoter, probably because they have diverse 
roles in the induction process serving to recruit distinct protein complexes. 
Furthermore, it has to be kept in mind that nucleosome N1 modifies its position 
during the expression of the gene and there must be specific modifications, not yet 
determined, that target the nucleosome that has to be displaced. 
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 8. BIOLOGICAL ROLE OF THE TRANSCRIPTIONAL FACTOR  EGR1 
 
8.1. EGR1 ACTIVITY ON OTHER TARGETS 
 
Egr-1 activity is partly modulated by the binding of two corepressors named 
NAB1 and NAB2 (NGFI-A-Binding Protein 1 and 2) (Miano et al., 1999; Srnivasan 
et al., 2006). NAB1 was first identified in a yeast two-hybrid experiment as 
interacting with the repression domain, subunit R1, of EGR1 and later, NAB2 was 
identified by homology with the previously-found protein (Svaren et al., 1996). Both 
proteins interact with EGR1 through its NCD1 domain (NAB conserved domain 1) 
and stimulate the repression activity of the transcriptional factor. Therefore, to 
deepen into the study of egr-1 regulation we decided to analyze nab1 and nab2 
genes.  
 
The measurement of the expression of these genes shows that nab1 is 
constitutively expressed in MLP29 (data not shown), whereas nab2 is induced by 
TPA (Figure 23 and Figure 46A). These results are in agreement with those 
described by Miano et al. (1999), in which they demonstrate that nab2 expression is 
also activated by the same stimulus that egr-1 expression. Moreover, since these 
three proteins EGR1, NAB1 and NAB2, are implicated together in the control of 
gene expression, we decided to analyze if there is any auto regulation in the 
expression of them. To do this, we performed a ChIP assay to study the binding of 
these factors to nab2 promoter (Figure 46B). The results demonstrate that EGR1, in 
conjunction with NAB1 and NAB2 is recruited to the nab2 promoter at 30 and 60 
min after TPA treatment and they are barely seen at 180 min post-induction. These 
results confirm that in our model system there seems to be a negative feed-back loop 
between egr1 and nab2 regulation.  
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Figure 46. Analysis of nab2 gene. (A) analysis of nab2 expression by 
RNAPol-ChIP technique (B) Time-dependent ChIP analysis of EGR1, NAB1 
and NAB2 binding to nab2 promoter upon TPA treatment of MLP29 cells. 
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 8.2. EGR1 SHORT INTERFERENCE RNA 
 
RNA interference is a powerful tool that simulates the cellular mechanism 
for the targeted destruction of gene specific RNA molecules, proving to be very 
useful to study the function of a protein. This technique is referred by many authors 
to as “knockdown”, as it may not totally abolish the expression of the gene, in 
contrast to the “knockout” procedures, in which gene expression is entirely 
eliminated by removing or destroying its DNA sequence.  
 
To gain more knowledge on the role of EGR1 as a transcriptional regulator, 
we produced egr-1 short-interfering RNAs and examined weather depletion of the 
protein had any effect over a functional target such as nab2 gene. Firstly, we 
selected three different target sequences (see Section 9.1 from Materials and 
Methods) and cloned them into a pSUPER vector and transfected NIH3T3 mouse 
fibroblasts. We also tried to transfect MLP29 cells but unfortunately the efficiency 
of the transfection measured by the green fluorescence of the GFP associated to the 
vector was very low (results not shown). The effectiveness of the ShRNA used to 
knockdown egr-1 is shown in Figure 47A. The expression of egr-1 is reduced to 
30% with Sh1egr-1, to 35% with Sh2egr-1 and just to 50% for Sh3egr-1, in 
comparison to the transfected cells with the vector containing the scrambled 
sequence (Shscrbl). Furthermore, the effect of Sh1egr-1 over egr-1 expression was 
further confirmed by confocal analysis of samples of cells that have been 
immunostained with the antibody against EGR1. Figure 47B shows, that the cells 
co-transfected with the interfence vector for EGR1 (red fluorescence) and GFP 
expressing vector (green fluorescence) contain a significantly reduced red 
fluorescence in comparison with the ones that have not been successfully 
transfected. To have an idea of the importance of these results we decided to 
quantify the fluorescent red signal, in the untransfected and in the transfected cells, 
by using ImageJ program (http://rsb.info.nih.gov/ij/). The results obtained 
assigning a 100% of EGR1 presence in the untransfected cells, showed that in the 
case of the cells co-transfected with the interference vector for EGR1 and GFP 
expressing vector, EGR1 presence was as low as 28,3%.  This data is totally in 
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 agreement with the decrease detected by egr-1 mRNA analysis by real-time RT-
PCR (see Figure 47A).    
 
Another important conclusion that could be extracted from the confocal 
analysis resides in the fact that EGR1 transcription factor seems to be mainly 
localized to the nucleus of the TPA stimulated cells, in contrast to the green 
fluorescent protein, which is unspecifically localized.  
 
 
Figure 47. Validation of the efficiency of egr-1 short interference 
RNA. (A) Cells co-transfected with GFP and pSUPER were sorted with a 
FACS and total RNA was extracted and egr-1 expression analyzed by 
real-time RT-PCR. Cells containing the vector with the scrambled 
(Shscrbl) sequence were arbitrarily assigned to 100 % expression. (B) 
Confocal image of NIH3T3 mouse fibroblast cells co-transfected with a 
vector containing GFP (Green Fluorescent Protein) and with Sh1egr-1 
pSUPER vector. Cells were immunostainned against EGR1. 
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  To validate the biological activity of egr-1 short interference RNA, as well 
as to confirm the importance of EGR1 as a key regulator of nab2, we analyzed nab2 
expression by real-time PCR in cells co-transfected with the GFP expressing vector 
and the sh1egr1 or sh2egr1 RNA expressing vector for EGR1. The histogram shown 
in Figure 48 confirms a decrease in the nab2 mRNA when cells bear shegr1 RNAs. 
This decrease is more pronounced in the case of sequence 1 than in the case of 
sequence 2. As a result, our experiments provide evidence that EGR1 is an important 
regulator of nab2 expression. This interrelation between egr-1 and nab2 was also 
stated by Kumbrink et al. (2005) in their model system, despite the fact that the 
triggering signal in their cells acted via PKC cascade.  
 
 
 
 
Figure 48. Validation of the biological activity of egr-1 short 
interference RNA. Cells co-transfected with GFP and pSUPER were 
sorted with a FACS and total RNA was extracted and analyzed by real-
time RT-PCR. Cells containing only empty vector with GFP were 
arbitrarily set to 100 % expression. 
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 9. TOWARDS A MODEL FOR egr-1 INDUCTION 
 
The whole of results obtained so far indicates that egr-1 gene expression is 
achieved by an ordered program of recruitment of activators, chromatin-remodelling 
complexes and coactivators to the promoter. The formation of the transcriptional 
activating complex in TPA-stimulated MLP29 cells is dependent on stimulation of 
MEK and p38 signalling pathways. In contrast, co repressor complexes are released 
from the promoter during transcriptional activation, driving specific histone 
modifications that allow a shift from repressive to permissive transcriptional state of 
egr-1. Chromatin remodelling, induced by BRM and/or BRG1, is also favouring this 
process.  Therefore, we propose a hypothetical model that attempts to explain the 
mechanism of egr-1 transcriptional regulation (Figure 49).  
 
The model is based on a “preassembled promoter”, in which transcriptional 
factors, such as SRF, ELK1, CREB and SP1 are bound to their cognate trans-
sequences in egr-1 promoter. These preassembled factors would be in charge of 
keeping co repressor complexes bound in the gene. Our time-dependent ChIP 
analyses at different times show, at least, two independent HDACs complexes, one 
represented by mSIN3A and another represented by NCoR-HDAC3 complex. 
According to Hong et al. (2000), NCoR is able to interact with mSIN3A complex, 
but our results do not confirm this contact, not only because mSIN3A is usually 
accompanied by HDAC1 and HDAC2 instead of HDAC3, but also because the 
recruiting time of both enzymes is slightly different. On the other hand, a complex 
formed by HDAC3, NCoR and enzymes like BRG1 has been effectively purified in 
HeLa cells (Underhill et al., 2000, Wen et al., 2000 and Guenter et al., 2001). 
Unexpectedly, a HAT complex, represented by CBP would also be attached to egr-1 
promoter under repression conditions (represented by the red traffic light in Figure 
49).  It is usually accepted that HDACs are in charge of maintaining a 
hypoacetylated transcriptional repressive state of chromatin, but this acetylation 
level must be achieved by a subtle balance between HDACs and HATs, usually 
considered as activators. We suggest that CBP found in egr-1 promoter before its 
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 induction would be responsible of maintaining the basal level of acetylated lysines 
9, 14 and 18 from H3 and lysine 5 from H4 found in the promoter.  
 
All the complexes that are present in the egr-1 promoter are able to be 
recruited by the bound transcriptional factors, as it has been demonstrated by pull-
down or two-hybrid analyses. For instance, ELK1 is able to recruit mSIN3A 
complex (Yang et al., 2001) and both, SRF and SP1 are able to interact with NCoR 
(Lee et al., 2000; Lee et al., 2005). Furthermore, SP1 and CREB can target CBP to 
the promoter of some genes (Deng et al., 2003). In conclusion, our model proposes 
that the bound transcriptional factors are responsible for the ordered recruitment and 
for the maintenance of co-repressors to the promoter. Anyway, further experiments 
would be necessary to corroborate the specific interactions that may drive such 
recruitments. 
 
The ChIP assays also demonstrated the presence of BRM and BRG1 
remodelling complexes in the egr-1 promoter prior to induction, as if they were 
somehow involved in the N1 nucleosome “oscillation” along the region next to the 
transcriptional start. This hypothesis would imply a permanent energy-consuming 
process while egr-1 is repressed, but a possible explanation for this energy waste 
might be that the importance of egr-1 regulation resides in its repression more than 
in its activation. For instance, the nucleosomal sliding would prevent the binding of 
some necessary components of the pre-initiation complex or components from the 
elongation complex needed by the egr-1 gene to be activated.  
 
Upon TPA treatment, the gene is induced (represented by the green traffic 
light in Figure 49), and p38 and MEK1 drive the signal to egr-1 promoter that leads 
to the phosphorylation of ELK1 and CREB. ELK1 phosphorylation would direct the 
formation to the ternary complex with SRF and DNA (TCF) (Chai et al., 2002, 
Lindecke et al., 2006),   and to the release of mSIN3A. In the same manner, CREB 
phosphorylation is able to diminish CBP activity, as it was pointed out in the 
experiments of Chen et al., (2001) and, as a consequence it may leave the promoter. 
However, there are other experiments in which CREB results phosphorylated by 
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 PKC and then it recruits and activates CBP (Molstad et al., 2004). Probably the 
function of CREB will depend on the characteristics of the kinase cascade and, by 
extension, on the type of cellular stimulus. When the ternary complex is formed, it 
would become an activator and, in turn, induce egr-1 transcription. This activation 
would be helped by the release of SP1 which would be acting as a gene repressor 
being responsible for the recruitment of NCoR-HDAC3 complex. The union 
between SP1 and NCoR complex would be broken by the phosphorylation of NCoR, 
as ChIP assays with pre-treated cells with MEK or p38 inhibitors show the 
permanent presence of the NCoR complex, absent in untreated cells. Lee et al., 
(2005) demonstrated, by co-immunoprecipitation assays, that SP1 and NCoR 
interaction is regulated by MEK signalling. 
 
In the context of chromatin remodelling, the ATP-dependent remodelling 
complexes leave the promoter possibly permitting the proximal nucleosome N1 to 
relocate itself and allowing the binding of new components to the transcriptional 
machinery. It could also be probable that phosphorylated ELK1 interacts with the 
mediator components to recruit lacking subunits or to enhance egr-1 transcriptional 
rate. It has been shown that phosphorylated ELK1 is able to interact with SUR2 
(Cantin et al., 2003) and with MED23 (Wang et al., 2005), two subunits of the 
mediator complex, and subsequently stimulate RNA Pol II initiation.  
 
All these changes induced in the promoter would recruit GCN5 that changes 
the level of acetylation of specific sites over the histone tails, creating another point 
of expression control. In addition to general increased acetylation levels, such as of 
lysines 9, 14 and 18 of H3 and of lysine 5 in H4, we found that there are subtle 
differences in each of the three nucleosomes arranged in egr-1 promoter. We 
observed an increment of levels of phosphoacetylation (H3S10-PhK9Ac) in 
nucleosomes N1 and N2, whereas these levels remain constant in nucleosome N3. 
This modification may be responsible for the relaxed chromatin structure, necessary 
for egr-1 expression, and would also be functionally linked to GCN5, as a first step 
for the enzyme-mediated acetylation of H3K14Ac (Cheung et al., 2000). It is 
noteworthy that H3K14Ac increases only in N3 remaining almost unchanged in N1 
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 and N2, implying that the acetylation mediated by GCN5 would be the consequence 
of a general increase but it seems not to be nucleosome-specific. H3K4Me3 and 
H4K5Ac are also generally increased all over egr-1 promoter. As previously 
mentioned, K4 methylation of H3 is a general mark for active gene transcription, 
and therefore is reasonable to find it increased in the nucleosomes of egr-1. All these 
modifications would help to recruit co-factors and polymerase II following the 
instructions given by the histone code and after an appropriated remodelling of the 
nucleosomes.  
 
 
 
 
 
 
 
 
 
 
 
Figure 49. Hypothetical mechanism of egr-1 induction upon TPA 
treatment in MLP29 mouse cells. In the arrested gene (red traffic light), SP1, ELK1, 
SRF and CREB transcription factors are bound to their recognition sequences in the 
promoter. The gene is kept repressed by two different HDAC complexes, one 
containing mSIN3A and the other containing HDAC3 and NCoR. Nevertheless there is 
a HAT complex, CBP, which is in charge of the basal acetylated state of the gene. 
Furthermore, there are two ATP-dependent remodelling enzymes: BRM and BRG1. 
Upon TPA treatment (green traffic light), p38 and MEK phosphorylate ELK1, which is 
able to form and activate ternary complex with SRF and CREB, interacting with the 
mediator and facilitating egr-1 transcription. At the same time, the remodelling and 
HDAC complexes leave the promoter, facilitating nucleosome N1 displacement, and 
GCN5 containing complex is recruited. To simplify the model, the modifications that 
take place in the tails of the histones H3 and H4 of the nucleosomes are only depicted 
in the activated state, and therefore only those that are increased in each of them are 
represented. Finally, in the repression process of the gene (yellow traffic light), EGR1 
binds to its own promoter and recruits NAB1 and NAB2, which in turn activate the 
repression domain of EGR1. GCN5 complex leaves the promoter and the HDAC and 
remodelling complexes are able to return. In the same manner, N1 returns to its initial 
repressive position. 
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 Once the roles of EGR1 have been fulfilled, the protein itself binds to its 
own promoter creating a negative autoregulatory loop (Figure 49, yellow traffic 
light), the protein itself binds to its own promoter creating an autoregulatory loop. 
Upon EGR1 binding to the promoter, the transcriptional factors NAB1 and NAB2 
bind to EGR1 and activate its repression domain. It has been demonstrated that 
NAB1 is able on its own to repress gene expression (Thiel et al., 2000) and also that 
both NAB1 and NAB2 are capable of interacting with subunits of the repressor 
NuRD complex (Srinivasan et al., 2006). Nevertheless, in our model system, as both 
NAB1 and NAB2 are bound to egr-1 promoter, it makes sense to think that both of 
them act synergistically to activate EGR1 repression domain. It could also be 
possible that only one of the co-factors would be enough to active EGR1 repressive 
properties, and therefore the coupling of them acts as a security brake.  
 
Consequetly, our results suggest a model in which EGR1 and SP1 would 
be responsible to return the gene to its basal repressive state, by recruiting again all 
the co-repressors found in the basal state (Figure 49, red traffic light). In addition, 
N1 will be again “oscillating” along the promoter, maybe preventing the 
recruitment of components of the basal transcriptional machinery, or avoiding 
further transcription factors, not yet identified, to interact with its DNA-binding 
sequence. Therefore, cell-specific factors and signalling pathways may regulate 
transcriptional activation of the murine egr-1 gene by modulating its gene-specific 
transcriptional program under the mitogenic signal of phorbol esters. 
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CONCLUSIONS 
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1- The gene egr-1 (early growth response-1) is highly expressed upon TPA 
treatment of different cell lines. RNAPol-ChIP experiments show a pattern 
of expression that begins as early as 5 min, with a peak around 30 min to 
decrease subsequently and be again undetectable at 3 h after the treatment. 
2- Egr-1 may be considered as a “potentially active gene” as it seems to be 
“ready” to be expressed after the appropriated stimulus, seeing that the 
RNApol II and all the necessary transcription factors are bound to the 
promoter in the basal state. The two SRE clusters seem to be occupied and, 
by contrast, only the more proximal SP1 binding site has the transcription 
factor attached. The existent transcriptional factors in the promoter (CREB 
and ELK1) need only to be phosphorylated by MEK and/or p38 network to 
induce expression. In concrete, ELK1 becomes phosphorylated to render 
active the ternary complex (TFC) with the pre-bound SRF. These results are 
in accordance with the lack of gene expression when MLP29 cells are 
treated with p38 and MEK kinases inhibitors.  
3- SP1, is the unique transcriptional repressor found in our studies which 
seems to leave the promoter during egr-1 induction to return subsequently 
when the gene starts to be repressed.  
4- The transcriptional factor EGR1 binds to its own promoter 15 min after TPA 
administration and therefore, it seems to operate as an enhancer of its own 
transcription. Afterwards, at 30 min of TPA induction, the factors NAB1 
and NAB2 interact with EGR1, activating its repression domain and hence 
repressing egr-1 expression.  
5- There are at least two histone deacetylase repressor complexes in egr-1 
transcriptional basal state: mSIN3A and HDAC3-NCoR. Those complexes 
leave the promoter during transcriptional activation and return afterwards 
when egr-1 is repressed. Furthermore, two histone acetyltransferases 
complexes have been involved in egr-1 gene expression. CBP, which would 
be in charge of the basal acetylated state of the gene, and GCN5, which 
activity would be specific for the gene induction by TPA. When histone 
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 modifications in egr-1 promoter are studied, we detect an increase in the 
H3K9AcS10P, which is a transcriptional mark for immediate-early genes. 
Furthermore, there is a significant increase in the acetylation of H3 and H4, 
in particularly H4, which only has K5 modified when the gene is not being 
expressed and, upon induction, K8 and K16 are also subject to acetylation. 
These modifications seem to be particular for immediate-early genes, as 
they are absent in the promoter of the constitutively active β-actin gene.  
6- We have also found that di- and tri-methylated  K4 of H3 are present along 
the promoter and coding region of the gene, but they are also present in the 
β-actin promoter, implying that they may be a general epigenetic signal for 
genes that are transcriptionally active. 
7- There are three regularly positioned nucleosomes along egr-1 promoter. 
Nucleosome N1 has its putative dyad axis position at -200 bp, nucleosome 
N2 at -510 bp and nucleosome N3 at -800 bp from transcriptional nucleotide 
initiation. Nucleosomes N1 and N3 would be positioned by its sequence, 
whereas N2 would be located indirectly by the boundary action of the other 
two. The nucleosome N1 moves around 50 bp upstream upon gene TPA 
induction, and it returns to the previous position during the subsequent gene 
repression. 
8- BRG1 and BRM remodelling complexes have also been found in the 
promoter when the gene is inactive, probably facilitating the nucleosome N1 
sliding. 
9- The phosphorylation of specific transcriptional factors or histones seems to 
be important for the remodelling process as phosphatase inhibitors alter the 
remodelers’ nucleosomal affinity. On the contrary, methylation of histones 
seem no to have any effect, as PRMT1 inhibitors or the lack of H4R3Me2a 
do not alter the nucleosomal positioning.  
10- Nucleosomal-resolution ChIP analysis of N1, N2 and N3 revealed general 
modifications in the three nucleosomes, as an augment in H3K4Me3, 
H3K9Ac and H4K5Ac. On the contrary, nucleosomes N1 and N2 increase 
its modification H3K9AcS10P, that remains unchanged for nucleosome N3, 
- 177 - 
 but the later is the one that has a considerable increase in H3K14Ac and 
H4hiperAc modifications. 
11-  The transcriptional factor EGR1 regulates nab2 expression, and the 
incubation of cells with short interference for EGR1 synthesis produces a 
noteworthy diminishing both in egr1 and nab2 expression. 
12- Sequence 1 of short interference for EGR1 on its own, is able to reduce    
egr-1 expression 70%, as it was demonstrated both by real-time analysis of 
the gene expression and, by confocal analysis of co-transfected cells with 
GPF expressing vector and EGR1 short interference expressing vector, 
analyzed with ImageJ program.  
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 I. INTRODUCCIÓN 
1.   PAPEL DE LA CROMATINA EN LA TRANSCRIPCIÓN 
 Las células eucariotas han resuelto el problema de adaptar su largo genoma 
(~ 2 metros) al pequeño espacio del núcleo (~ 10 µm de diámetro), mediante la 
formación de una estructura compacta básica, formada por DNA y proteínas, 
llamada nucleosoma, que es además capaz de plegarse formando estructuras más 
complejas (Figure 2). La unión del DNA con proteínas histona y no histona, es 
decir, la cromatina (Fleming, 1882), a pesar de ser una estructura dinámica crea un 
obstáculo para la maquinaria transcripcional puesto que dificulta la unión de los 
factores transcripcionales al DNA. Para superar estas restricciones, la célula ha 
organizado el reclutamiento de enzimas modificadores de la cromatina, que son 
capaces de producir cambios en los promotores de los genes, alterando así la 
accesibilidad de los factores necesarios para la transcripción. Estas enzimas pueden 
ser clasificadas en dos grandes grupos: enzimas modificadoras de la cromatina y 
complejos remodeladores de la cromatina dependientes de ATP. Las enzimas del 
primer grupo son las encargadas de modificar covalentemente las histonas, alterando 
con ello la carga generalmente positiva de las mismas y perturbando la estructura de 
la cromatina. Por el contrario, los complejos del segundo grupo utilizan la energía 
procedente de la hidrólisis del ATP para modificar las interacciones histona-DNA, 
incrementando la accesibilidad al DNA nucleosomal tanto de los factores 
transcripcionales como de la maquinaria transcripcional. Además, la transcripción en 
eucariotas puede también ser facilitada por las alteraciones que tienen lugar en el 
“core” del nucleosoma (Becker et al., 2002). 
1.1 Estructura de la cromatina e hipótesis del código de histonas 
 El nucleosoma está formado por unos 200 pb (dependiendo del organismo), 
un octámero de histonas, formado por un tetrámero de H3/H4 y dos dímeros de 
H2A/H2B, y una copia de la histona H1. El “core” nucleosomal, por su parte tiene 
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 147 pb y le falta la histona H1, que se sitúa en el DNA espaciador entre dos 
nucleosomas consecutivos (Thomas et al., 1975 y Richmond, 1985). 
 Las histonas son proteínas básicas altamente conservadas a lo largo de la 
evolución y que se caracterizan por poseer un dominio estructural denominado 
“histone fold”. Este dominio se compone de una hélice α central, separada mediante 
dos giros de hojas β de dos hélices α en los extremos, y es el responsable de la 
dimerización de histonas (Arents et al., 1991 y Richmond et al., 2003). Las colas N-
terminal de las histonas sobresalen del “core” nucleosomal y pueden ser modificadas 
covalentemente por reacciones de acetilación, fosforilación, metilación y otras 
(Figure 3 y Table 1). Estas modificaciones, tienen una doble importancia: por un 
lado, son importantes para la formación de estructuras de orden superior  y por otro, 
sirven para reclutar cofactores (Cosgrove et al., 2004) y transmitir la información 
epigenética contenida en el DNA (López-Rodas et al., 1993). El hecho de que 
combinaciones específicas de modificaciones de histonas tengan lugar durante 
determinadas funciones biológicas ha llevado a proponer la hipótesis del “código de 
modificación de histonas” (Strahl et al., 2000). Sin embargo, hay que tener en cuenta 
que una modificación determinada puede tener, en contextos celulares diversos, 
diferentes funciones. Por ejemplo, la metilación de la lisina 9 de H3, generalmente 
asociada a represión transcripcional, puede asociarse en determinadas circunstancias 
con genes que están siendo activamente transcritos (Beisel et al., 2002). 
 La hipótesis del código de histonas se apoya en varios hechos. Por un lado, 
la existencia de enzimas modificadoras de la cromatina, como son los complejos 
enzimáticos histona acetiltransferasa o histona desacetilasa (Tables 2, 3 y 4), que son 
reclutados específicamente a determinados residuos. Por otro lado, en el hecho de 
que estas modificaciones específicas pueden ser reconocidas por dominios concretos 
de diversos cofactores necesarios para el proceso transcripcional, permitiendo así la 
lectura del código. Por ejemplo, los bromodominios, generalmente presentes en 
complejos histona acetiltransferasa, son capaces de reconocer lisinas acetiladas de 
las colas N-terminales de las histonas, o los cromodominios, encontrados 
generalmente en complejos remodeladores y que reconocen específicamente lisinas 
metiladas. 
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1.2 Enzimas modificadoras de la cromatina 
 Como se ha comentado anteriormente, las colas N-terminales de las histonas 
son susceptibles de ser acetiladas, metiladas y fosforiladas en residuos específicos. 
Estos procesos son llevados a cabo por diferentes complejos enzimáticos: histona 
acetiltransferasas, histona desacetilasas, histona metiltransferasas e histona quinasas.  
 Las histona acetiltransferasas (HATs) catalizan la transferencia de un grupo 
acetilo del acetil-coenzima A al grupo ε-amino de los residuos de lisina presentes en 
las colas de las histonas (Figure 4). Este proceso está generalmente relacionado con 
la activación transcripcional (Kouzarides, 1999). Las HATs pueden ser clasificadas 
en 3 superfamilias: la superfamilia GNAT, que incluye enzimas como GCN5, 
PCAF, ELP3 o HAT1; la superfamilia MYST, dentro de la se encuentran MOZ y 
ESA1 y la superfamilia p300/CBP (Table 2). 
 Las histona desacetilasas (HDACs) por el contrario catalizan la eliminación 
de los grupos acetilo de los residuos de lisina, revirtiendo la modificación de las 
HATs, y por tanto su actividad ha sido relacionada con la represión y el 
silenciamiento génicos. Estas enzimas se clasifican en tres subfamilias (I, II y III). 
Las subfamilias I y II contienen un catión de zinc en su sitio catalítico y se inhiben 
con la tricostatina A (TSA), mientras que la subfamilia III requieren el coenzima 
NAD+ como cofactor y son insensibles al tratamiento con TSA (Sengupta et al., 
2004) (Table 3). 
 Los residuos de lisina y arginina de las colas N-terminales pueden ser 
asimismo metilados, en un proceso llevado a  cabo por los complejos histona 
metiltransferasa (HMTs), consistente en la transferencia de un grupo metilo de la S-
adenosil-L-metionina al residuo receptor. Esta reacción incrementa la hidrofobicidad 
de la molécula pero no altera la carga global de las histonas como ocurre en el caso 
de la acetilación. Existen dos familias principales de HMTs clasificadas atendiendo 
a si modifican lisinas (HMTs) o argininas (PRMTs) (Table 5). La metilación de 
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 histonas se ha asociado tanto con procesos de activación (Castellano et al., 2006) 
como de represión transcripcional (Mal, 2006).  
Recientemente se han aislado enzimas capaces de revertir la reacción de 
metilación (Steward et al., 2007), pero además se han propuesto varios mecanismos 
capaces de eliminar el grupo metilo como son la oxidación, el recambio de histonas 
o la eliminación de la cola N-terminal (Jenuwein et al., 2001, Ahmad, 2002 y 
Benister 2002) (Figure 5). 
 Otra modificación que afecta a las histonas es la fosforilación de residuos de 
serina y treonina (Davie et al., 1999). De todas las fosforilaciones posibles, la más 
estudiada ha sido la fosforilación de la serina 10 de la H3, que puede ser llevada a 
cabo por enzimas como RSK2 y MSK1 y que suele estar relacionada con la 
activación transcripcional de genes inmediato-tempranos. La reacción de 
eliminación del grupo fosfato es generalmente llevada a cabo por la fosfoproteína 
fosfatasa 1 (PP1). 
1.3 Remodelación de la Cromatina 
 Una de las barreras a las que se enfrenta la maquinaria transcripcional 
durante el ensamblaje de la RNA polimerasa II es el acceso al DNA dificultado en la 
estructura de la cromatina. Para salvar este obstáculo, la célula posee familias de 
enzimas remodeladoras de la cromatina, que pueden alterar las interacciones DNA-
histona usando la energía liberada por la hidrólisis del ATP, y facilitar de este modo 
las interacciones necesarias.  
 Todos los complejos remodeladores, poseen una subunidad ATPasa y 
pueden clasificarse, atendiendo al tipo de ésta, en tres subfamilias diferentes: ISWI, 
SWI/SNF y CHD (Table 6). Estos complejos enzimáticos pueden estar además 
asociados a complejos modificadores de la cromatina, como por ejemplo HDACs en 
el caso del complejo remodelador NuRD (Serna et al., 2006).  
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  La regulación de los complejos remodeladores de la cromatina no es todavía 
completamente conocida, pero modificaciones de alguna de sus subunidades, por 
ejemplo por fosforilación, producen cambios en las propiedades del complejo y por 
tanto en su actividad (Becker, 2002).  
2. EL GEN egr-1. 
El gen egr-1 (early growth response-1), también llamado tis8, zif268, ngfi-A 
o krox-24, pertenece a una familia génica que codifica factores transcripcionales con 
motivos de dedos de zinc. La inducción de egr-1 se produce rápidamente en repuesta 
a una gran variedad de estímulos como son: factores de crecimiento, citoquinas, 
hormonas, ésteres de forbol o radiación ultravioleta. La expresión de egr-1 se ha 
relacionado con diferentes procesos biológicos como son el crecimiento, la 
diferenciación celular y la apoptosis (Thiel et al., 2002). Ahí radica justamente su 
importancia como puente entre las señales extracelulares que afectan a la célula y el 
mantenimiento de la homeostasis de la misma mediante la alteración de genes de 
respuesta secundaria. 
El promotor de egr-1 contiene sitios de unión para factores transcripcionales 
como: SRE (elemento de respuesta al suero), ETS (elemento de respuesta a factores 
Ets, como ELK1), CRE (elemento de respuesta al AMP cíclico), caja GC (sitio de 
unión del factor SP1) o EBS (elemento de respuesta a EGR1) (Figure 9). El factor de 
respuesta al suero SRE es un factor transcripcional que se une como dímero a la 
secuencia CC(A/T)6GG y que necesita formar un complejo ternario con el DNA y 
un elemento Ets adyacente para ser activo. Igualmente, el factor CREB es capaz de 
formar dímeros, y dependiendo de la naturaleza de los mismos puede tener función 
activadora o represora. Por ejemplo, cuando dimeriza con CREM actúa como 
represor transcripcional mientras que su interacción con ATF2 o con si mismo le 
otorga un papel como activador (Carlezon et al., 2005). Además, estos factores 
transcripcionales pueden ser modificados mediante acetilaciones y/o fosforilaciones, 
como otro modo de regular sus propiedades de unión al DNA y su actividad. 
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 2.1 EGR1 como factor transcripcional 
EGR1 es una proteína modular de aproximadamente 80 kDa, que tiene un 
dominio activador N-terminal, un dominio inhibidor central y un dominio de unión 
al DNA formado por tres dedos de zinc (Figure 10). El dominio central es capaz de 
unir dos co-factores transcripcionales, NAB1 y NAB2, que modifican la actividad 
biológica de EGR1 transformándolo de activador en represor. Otros miembros de 
esta familia de factores transcripcionales contienen también motivos de dedo de 
zinc, pero difieren en el resto de dominios y, por tanto, ejercen funciones biológicas 
diferentes. 
EGR1 se une a secuencias específicas de DNA, ricas en GC, como son los 
casos 5’-GCG(G/C)GGGCG-3’ (Lemaire et al., 1990 y Cao et al., 1990) o 5’-
TGCGTG/AGGCGGT-3’ (Thiel et al., 2002). Estos sitios de unión son altamente 
similares a aquellos que reconoce el factor SP1 y se han descrito casos en que se 
estable una competencia entre ambos factores por el sitio de unión común 
(Kachigian et al., 1995). 
La regulación de la proteína EGR1 se consigue mediante modificaciones 
post-traduccionales como glicosilación (Hedegen et al., 1998), fosforilación (Huang 
et al., 1998), acetilación (Adamson et al., 2005) y poliadenilación (Simon et al., 
2004). La fosforilación de EGR1 llevada a cabo por la quinasa CKII, parece 
disminuir las propiedades de unión de la proteína y se ha relacionado con la 
activación de genes pro-apoptóticos como p53 (Mora et al., 2005). Sin embargo, la 
acetilación de EGR1 mejora la estabilidad de la proteína y se ha relacionado con la 
activación de genes de proliferación celular.  
En general la proteína EGR1 tiene efectos ambiguos, ya que puede estimular 
o suprimir el crecimiento celular dependiendo de la intensidad de la inducción de 
egr-1 y del gen diana sobre el que vaya a actuar. Por ejemplo, Yu et al., (2004) 
demostraron que EGR1 puede inducir además de apoptosis así como la 
supervivencia celular por medio de la activación del gen p21, en lugar del gen p53. 
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II. OBJETIVOS 
 La regulación génica en eucariotas requiere de múltiples pasos que deben ser 
altamente regulados para asegurar una adecuada respuesta celular a los diferentes 
estímulos que sufre la célula. La comprensión del modo en que dichos mecanismos 
tienen lugar es de gran importancia tanto para el conocimiento básico molecular 
como para la comprensión de diferentes patologías. La acción coordinada de las 
diferentes cascadas de señalización y la unión de factores transcripcionales y de 
complejos enzimáticos modificadores a la cromatina es fundamental para la correcta 
interpretación del código genético. Actualmente, no existe un mecanismo general 
para la regulación génica, puesto que cada gen tiene tanto características 
independientes como generales. 
 Los objetivos del presente trabajo se centran en el estudio de algunos de los 
mecanismos epigenéticos que subyacen a la activación y represión transcripcional de 
genes inmediato-tempranos. 
1- El primer objetivo consistió en la selección de un sistema biológico 
adecuado para el análisis temporal de los diferentes eventos que tienen 
lugar durante la regulación transcripcional. 
2- El segundo objetivo fue el estudio de las diferentes cascadas de señalización 
implicadas en la transducción de la señal desde la superficie celular hasta el 
núcleo regulando el acceso y la unión de factores transcripcionales y de la 
RNA polimerasa al gen o genes de interés. 
3- Del mismo modo, se quiso averiguar qué factores transcripcionales están 
implicados en la expresión de genes inmediato-tempranos, y si esos factores 
están o no sujetos a modificaciones post-traduccionales durante el proceso 
de activación. 
4- Como el DNA eucariótico se encuentra empaquetado con proteínas 
histonas, el estudio de la regulación transcripcional tiene que realizarse 
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 teniendo en cuenta el contexto cromatínico en que se encuentran los 
promotores de los diversos genes. Consecuentemente, nuestro principal 
propósito fue determinar qué complejos modificadores de la cromatina eran 
necesarios para la adecuada regulación de la expresión e intentar 
correlacionar la existencia de dichos complejos con las modificaciones en 
las histonas que tienen lugar durante la inducción de egr-1. Igualmente, se 
intentó establecer la distribución nucleosomal durante la inducción del gen 
para determinar la posible existencia de remodelación nucleosomal. 
5- Puesto que la traducción del gen bajo estudio tiene importantes 
consecuencias se consideró conveniente estudiar alguno de los efectos que 
tendría la falta de su traducción en el sistema biológico de estudio. 
6- Finalmente, mediante la combinación de los resultados obtenidos en los 
objetivos previos, se pretendió postular un modelo de regulación 
epigenética para el gen egr-1 en células MLP29 inducidas con miristato de 
12-O-tetradecanoilforbol (TPA). 
 
III. RESULTADOS Y DISCUSIÓN 
1. SELECCIÓN DEL SISTEMA DE ESTUDIO. 
Para la selección del sistema de estudio se analizó mediante RT-PCR la 
expresión de genes sensores de estrés (gadd 153 y c-fos entre otros) en dos líneas 
celulares: C3H10T1/2 y MLP29 tratadas con arsenito 400 µM (Figure 17). Del 
mismo modo, se probó el nivel de inducción de dichos genes producido por 
diferentes agentes como: el arsenito, el tert-butilhidroperóxido, el TPA o la radiación 
ultravioleta (Figures 19, 20 y 21). Con los resultados obtenidos se eligió como 
sistema biológico más apropiado para los estudios la línea celular progenitora de 
hepatocitos MLP29, como agente inductor el TPA a una concentración 50 nM y, tras 
un rastreo en que se analizó la inducción de diferentes genes (Figure 22), se eligió el 
gen egr-1 para el estudio detallado de su proceso de inducción.  
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2. ANÁLISIS DE LA EXPRESIÓN DE egr-1. 
El análisis de la expresión de egr-1 en células MLP29 tratadas con TPA a 
diferentes tiempos se realizó mediante dos técnicas: la extracción del RNA total y su 
análisis mediante RT-PCR semi-cuantitativa y a tiempo real, y mediante la técnica 
de la RNAPol-ChIP consistente en la inmunoprecipitación de la cromatina a la que 
está unida la RNA pol II y la amplificación a partir del DNA inmunoprecipitado de 
la región codificante del gen bajo estudio.  
Los resultados obtenidos mediante la RNAPol-ChIP (Figure 23A) 
demuestran que egr-1 comienza a expresarse a los 5 min. del tratamiento, alcanza un 
máximo a los 30 min. y a partir de este momento comienza a decrecer hasta que ya 
no se detecta a los 180 min. de la inducción. Por su parte, mediante RT-PCR (Figure 
23B y C) se detecta expresión a los 15 min., con un máximo a los 45 min. Estas 
pequeñas variaciones con respecto a la otra técnica son debidas a que la RNAPol-
ChIP es capaz de detectar la transcripción en tiempo real, mientras que la RT-PCR 
analiza los niveles estacionarios de mensajero, que pueden estar influenciados por el 
metabolismo del mismo. 
3. CASCADAS DE SEÑALIZACIÓN IMPLICADAS EN LA ACTIVACIÓN 
DE egr-1. 
Con objeto de estudiar las cascadas de señalización implicadas en la 
activación del gen egr-1 por TPA se trataron las células MLP29 con inhibidores de 
las diferentes rutas de señalización (MEK1/2, p38, JNK, ERK, PI3K, PKC, NFκB y 
STAT3) durante 1 h y posteriormente se estimularon con TPA durante 30 min. El 
análisis de la expresión de egr-1 mediante RT-PCR y su comparación con las células 
control no tratadas, han permitido implicar a las rutas reguladas por las quinasas 
MEK1/2 y p38 en el proceso de inducción del gen bajo estudio (Figure 24).  
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4. FACTORES TRANSCRIPCIONALES ASOCIADOS AL PROMOTOR DE 
egr-1 DURANTE SU INDUCCIÓN. 
El estudio de los factores transcripcionales asociados al promotor de egr-1, 
requiere como paso previo el análisis bioinformático de los promotores para 
identificar los potenciales sitios de unión de dichos factores a la cromatina. Una vez 
identificados, utilizando el programa TRANSFAC (Figure 25A), se comprobó 
mediante inmunoprecipitación de cromatina (ChIP) la presencia o no de los mismos 
en el promotor de egr-1 in vivo.  Los resultados de los experimentos de ChIP 
realizados a diferentes intervalos de tiempo tras la administración del TPA muestran 
que los factores SRF, ELK1 y CREB se encuentran presentes constitutivamente en 
el promotor del gen (Figure 25B). Por el contrario, el factor SP1 está unido a tiempo 
0, se libera a los 15 min y vuelve a ser detectado en el promotor a los 60 min (Figure 
25B y 28), lo cual le atribuiría un posible papel represor en la inducción de egr-1. El 
análisis de la ocupación de los diferentes sitios de unión de los factores SRF y SP1, 
demuestra que las dos agrupaciones de sitios de unión de SRF (Figure 25A) están 
ocupadas, mientras que para el caso de SP1, únicamente el sitio de unión más 
próximo al inicio de la transcripción estaría ocupado a tiempo 0 (Figures 26 y27). 
Por otra parte, el producto del gen, la proteína EGR1, se une a su propio 
promotor  a los 15 min del tratamiento con TPA, para abandonarlo posteriormente a 
los 60 min (Figure 25B). Otros dos cofactores que se unen al promotor a los 30 min 
de tratamiento son: NAB1 y NAB2 (Figure 25B), que probablemente interactúan 
con EGR1 para activar su dominio represor. Estos resultados sugieren que EGR1 se 
une a su promotor activando la transcripción a los 15 min, para después regular su 
represión a los 30 min con la ayuda de NAB1 y NAB2. 
Debido al hecho de que todos los factores encontrados se encuentran 
presentes en el promotor de egr-1 antes de la inducción, se decidió estudiar si dichos 
factores eran susceptibles de ser modificados por fosforilación, de tal forma que se 
modificase su función y activar en esta forma al gen egr1. Los resultados obtenidos 
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 mediante ChIP muestran que ELK1 se encuentra fosforilado a los 15 y 30 min tras la 
inducción, mientras que CREB sólo aparece con la forma fosforilada a los 15 min de 
la inducción (Figure 28). En ambos casos, cuando se tratan previamente a las células 
con inhibidores de las rutas MEK1/2 y p38, la forma fosforilada de CREB es 
detectada con menor intensidad en el promotor del gen (Figure 29). Con estos 
resultados parece lógico pensar que el TPA induce  egr-1 a través de la activación de 
las rutas de quinasas MEK1/2 y p38, las cuales encargarían de fosforilar, al menos, 
los factores CREB y ELK1 para que puedan actuar  como activadores de la 
transcripción del gen. 
5. ENZIMAS MODIFICADORES DE LA CROMATINA ASOCIADOS AL 
PROMOTOR DE egr-1 DURANTE SU INDUCCIÓN. 
Debido a la importancia de las modificaciones de las histonas como 
mecanismo de regulación de la expresión génica se decidió estudiar, por un lado, si 
existía algún represor que debiera ser sintetizado continuamente y, por otro, qué 
complejos HDAC y HAT se encontraban presentes en el promotor de egr-1. Para 
abordar la primera cuestión,  las células con cicloheximida, un inhibidor de la 
síntesis de proteínas, previo a la estimulación de la  células con TPA. El análisis del 
RNA mediante RT-PCR a tiempo real determinó que las células tratadas con 
cicloheximida tenían una mayor grado de expresión de egr-1 (Figure 30) lo cual 
indicaba la necesidad de síntesis de algún componente para la represión del gen. 
Por otro lado, para detectar la presencia de enzimas modificadores de la 
cromatina, realizamos estudios de ChIP a diferentes tiempos tras el tratamiento con 
TPA. Dichos experimentos revelaron la presencia de dos complejos represores 
HDAC (mSIN3A y HDAC3-NCoR), unidos a tiempo 0 min, que se liberaban 
durante la inducción del gen, para volver al promotor a los 60 min de tratamiento 
(Figure 31). Igualmente, se observó la presencia de dos complejos HAT: CBP y 
GCN5 (Figure 32). CBP se libera del promotor durante la inducción, lo cual le 
otorgaría un papel como posible encargado de mantener el nivel basal de acetilación 
del gen. Por el contrario, GCN5 entra en el promotor entre los 5 y los 15 min, con lo 
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 cual las acetilaciones de las que es responsable podrían tener una función más 
relevante en el proceso de inducción de egr-1.   
En un intento de correlacionar la presencia de estos complejos con las 
diferentes modificaciones que tienen lugar en egr-1 durante la inducción, se 
realizaron experimentos de inmunoprecipitación utilizando anticuerpos específicos 
frente a modificaciones concretas de las histonas. En general, los resultados 
muestran un alto nivel de acetilación basal cuando el gen no se está transcribiendo y 
un claro aumento de las modificaciones H3K9Ac, H3K14Ac, H3K18Ac, H3K27Ac, 
H4K5Ac, H4K8Ac, H4K16Ac y H3K9AcS10P durante la inducción (Figure 37). 
6.   POSICIONAMIENTO NUCLEOSOMAL DEL PROMOTOR DE egr-1. 
Uno de los factores a tener en cuenta durante la inducción de egr-1 es el 
posicionamiento de los nucleosomas que se encuentran presentes en el promotor y 
que pueden facilitar o dificultar la interacción con factores y cofactores necesarios 
para el proceso de expresión del gen. Por este motivo, se analizó la secuencia de 
DNA del promotor de egr-1 con dos programas informáticos diferentes para 
determinar el posible posicionamiento. En ambos casos, es posible detectar una alta 
probabilidad de formación nucleosomal alrededor de las posiciones -200 pb y de -
800 pb en el promotor (Figure 38). Para comprobar experimentalmente estos 
resultados, se utilizó una variación de la técnica descrita por Steward y Sano (2004) 
que se basa en la protección del nucleosoma frente a la digestión por MNasa y en la 
posterior amplificación de los fragmentos protegidos mediante PCR a tiempo real. 
Para la amplificación se utilizan oligonucleótidos cuyos amplicones están solapados 
a lo largo del promotor del gen. De este modo, sólo si el amplicón se encuentra 
dentro del nucleosoma podrá ser amplificado.  
Los resultados obtenidos con los experimentos de protección frente a la 
nucleasa de micrococo apuntan hacía la existencia de 3 nucleosomas posicionados, 
dos de ellos cuya posición coincide con la predicción teórica, y un tercero entre 
ambos, que se encontraría posicionado por el efecto barrera que producirían los otros 
dos nucleosomas posicionados por secuencia (Figure 39). En el caso del nucleosoma 
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 más próximo al inicio de la transcripción, N1, se observa un desplazamiento hacía la 
izquierda durante la inducción de egr-1, es decir a los 15 y 30 min tras el tratamiento 
con TPA, para posteriormente volver a ocupar su posición inicial a los 180 min del 
estímulo (Figure 41).  
En vista de los resultados que argumentan una remodelación del nucleosoma 
N1 durante la inducción, se procedió al estudio mediante la técnica de ChIP de la 
presencia de enzimas remodelantes en el promotor de egr-1. Los resultados 
obtenidos muestran que tanto BRG1 como BRM se encuentran unidas al promotor a 
0 y 5 min tras el tratamiento con TPA, luego se altera su estructura o desaparecen 
del promotor, y finalmente regresan a los 60 min (Figure 40). Estos resultados, 
podrían otorgar un papel represor a estos complejos impidiendo la correcta posición 
nucleosomal para la expresión de egr-1. A pesar de que hasta la fecha no se ha 
establecido que una remodelación nucleosomal esté dificultando la transcripción, sí 
que se han descrito casos en los que BRG1 y BRM forman parte del mecanismo de 
represión de la inducción (Wang et al., 2004). 
7. MODIFICACIONES EN LAS COLAS DE LAS HISTONAS DE LOS 
NUCLEOSOMAS DEL PROMOTOR DE egr-1. 
Para estudiar las modificaciones específicas en cada nucleosoma presente en 
el promotor de egr-1, se realizaron experimentos de ChIP con resolución 
mononucleosomal, en los que se utilizaron anticuerpos frente a modificaciones 
específicas de las histonas H3 y H4. Los resultados obtenidos indican un aumento de 
las modificaciones H3K9Ac, H4K5Ac y H3K4Me3 en los tres nucleosomas 
estudiados, mientras que la H3K9AcS10P parece constante en el nucleosoma N3 y 
aumenta claramente en los nucleosomas N2 y N1. Por el contrario, la 
hiperacetilación de la H4 incrementa en mayor medida en el caso del nucleosoma 
N3 que en el de los otros dos (Figure 45).   
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8. PAPEL BIOLÓGICO DEL FACTOR TRANSCRIPCIONAL EGR1. 
En el sistema biológico estudiado, el gen nab2 se expresa entre los 5 y 60 
min de tratamiento con TPA, como demuestran los resultados obtenidos por 
RNAPol-ChIP (Figure 46A). Por su parte, EGR1 se une, junto con NAB1 y el 
propio NAB2, al promotor del gen egr1 para frenar su inducción a partir de los 30 
min del tratamiento (Figure 46B).  
Para estudiar con mayor profundidad el papel de EGR1, diseñamos una 
secuencia para RNA de interferencia la cual es capaz de reducir la expresión de egr-
1 hasta un 70%. Los resultados obtenidos coinciden al analizar la expresión del gen 
mediante RT-PCR a tiempo real (Figure 47A) y la intensidad de fluorescencia, con 
el programa ImageJ, de las imágenes de microscopio confocal obtenidas al co-
transfectar células con un plásmido que expresa la proteína GFP y un plásmido que 
expresa el RNA de interferencia. La acción del RNA de interferencia de egr1 es 
también capaz de reducir la expresión del gen nab2 (Figure 48) mostrando un efecto 
in vivo de la inhibición de la síntesis del factor EGR1. 
9. HACIA UN MODELO DE INDUCCIÓN DE egr-1. 
Con el conjunto de resultados anteriores, intentamos proponer un modelo de 
los acontecimientos que tienen lugar en el promotor de egr-1 durante su inducción 
por TPA en células MLP29. El modelo sugiere un promotor “preparado” para 
expresarse, en el que todos los componentes se encuentran presentes y que deben ser 
posiblemente modificados, por fosforilación, para ser activos. Además existirían dos 
complejos HDACs co-represores (mSIN3A y HDAC3-NCoR) a tiempo 0 min, , un 
complejo HAT (CBP) que estaría manteniendo el nivel de acetilación basal del 
promotor y dos complejos remodeladores, BRM y BRG1. Una vez las células se 
estimulan con TPA, SP1 se libera del promotor, CREB y ELK1 se fosforilan, el 
nucleosoma N1 se remodela y los complejos mSIN3A, HDAC3-NCoR, CBP, BRM 
y BRG1 abandonan el promotor. En este momento entra otro complejo HAT que 
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 contiene a GCN5 y que se encargaría de acetilar específicamente determinadas 
posiciones de histonas que conllevarían a la inducción del gen. El proceso de parada 
de la expresión de egr-1 estaría regulado por la unión de EGR1 y los dos cofactores 
NAB1 y NAB2 encargados éstos de activar el dominio represor de EGR1. 
Igualmente, a lo largo de este proceso volverían todos los factores y/o complejos 
presentes a tiempo 0 min (Figure 49).  
 
IV. CONCLUSIONES 
1- El gen egr-1 (early growth response-1) se expresa activamente, en diferentes 
líneas celulares como respuesta al tratamiento con TPA. Su patrón de 
expresión comienza a los 5 min,, tiene un pico alrededor de los 30 min, y 
después comienza a decrecer hasta dejar de ser detectable a los 180 min. 
2- Egr-1 puede ser considerado como un gen “potencialmente transcribible”, 
ya que parece estar “preparado” para ser expresado en respuesta al estimulo 
adecuado, como se demuestra porque tanto la RNA pol II como diversos 
factores transcripcionales se encuentran presentes en el promotor en el 
estado basal del gen. Existen dos grupos de elementos de respuesta al suero, 
presentes en el promotor de egr-1, y nuestros experimentos indican que 
ambos están ocupados por SRF. Del mismo modo existen también dos sitios 
de unión para el factor transcripcional SP1,aunque sólo el más cercano al 
inicio de la transcripción parece estar ocupado en nuestro sistema. El resto 
de factores transcripcionales presentes en el promotor (CREB y ELK1) 
deben sen fosforilados para la inducción del gen. Puesto que esta 
fosforilación es eliminada, o al menos disminuida, por los inhibidores de las 
quinasas MEK1/2 y/o p38, capaces de inhibir la expresión del gen, los 
resultados son compatibles con asignar un papel importante a CREB y a la 
formación del complejo ternario (DNA, SRF y ELK1) en la inducción de 
egr-1 en células MLP29 estimuladas con TPA. 
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 3- El factor transcripcional SP1 parece ser el único encontrado en nuestro 
sistema que es capaz de actuar como represor de la transcripción de egr-1, 
ya que durante el proceso de inducción abandona el promotor, como 
demuestran los experimentos de ChIP realizados, y posteriormente, cuando 
comienza el proceso de represión, vuelve a detectarse su presencia en el 
promotor.  
4- El factor EGR1 se une a su propio promotor tras 15 min de tratamiento con 
TPA, lo cual le atribuiría un papel como activador de su propia 
transcripción. Posteriormente, a los 30 min de la estimulación, los co-
represores NAB1 y NAB2 se unen al promotor, interaccionando 
probablemente con EGR1, y activando su dominio represor. 
5- Hemos detectado, al menos, dos complejos histona desacetilasa implicados 
en la represión de egr-1: mSIN3A y HDAC3-NCoR. Ambos complejos se 
liberan del promotor durante el proceso de activación del gen y vuelven 
durante el proceso de represión. Hay también al menos dos complejos 
histona acetiltransferasa implicados en la regulación de egr-1. CBP, cuya 
actividad podría consistir en mantener el nivel basal de acetilación en las 
histonas del promotor del gen, y GCN5, cuya actividad sería más especifica 
del proceso de inducción del gen por TPA. 
6- Cuando se estudian las modificaciones presentes en las histonas del 
promotor de egr-1, se detecta un incremento en H3K9AcS10P, una 
modificación tradicionalmente asociada con la activación de genes 
inmediato-tempranos. Existe además un incremento significativo en los 
niveles de acetilación de las histonas H3 y H4, en particular de ésta última, 
que sólo tiene modificada la lisina 5 en el estado inactivo del gen y que 
durante la inducción se acetilan además las lisinas 8 y 16. Estas 
modificaciones parecen ser específicas de genes inmediato-tempranos, ya 
que están ausentes del promotor de la β-actina, un gen que se  expresa de 
forma constitutiva. 
7- Hemos encontrado que la di- y tri-metilación de la lisina 4 de la histona H3 
está presente a lo largo del promotor y de la región codificante tanto de egr-
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 1 como de la β-actina. Este hecho otorgaría una posible función como señal 
epigenética general de genes transcripcionalmente activos a esta 
modificación post-traduccional.  
8- Existen tres nucleosomas posicionados a lo largo del promotor de egr-1. El 
nucleosoma N1 tiene su centro alrededor de -200 pb, el nucleosoma N2 a  -
510 pb y el nucleosoma N3 sobre los -800 pb. Los nucleosomas N1 y N3 se 
encontrarían posicionados en base a su secuencia, mientras que N2 estaría 
posicionado indirectamente por la acción barrera de los otros dos. El 
nucleosoma N1 se mueve en dirección 5’ durante la inducción del gen por 
TPA y posteriormente vuelve a su posición inicial durante el proceso de 
represión del gen. 
9- Los complejos remodeladores que contienen a BRG1 y BRM han sido 
también identificados en el promotor de egr-1. Su presencia coincide con el 
estado reprimido del gen por lo que se les podría asignar una función 
represora. 
10- La fosforilación específica de factores transcripcionales o de histonas, 
parece ser importante para el proceso de remodelación de los nucleosomas, 
puesto que la inhibición de fosfatasas altera el proceso de remodelación. Por 
el contrario, la metilación de histonas no parece ser indispensable en el 
proceso de remodelación, como demuestra el hecho de que la inhibición de 
PRMT1 y de la modificación que produce, H4R3Me2a, no afecta de manera 
significativamente el posicionamiento nucleosomal. 
11- El análisis mediante ChIP con resolución nucleosomal de N1, N2 y N3, 
revela modificaciones generales en los tres nucleosomas, como son el 
aumento de H3K4Me3, H3K9Ac y H4K5Ac. Por el contrario, la 
modificación H3K9Ac aumenta principalmente en los nucleosomas N1 y 
N2, mientras que el nucleosoma N3 posee el mayor incremento en el nivel 
general de acetilación de la histona H4 y en la acetilación de la lisina 14 de 
la H3. 
12- El factor transcripcional EGR1 regula la expresión de nab2, ya que la 
incubación de células con RNA de interferencia para EGR1 produce una 
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 considerable disminución en la expresión tanto de  egr-1 como de nab2. La 
secuencia 1 utilizada en la construcción del RNA de interferencia para egr-1 
es capaz, por si sola, de disminuir la expresión de egr-1 hasta un 70%, como 
se comprueba mediante experimentos de RT-PCR a tiempo real y por 
análisis mediante el programa Image J de los resultados de confocal de 
células co-transfectadas con un vector que expresa la proteína GFP y un 
vector que expresa el RNA de interferencia para egr-1. 
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